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Preface
Vascular malformations of the central nervous system are challenging pathologies. 
Our knowledge about their biology and natural history is increasing. Diagnostic 
modalities help clinicians to better evaluate the individual cases, and to decide the 
best treatment options. Treatment alternatives are also evolving and clinicians 
are doing their best for each individual patient. The purpose of this book is to 
review the current knowledge about vascular malformations of the central nervous 
 system, to evaluate the treatment alternatives, and to make suggestions for special 
 considerations. We hope the informations gathered in this book will be helpful for 
our readers.
Pınar Kuru Bektaşoğlu, MD
Istanbul Fatih Sultan Mehmet Education and Research Hospital,
Department of Neurosurgery,
Istanbul, Turkey

















Malformations (cAVMs): What Is 
New?
Adel E. Ahmed Ganaw, Abdulgafoor M. Tharayil, 
Moad Ehfeda, Mohamed Hassan Alfared, Qazi Zeeshan,  
Sohel M.G. Ahmed, Ali Ayyad, Ibrahim Naemi, 
Hossam Algallie, Nissar Shaikh and Nabil Shallik
Abstract
Cerebral arteriovenous malformations (cAVMs) are rare congenital anomalies 
of cerebral blood vessels that result from maldevelopment of the capillary bed, 
permitting direct communication between cerebral arteries and veins. It usually 
occurs in the supratentorial area of the brain; however, it can occur anywhere in the 
brain and spinal cord. Most of the patients with cAVMs present with a variety of 
complaints such as seizures, intracerebral hemorrhage, headache, and progressive 
focal neurological deficit. Imaging such as CT, MRI, and angiography plays a vital 
role in diagnosis, grading, risk assessment, and posttherapeutic follow-up. The 
multidisciplinary team use three therapeutic modalities in the treatment of cAVMs. 
This chapter reviews the clinical presentations, diagnosis, classification, and treat-
ment of cAVMs.
Keywords: cerebral angiography, endovascular embolisation,  
focal neurological deficit, headache, intracerebral hemorrhage, microsurgery, 
radiosurgery, seizers
1. Introduction
Arteriovenous malformations (AVMs) are rare congenital anomalies of cerebral 
blood vessels with critical clinical implications. These anomalies may occur any-
where in the central nervous system (brain and spinal cord). It is a neurosurgical 
emergency that is characterized by abnormal vascular web, consisting of a tangle of 
dysplastic vessels (nidus) fed by arteries and drained by veins without intervening 
capillaries, generating a high flow, low resistance shunt between cerebral arteries and 
veins (Figure 1). They are a significant form of vascular malformation, with dilated 
arteries congregating from different directions and distended veins twisting from 
turbulence of shunted blood flow. This gives the pathology its radiological char-
acteristic (early venous drainage) on formal catheter-based cerebral angiography. 
Although cAVMs are considered as a congenital cerebrovascular disease, patients 
may present with intracerebral hemorrhage, convulsions, chronic headache, and 
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progressive neurological deficit. Some of them remain asymptomatic and are noticed 
only incidentally on cerebral imaging for other indications. AVMs are associated with 
a lifelong risk of intracerebral hemorrhage (ICH); therefore, these lesions necessitate 
appropriate assessment, workup, and considerations for treatment based upon many 
factors such as age, size, and location of the lesions [2–5].
2. Epidemiology
The prevalence of cAVMs is very low, and a collection of population-based 
studies from the literature estimates the incidence of cerebral AVMs at 0.69–1.32 
per 100,000. However, they are considered as an important cause of intracerebral 
hemorrhage in a young age group. Bleeding rate is almost 1% per year in previously 
unruptured arteriovenous malformations. cAVMs cause approximately 2–4% of all 
hemorrhagic strokes [2, 4, 6, 7].
They are a congenital disease that is developed from indistinguishable causes 
in developing a fetus. While numerous mechanisms of cAVM formation have been 
suggested, the heterogeneity and lack of inheritance of these pathologies make their 
exact cause to remain idiopathic. They are associated with a few syndromes, such 
as hereditary hemorrhagic telangiectasia, Wyburn-Mason syndrome, von Hippel-
Lindau disease, and Sturge-Weber syndrome [2].
Cerebral AVMs generally occur as a single lesion, and multiple lesions are observed 
only in 9% of the patients. cAVMs are equally distributed between sexes [8, 9].
Patients may present at any age, although they most commonly present in the 
second through fourth decades of life [6, 7].
3. Clinical manifestation
cAVM patients may present with a variety of clinical symptoms such as hemor-
rhage, seizure, headaches, or focal neurologic deficits. The clinical presentations 
of cAVMs depend on the patient’s age, size, location, and vascular features of the 
cAVMs. Some patients are asymptomatic at presentation and cAVMs are accidently 
discovered when imagines are performed for potentially unrelated reasons.
3.1 Hemorrhage
Hemorrhage is the most common initial presentation of cAVMs. Studies 
reported that hemorrhage is the initial presentation in 50% of patients with cAVMs. 
The risk of hemorrhagic stroke in cAVM patients is about 2–5% per year. It is fatal 
Figure 1. 
(A) Normal vasculature, arteries, and veins communicate at capillary bed. (B) cAVM direct communication 
between high-flow arterial vessels and low-resistance venous capacitance vessels. And an arteriovenous 
malformation. Steal phenomenon (blood flow through low resistance shunt (low resistance) and stealing blood 
flow from adjacent brain) [1].
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in 5–25% of all cAVM patients. Children more frequently present with intracerebral 
hemorrhage than do adults. Hypertension, previous intracerebral hemorrhage 
(ICH), AVMs with feeding artery aneurysm, AVMs with multiple arterial feed-
ers, deep-seated cAVMs, and cAVMs with limited venous drainage are associated 
with increased risk of hemorrhagic stroke. Hemorrhage begins in the lesion itself 
and then accumulates, increases in size, and produces a mass effect. Therefore, 
hemispherical lesions generate less severe syndromes in comparison with primary 
hemorrhage that originates from functioning parts of the brain. Hemorrhages in 
polar regions such as frontal, temporal, and occipital regions may cause only minor 
headache, while those in deeper structures affect vital regions packed into tiny 
spaces and produce severe neurological manifestations. Hence, patients with ICH 
may present with a wide span of presentations such as sudden severe headache, 
drop in the level of consciousness, progressive neurological deficits, hemiparesis, 
aphasia, cranial nerve palsy, visual field deficits, and coma [2, 9–11].
The type of the hemorrhage and clinical presentations depend on the location of 
cAVMs. Superficial lesions cause subarachnoid hemorrhage with low risk of cerebral 
vasospasm and the bleeding confined in local sulci, whereas lesions with deep drainage 
may vent blood in the ventricular system, causing hemohydrocephalus. Lesions embed-
ded in the brain parenchyma cause parenchymatous hemorrhage. Figure 2 [11, 13].
3.2 Seizure
Seizures are the second most common presentation of cAVMs; it occurs in 20–29% 
of patients with cAVMs at initial diagnosis. One study showed that the 5-year risk of first 
seizure was 8% (95% CI 0–20). The risk of the seizures rose to 23% in the presence of 
ICH and focal neurological deficit. The seizures are frequently observed in male patients 
with cortical lesions, especially in the frontal and temporal lobe. Large lesions (nidus 
greater than 3 cm in diameter) and superficial venous drainage are associated with 
increase in seizure frequency. Posterior fossa, coexisting aneurysms, and deep locations 
were associated with the absence of seizures. AVM may cause focal or generalized sei-
zures or both. The exact pathophysiology of the seizures is not completely understood. 
However, increased venous back pressure secondary to venous outflow obstruction may 
be involved. cAVM-related seizures may occur secondary to ICH, from the hemosiderin 
deposition, or secondary to venous hypertension, and ischemia following steal. Seizure 
control rate ranges between 49 and 85% according to approach (surgery, radiosurgery, 
or embolisation), and the highest seizure freedom has been achieved in patients with 
approved complete angiographic obliteration after radiosurgery [2, 9, 14].
Figure 2. 
(A) Axial and (B) sagittal plain CT brain of 13-year-old patient presented with sever headache; the scan 
demonstrates right parieto-occipital intra-axial hemorrhage with intra-ventricular extension. Urgent 
craniotomy was done due to deterioration of the neurological status confirming underlying AVM [12].
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3.3 Headache
Approximately 0.2% of cAVM patients present with headache and normal 
neurologic examination. The headache associated with cAVMs is incidental, 
without any specifications. Headache is the presenting symptom in nearly 15% 
of cAVM patients without evidence of rupture. Headache can be characterized as 
similar to migraines with lateralization to one side [11, 13]. The attack occurrence, 
aurae, duration, and pulsatile quality are all shared. Treatment of headache in AVM 
patients has not been studied so far. No specific medication has been exclusively 
useful in headache management. Expert opinions do not recommend using any 
vasoconstrictors in these patients as it may lead to rupture and ICH. However, there 
are limited data to support this recommendation [9].
3.4 Neurological deficit
Neurological deficit is a relatively rare presentation of cAVMs. Patients may 
present with transient, progressive, permanent, or progressive focal neurological 
deficits not secondary to ICH or seizures. Vascular steal syndrome is assumed to be 
the main reason of neurologic deficit. Moreover, recurrent ICH, local mass effect, or 
hydrocephalus may cause neurological deficits [2, 9].
4. Diagnosis of cAVMs
Diagnosis of cAVMs must include a detailed assessment of the nidus and the 
adjacent structures. Plain CT is the initial diagnostic tool for cAVM patients who 
present with one of previously mentioned clinical manifestations, while CT angiog-
raphy or digital subtraction angiography are used to locate the exact site of rupture 
in patients with ICH. Magnetic resonance imaging (MRI) is the recommended 
investigation for patients with nonhemorrhagic manifestations. Digital subtraction 
angiography is the investigation of choice for the characterization of the feeding 
arteries, nidus angioarchitecture, and draining veins and is mandatory for precise 
AVM grading and management planning [2, 4].
4.1 Computerized tomography (CT) and related techniques
CT scan is the first radiological investigation that is performed in patients 
who present with convulsions, focal neurological deficit, or clinical signs of 
ICH. Plain head CT is useful for confirming ICH or assessing abnormal suspi-
cious dilated dural veins, abnormal faint hyperdense cerebral mass, and focal 
cerebral calcification, which are alert signs for the radiologist for the possibility 
of underlying cAVMs; however, negative CT scan cannot be excluding the pres-
ence of cAVMs. Compression of the nidus by hematoma impedes CT diagnosis 
of cAVM in patients with acute ICH. Therefore, CT angiography should be done 
promptly to diagnose the underlying cAVMs. CT angiogram with intravenous 
iodinated contrast media with images acquired by bolus tracking technique is 
very helpful for maximum cerebral as well as cAVM arterial opacification. The 
CT head angiogram is used for confirming the diagnosis, assessing the cAVM 
size, site, number, and origin of feeding arteries and draining vein as well 
as the presence of associated aneurysm and site of bleeding. The high spatial 
resolution of CTA allows the generation of multiplanar reformations, maximum 
intensity projections, and volumetric reconstructions for analysis (Figures 3–5) 
[4, 16, 18].
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Figure 3. 
Plain CT head (A) and CT head angiogram (B) of young adult patient demonstrate right parietal 
parenchyma brain hemorrhage (the arrow on A image) and multiple serpiginous tortuous vascular 
malformation AVM (the arrow on the B image) [15].
Figure 4. 
Plain CT shows hyperdense tortuous structure at lateral ventricular region representing AVM [16].
Figure 5. 
CT head angiogram MIP (maximum intensity projection) axial and sagittal view (A and B respectively) 
demonstrates right occipital lobe AVM supplied mainly by right posterior cerebral artery and drained to 
straight and right transverse dural sinuses [17].
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In recent decades, the radiological equipment has showed visible development 
making us more aware of the pathophysiology of many diseases by using perfu-
sion CT and MRI scan for cAVMs to provide information regarding the blood 
flow abnormality within and around such vascular anomalies by assessing cerebral 
blood flow (CBF),  cerebral blood volume (CBV), and the mean transient time 
(MTT). Through these, we can demonstrate three different forms of extra-nidal 
parenchymal perfusion abnormalities:
1. Functional steal is characterized by redistribution of the blood flow from 
surrounding brain tissue through the arteriovenous malformation that leads 
to disturbance of normal cerebral perfusion. Patients with this phenomenon 
usually present with convulsions. CT scan shows decrease in CBV, CBF, and 
MTT as a result of sump effect from the artery supplying the arteriovenous 
malformation Figures 6 and 7.
Figure 6. 
Normal and Perfusion abnormalities diagram in cAVMs. (A) Illustrate normal brain tissue blood flow. (B) 
Illustrate the abnormal brain tissue blood flow within and adjacent to the AVM. The Black arrow represent 
functional steal region in which the blood shunted away to the nearby AVM. The red arrow representing 
ischemic steal region due to indirect collateral of the near the AVMs. The blue arrow is a brain region drained 
by high pressure veins of AVM leading to venous congestion [15].
Figure 7. 
Illustrate the effect of steal phenomenon in Brain’s AVM on adjacent brain tissue (A) and (B) CT angiograms 
demonstrate right side occipital AVM (arrows). Selected images from brain CT perfusion (C and D) shows 
high CBF (black arrows in C) and CBV (black arrows in D) in the nidus and low CBF (white arrows in C) 
and CBV (white arrows in D) in the perinidal area, suggestive of perinidal ischemia. There is no evidence of 
cerebellar ischemia on the FLAIR (E) and diffusion (F) images. CBF (arrows in G) and CBV (arrows in H) 
are low in the contralateral cerebellar hemisphere, suggestive of cerebellar diaschisis [19].
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2. Ischemic steal is characterized by a reduction in CBF and CBV with increased 
MTT in the brain parenchyma secondary to indirect collateral flow to the shunt 
from nearby arteries. These patients usually present with a focal neurological 
deficit.
3. Venous congestion is characterized by increased CBV and MTT in remote 
parts of the brain as a result of the high-pressure flow in the draining veins of 
the AVM. These patients may present with progressive neurological deficits 
[4, 15, 16, 18].
4.2 Magnetic resonance imaging (MRI) of the brain and related techniques
MRI of the brain is very sensitive for the exact determination of the cAVM 
nidus location and an associated draining vein; it also has exclusive sensitivity in 
determining remote bleeding due to these lesions. On noncontrast brain MRI, the 
cAVM nidus is seen as signal void on T2-weighted images with dilated feeding 
arteries and draining veins, and susceptibility-weighted imaging can detect the 
presence of hemosiderin component of chronic bleeding as low signal intensity. 
The ischemic and brain steal area can appear as hyperintense T2 weighted and 
FLAIR. MRA also could be used to add crucial information regarding the feeding 
arteries, draining veins, and the presence of associated aneurysm, which appear 
Could be gained from CT perfusion (CTP). The same pathophysiological infor-
mation that could be gained from CTP can also be done by MRI perfusion using 
noncontrast ALS (arterial spine labeling) technique or with the usage of contrast 
media Figures 8 and 9 [2, 4].
MRI of the brain is especially valuable in follow-up patients after treatment. 
After radiosurgery, MRI is essential to follow up regression of the nidal volume. 
While the MR angiography is very useful to characterize the venous drainage and 
other vascular features, the adjacent tissue that is exposed to the radiation field can 
be precisely observed for posttherapy edema or radiation necrosis [4, 16].
4.3 Digital subtraction angiography (DSA)
Digital subtraction angiography is the gold standard for assessment of nature 
and number of the feeding arteries, presence of flow-related aneurysms, quality of 
venous drainage, associated varices, and stenosis.
Figure 8. 
MRI brain of an adult patient T2-weighted image A and SWI (susceptibility weighted image). B demonstrates 
right temporal T2WI and DWI serpiginous hypointensity representing AVM [20].
Vascular Malformations of the Central Nervous System
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Two types of feeding arteries that can be identified by DSA are as follows:
1. Direct arterial feeders: they end in the AVM; it is either large cortical arteries 
or small perforator coursing through white matter or ventricles.
2. Indirect arterial feeders: they supply the AVM through small branches that 
arise from the involved but also pass to healthy brain tissue distal to AVM.
Flow-related aneurysms in the feeding arteries usually result from amplified 
shear stress and considered as an indicator of vascular friability and hemor-
rhage risk. These aneurysms may resolve following curative treatment of the 
AVM. Intranidal aneurysms are usually small, less than 3 mm, and pseudoaneu-
rysms and can be successfully treated with embolisation.
The AVM nidus may have both fistulous and glomerular compartments; the 
fistulous compartments form high-flow shunt that can be treated with endovascu-
lar therapy, while the glomerular compartments form an intervening network of 
pathological vessels and are very difficult to treat with embolisation.
Assessment of the venous part of AVM is critical and should include the 
anatomy of drainage (superficial, deep, or mixed) and characteristics of the 
venous outflow (focal stenosis, venous pouches, and sinus stenosis or occlu-
sion). Drainage into the deep venous system is associated with a high risk of 
bleeding and indicates deep location that may make surgical intervention 
difficult [2, 4].
Figure 9. 
MRI T2-weighted image A&B and MRA brain C&D images the brain demonstrate T2 weighted signal void 
serpiginous structure at left inferior parietal lobe; on MRA, images show the nidus fed by arterial feeder 
from left middle cerebral artery and drained to superficial cortical veins to left transverse sinus [16].
11
Cerebral Arteriovenous Malformations (cAVMs): What Is New?
DOI: http://dx.doi.org/10.5772/intechopen.90096
5. Grading of cAVMs
Before starting the management of cAVMs, all management risks should be 
considered, starting from those associated with diagnosis, surgical intervention, 
radiotherapy, to interventional radiology. Treating physicians should also consider 
both early and late complications such as hemorrhage and convulsions. There are 
many grading systems that may help physicians to assess the risk of these com-
plications, take appropriate intervention for each patient, predict prognosis, and 
standardize patient’s evaluation for scientific study purposes [21–23].
5.1 Spetzler-Martin (S-M) grading
In 1986, Spetzler and Martin introduced the most commonly used grading scale 
for cAVMs; it uses three anatomical features of AVM (nidus size, nidus location 
relative to the eloquent brain (Figure 10), and pattern of venous drainage) to gener-
ate five cAVM grades (Table 1).
To determine S-M grade of cAVMs, size of the nidus, venous drainage, and 
eloquence of adjacent brain tissue are determined in angiography, brain CT scan, and/
or MRI of the brain. A numerical value is assigned for each category, as described in 
Table 1. The grade is derived from adding the points awarded for each category; for 
example, for grade I, the lesion would be small (less than 3 cm/1 point), in nonelo-
quent region (0 point), and have only superficial drainage (0 point) (Figure 11); 
therefore, excision of such lesion would be complete, minimally invasive, and 
associated with low surgical complications. Whereas for grade V, the lesion would be 
large (more than 6 cm/3 points), sited within or immediately close to eloquent brain 
Figure 10. 
The anatomic areas considered neurologically eloquent. (A) Deep eloquent area (hypothalamus, thalamus, 
brain stem, and cerebellar peduncle). (B) Eloquent area in cerebral cortex (sensory-motor, primary visual, 
and language area) [19].
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(1 point), and venous drainage would drain into deep venous system (Figure 12), so 
excision of such lesion is extremely difficult and associated with significant risk of 
bleeding and surgical morbidity and mortality. Moreover, obliteration of large cAVMs 
leads to sudden increase in perfusion, which leads to vasogenic edema or hemorrhage 
(normal perfusion pressure break through phenomenon). There are certain lesions 
that should not be considered for surgery such as large AVM that invades eloquent 
critical area or diffuse nidus that involves crucial structure such as hypothalamus or 
brain stem (Figure 13), so the surgical resection of such lesions would necessarily 
be associated with significant neurological deficit or death. These AVMs are graded 
under separate category (grade VI) and considered as inoperable AVM [22, 23].
The S-M grading scale was introduced to predict the outcome of surgical resec-
tion but can also be used to predict the radiosurgical outcome. Lower grades (grades 
I and II) are associated with a good result and less postoperative neurological deficit 
in comparison with grades IV and V [21–23].
Multiple retrospective studies showed that rates of poor outcome were highly 
correlated with S-M grade. Precisely, rates of poor outcome were calculated as 
follows: S-M grade I = 4% (95% CI, 2–7), S-M grade II = 10% (95% CI, 7–13), S-M 
Figure 11. 
Grade I AVM; (A) Vertebral angiograms. (B) Anteroposterior view cerebellar AVM less than 3 cm (1 point), 
superficial on cerebellar cortex (0 point), superficial drainage (through superficial cerebellar hemisphere 
veins–arrows: 0 point) [19].











Spetzler-Martin (S-M) grading scale is used to make decisions about treatment risks.
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grade III = 18% (95% CI, 15–22), S-M grade IV = 31% (95% CI, 25–37), and S-M 
grade V = 37% (95% CI, 26–49). These results prove that microsurgical resection 
is suitable for low-grade cAVMs (S-M grades I and II), whereas surgical resection 
of high-grade cAVMs (S-M grades IV and V) is associated with a high risk of poor 
patient outcome. Lawton and Davies et al. subcategorized grade III into three 
groups based on a specific combination of the same anatomical features (size, loca-
tion, and venous drainage) to improve prediction of treatment outcome:
Group 1: Patients with S-M grade III cAVMs (a combination of small size, elo-
quent location, and deep venous drainage) have surgical outcomes similar to those 
of S-M grades I and II.
Figure 12. 
Grade VAVM; (A) Carotid angiogram, arterial phase. (B) Venous phase, AVM greater than 6 cm (3 points), 
situated in corpus callosum with a deep thalamic component (eloquent: 1 point), draining into a hugely dilated 
internal cerebral vein (deep drainage–arrow 1 point) [19].
Figure 13. 
Grade IV AVM (inoperable AVM), (A) Vertebral angiogram, anteroposterior view. (B) Lateral view, 
arterial phase this lesion fed by multiple vessels from rostral basilar artery, surrounding and invading the 
mesencephalon [19].
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Group 2: Patients with S-M grade III cAVMs (a combination of medium size, 
noneloquent location, and deep venous drainage) have a poor surgical outcome 
similar to that of S-M grades IV and V.
Group 3: Patients with S-M grade III cAVMs (a combination of medium size, 
eloquent location, and superficial venous drainage) have a poor surgical outcome 
similar to that of S-M grades IV and V [23].
Supplementary grading scale to traditional S-M grading scale was proposed in 
2010 to enhance its predictive power for predicted outcomes after surgical resec-
tion of cAVMs. This supplemental scoring system added three factors that affect 
patient’s outcome (age, hemorrhagic presentation, and nidus configuration) 
(Table 2). The supplementary grading scale named Lawton-Young supplementary 
grading scale has been authorized in a separate cohort of 1009 patients [21, 23].
6. Treatment of cAVMs
Complete resection or obliteration of the nidus and AV shunt is considered as 
the treatment of choice of cAVMs. Incomplete nidal resection does not decrease 
hemorrhage risk. However, There are few reports of partial resection may improve 
neurological symptoms in patients who have neurological symptoms related to 
hemodynamic. There are three complementary therapeutic techniques that have been 
developed to achieve these goals (microsurgery ± embolization, stereotactic radio-
surgery, and embolisation). The treatment plans of cAVMs should be carefully taken 
by a multidisciplinary team of knowledgeable and skilled physicians. They should 
take the size, location, and vascular features of the AVM in consideration. Moreover, 
risks of significant complications such as short- and long-term hemorrhage risk, 
feasibility, associated aneurysm, patient’s age, risks of intervention, availability of 
interventional radiologist, and size and compactness of the nidus should be assessed. 
The short- and long-term hemorrhage risk is associated with a history of raptured 
cAVM, patient age, AVM location, size, and vascular morphological features [23–25].
Children and young adults have a long life expectancy, and the risk of intrace-
rebral hemorrhage (ICH) is gradually increasing over the years. Therefore, curative 
therapy and complete obliteration are recommended whenever possible, while 
conservative treatment may be considered for elderly patients. The cumulative risk 
of hemorrhage can be calculated by the formula: lifetime risk of hemorrhage = 1 – 
(1 − P) × N (N is the expected years of life remaining, and P is the annual probabil-
ity of hemorrhage). Another more straightforward formula is as follows: lifetime 
risk of hemorrhage = 105-patient’s age in years.
Size of cAVM Point Patient’s age
0-3 cm 1 <20
3.1-6 cm 2 20-40
>6 cm 3 >40







Supplementary Spetzler-Martin or Lawton-Young cAVM grading scale.
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6.1 Microsurgery
Craniotomy and surgical resection of cAVMs were first introduced in the 1920s, 
where the outcomes were inferior. The development of angiography played an 
essential role in understanding vascular anatomy and hemodynamics of AVM 
lesions. The introduction of microsurgery and bipolar diathermy has resulted in 
significant improvement of morbidity and mortality in comparison to the early 
known surgical resections. Microsurgical excision of cAVMs is considered as the 
most efficient approach as it offers the best chance of immediate cure and elimi-
nates morbidity and mortality associated with its potential rupture. Before taking 
patients to the operating theater for surgical resection, preoperative angiogram 
and MRI should be done for intraoperative stereotactic localization of the lesion. 
Moreover, endovascular embolisation has frequently been considered to improve 
surgical safety and to possibly magnify the pool of cAVMs amenable to safe surgical 
resection. The main goals of endovascular embolisation are elimination of arterial 
feeders (particularly those that would be challenging to access in early stages of 
surgical intervention), decrease of nidus volume that would warrant safer surgical 
resection, and management of high-risk angiographic characters such as feeding 
artery and intranidal aneurysms.
Essential steps in the resection process of AVM are wide dural opening, identi-
fication of AVM lesion, elimination of superficial feeding arteries, circumferential 
resection of the nidus with control of deep arterial pedicle, and transection of 
draining veins. When all arterial feeders to the nidus have been determined and 
coagulated, the direct venous drainage can be blocked and the nidus resected. 
Intraoperative vascular imaging, such as DSA, is beneficial to confirm complete 
nidus resection at the time of surgery. Furthermore, indocyanine green videoan-
giography with either fluorescein or indocyanine can be very useful to intraopera-
tively map the angioarchitecture of the lesions, including distinguishing arterial 
feeders from arterialized draining veins.
The surgeons should vigilantly inspect the resection bed microscopically to 
make sure that hemostasis has been achieved, during which the blood pressure 
is maintained at 15–20 mm Hg above the baseline. Oxidized cellulose (Surgicel) 
can be used to line the nidus bed, and the patient’s goal blood pressure should be 
maintained within the normal range for the first 24 hours after surgical resection.
Although the microscopic complete nidus resection has long-term durability and 
leads to abrupt elimination of hemorrhage risks, it is an invasive intervention and 
associated with neurological risks [23, 25].
6.2 Stereotactic radiosurgery (SRS)
Radiosurgery is typically reserved for the obliteration of compact cAVMs 
(less than 3 cm) in patients who are poor surgical candidates either radiographi-
cally (Spetzler-Martin grades >III) or due to existing medical comorbidities. SRS 
promotes endothelia cell proliferation, gradual, concentric vessel wall thickening, 
and ultimately luminal closure. Numerous studies about efficiency and safety 
of radiosurgery indicated that radiosurgery seems to be suitable for small-to-
moderate volume lesions (less than 12 cm3 in volume or less than 3 cm in maximum 
diameter). Furthermore, radiosurgery is best suited for injuries situated in deep 
or eloquent regions of the brain. The primary goal of SRS is the obliteration of 
cAVMs. With obliteration, the risk of hemorrhage from cAVM nidus is eliminated. 
Complete obliteration of cAVM nidus after SRS is associated with fading of cAVM-
associated epilepsy as well as improvement of nidus-associated neurological signs 
and symptoms.
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Most series with long-term follow-up show obliteration in 70–80% of cAVMs 
and it is achieved within 2–3 years after starting stereotactic radiosurgery (Table 3) 
[17, 20]. The time between starting radiosurgery and complete obliteration is named 
the latency period; it varies from 1 to 3 years. During this latency period, the risk 
of hemorrhage ranges between 1 and 3% per year. The outcome of radiosurgery has 
been affected by many factors such as age, nidus volume, preceding embolisation, 
and previous hemorrhage. Therefore, all these factors should be considered before 
deciding to proceed with radiosurgery.
Though preceding endovascular embolisation may shrink large nidus to a 
suitable target volume for SRS as well as eradicate high-risk characters associated 
with cAVM such as perinidal or intranidal aneurysms, it may lead to difficulties 
in precisely targeting residual nidus and reducing successful obliteration rates 
after SRS.
Radiosurgery is not entirely safe; during latency period, symptomatic changes 
secondary to radiation occur in 10 percent of the patients. However, permanent 
neurological changes are reported only in 2–3% of patients.
The main risk factors for symptomatic changes secondary to radiations are the 
location of AVM, target volume, and dose to surrounding healthy tissue (margin 
dose). The symptomatic changes secondary to radiation effect can be reduced with 
corticosteroids and bevacizumab.
Delayed cyst formation and radiation-induced neoplasia are uncommon 
although may occur after 10 years from radiosurgery [23, 26, 27].
6.3 Embolisation
Endovascular embolisation plays a crucial role in multidisciplinary approach to 
treat cAVMs. Embolisation may be considered in the following scenarios:
6.3.1 Preoperative embolization
The primary goal of preoperative embolisation is to facilitate surgical resec-
tion of cAVMs and reduce complication rates of microsurgery. It is instrumental 
in the reduction of intraoperative bleeding and postoperative complications 
such as healthy perfusion pressure breakthrough. The healthy brain tissue sur-
rounding cAVMs exposes to chronic low perfusion pressure. When the lesion is 
wholly or partially resected, these areas are suddenly subject to normal perfusion 
pressure, and their autoregulation ability may be impaired. Therefore, a sudden 
increase in perfusion pressure may lead to brain edema, delayed hemorrhage, 
and seizures. Large cAVMs should go through staged embolisation to gradually 









Ding et al 444 2013 Retrospective 86 Month 
(mean)
62 1.6 2





Pollock 174 2013 Retrospective 64 month 
(mean)
78.9 Not reported 4
Table 3. 
Radio-surgical outcomes for unruptured cAVMs [23].
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reduce flow to the AVM before resection. Moreover, preoperative embolisation 
may be useful in the elimination of feeding artery pedicles that may be deep and 
not accessible [23, 28, 29].
6.3.2 Curative embolisation
The role of endovascular embolisation as a stand-alone treatment in AVM has been 
reported in small case series. The introduction of detachable-tip microcatheters plays a 
vital role in improvement of curative embolisation rates as it facilitates extended Onyx 
infusion. Small lesions with few arterial feeders are most suitable for complete curative 
embolisation. However, most of these lesions are graded as S-M grades I and II, for 
which microsurgery is considered as the best therapeutic approach. Therefore, the rela-
tive risk of curative embolisation must be weighed cautiously against this traditional 
therapeutic approach. The durability of embolic materials and the length of follow-up 
are needed to establish a complete cure. AVM recurrence after successful complete 
angiographic elimination has been reported in various case reports [23, 30, 31].
6.3.3 Before radiosurgery
Embolisation before radiosurgery is commonly used when cAVM nidus is greater 
than 3 cm in diameter to reduce the size of the nidus. However, embolisation may 
lower rates of successful obliteration, most likely due to the artifact effect of the 
radiopaque embolic interfere with targeting the lesion [23, 32].
6.3.4 Targeted embolization
Targeted embolisation is used to treat high-risk angiographic features such as 
nidal and perinidal aneurysms and arteriovenous fistulas that may lead to rupture 
of AVM [33].
6.3.5 Palliative embolization
Infrequently, cAVMs may cause focal neurological deficits as a result of vascular 
steal or local venous hypertension. In these situations, decreased venous hyper-
tension and steal by embolisation of select, high-flow feeders may improve focal 
neurological deficit and quality of life. However, there is no substantial evidence to 
support this approach and further studies are needed [23, 34, 35].
6.3.6 Complications of embolization
Stroke and ICH are the most common complications of endovascular embolisa-
tion. The ischemic stroke is most likely secondary to thromboembolic complications 
of catheterization and nontarget embolization, while ICH may occur secondary 
to vascular injury or AVM rupture. Arterial feeders’ injury and perforation occur 
when a microcatheter or wire is introduced through tiny tortuous pial arteries. 
Accidental closure of draining veins before elimination of the nidus during emboli-
zation may cause nidal rupture and ICH [23, 35, 36].
7. Conclusion
Cerebral arteriovenous malformations (cAVMs) are rare congenital disease. 
However, they are considered as a significant cause of hemorrhagic stroke in 
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children and young adults. They account for 33% of intracerebral hemorrhage 
in young patients. Although it is congenital disease, patients with cAVMs mostly 
present in their second and fourth decades of life. Intracerebral hemorrhage is the 
most common presentation of AVM patients. Imaging such as CT, MRI, and angiog-
raphy is advantageous in diagnosis, grading, risk assessment, and posttherapeutic 
follow-up. cAVMs are graded by many grading systems. However, Spetzler-Martin 
grading and supplementary Spetzler-Martin grading scales are the most important 
grading scales as they can be used to assess risk of postoperative complications and 
therapeutic outcomes. Therefore, they are beneficial in deciding best therapeutic 
approach for each patient. There are three therapeutic modalities for management 
of cAVMs. The multidisciplinary team approach is the best for management of 
cAVM patients. The surgical excision of cAVM gives definitive therapy in cAVM 
patients. Radiosurgery is a curative approach in selected cAVM patients, and 
embolisation is rarely used as a sole therapy. It is usually used as adjunctive therapy 
to microsurgery and SRS.
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Aneurysmal subarachnoid hemorrhage is an important group of intracranial 
hemorrhage with a high risk of disability and mortality. The initial amount of 
bleeding, rebleeding, and delayed cerebral ischemia are considered as the most 
important factors in determining the prognosis of aneurysm-induced bleeding. 
In arteriovenous malformations, its location and deep venous drainage play a 
role in the prognosis. Cardiac complications, neurogenic pulmonary edema, 
hypertension, hyperglycemia, infections, and prolonged mechanical ventila-
tion in aneurysmal subarachnoid hemorrhage lead to morbidity and mortality. 
Aneurysm bleeding control, appropriate fluid replacement to ensure euvolemia, 
when necessary external ventricular drainage and/or decompressive craniectomy, 
mannitol or hypertonic saline application, and infection control are the main 
principles of treatment.
Keywords: aneurysmal subarachnoid hemorrhage,  
cerebral arteriovenous malformation, cerebral vasospasm, delayed cerebral ischemia, 
intracranial pressure
1. Definition and etiology
The modern definition of cerebral artery aneurysms began in 1874 with Duret’s 
description of the middle cerebral artery (MCA). It is known that 20% of all 
aneurysms are composed of MCA aneurysms and 90% of aneurysms originate 
from anterior circulation. It is more common in women aged 35–60 years [1]. 
Subarachnoid hemorrhage (SAH) is a major health problem worldwide with a high 
mortality rate. Despite a 17% decrease in case fatality in the last three decades asso-
ciated with improved management strategies, 30-day mortality and sudden death 
rate unfortunately are still high, around 35 and 15%, respectively [2].
Cerebral arteriovenous malformations (AVM) are composed of a complexity of 
abnormal arteries and veins and are a major source of brain hemorrhage, resulting 
in morbidity and mortality, representing a diagnostic and therapeutic challenge in 
young adults. Cerebral AVM generally represents 1 and 3% of the total annual risk 
for epilepsy and bleeding in patients with AVM. The rate risk of bleeding in undam-
aged AVMs is 2.2% per year, and the rate of torn lesions is 4.5% per year. Important 
risk factors for the development of bleeding due to AVM include deep localiza-
tion, deep venous drainage, associated aneurysms, pregnancy, age, and gender. 
Disconnection of arteriovenous malformations from circulation and prevention 
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of epileptic seizures remain the mainstay of treatment. The size, location, and 
presence of deep venous drainage (using the Spetzler-Martin score) determine the 
mortality and management of the arteriovenous malformations.
The most common causes of aneurysm remain hemodynamic instability, 
degenerative changes, vascular injury, atherosclerosis, vasculopathy, high flow, 
arteriovenous malformation, and fistula. In addition, the important risk factors 
for the development of cerebral aneurysms are hypertension, smoking, chronic 
alcohol use, family history of intracranial aneurysms in first-degree relatives, and 
female sex. Autosomal dominant polycystic kidney disease is an inherited sys-
temic disorder that is strongly associated with intracranial aneurysms. Autosomal 
dominant polycystic kidney disease has a prevalence rate 2–4 times higher than 
the general population. Other conditions such as Marfan syndrome, Ehler-Danlos 
syndrome type IV, neurofibromatosis type I, hereditary hemorrhagic telangiectasia, 
Moyamoya disease, pseudoxanthoma elastum, and fibromuscular dysplasia are 
weakly associated with intracranial aneurysms. Multiple aneurysms are detected in 
10–30% of cases. Both localization and type of aneurysm are important consider-
ations in describing the risk for rupture. Aneurysm rupture is directly proportional 
to size, and ruptured aneurysm causes subdural, subarachnoid, or intracranial 
hematoma. 25% of the cases with ruptured aneurysm are lost and 50% of them have 
partial or complete recovery. Overall incidence of mortality and complications in 
ruptured aneurysm is 80%. Risk factors for the formation of and rupture of intra-
cranial aneurysms are shown in Tables 1 and 2 [1, 3, 4].
Aneurysms are classified according to their shape or size.
According to the shape:
1. Saccular (traumatic, mycotic, oncotic, flow-dependent vasculopathy, drug-
induced).
2. Fusiform.









Risk factors for the rupture of intracranial aneurysms.











Risk factors for the formation of intracranial aneurysms.
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3. Dissecting.




4. Super giant (>50 mm).
Saccular berry aneurysms account for 90% of the total aneurysm morphology, 
and their rupture is the most common cause of SAH. Fusiform aneurysms account for 
the remaining 10%, and their most common location is posteriorly. Atherosclerosis 
and dissection are found to be responsible as possible mechanisms for formation of 
fusiform aneurysms.
2. Clinical presentation of subarachnoid hemorrhage
The most common clinical reflection of aneurysm is SAH; it can occur in several 
ways: headache, bilateral temporal hemianopsia and bilateral lower limb weakness, 
unilateral nerve palsy, facial or orbital pain, nosebleed, progressive vision loss 
and/or ophthalmoplegia, and symptoms of brain stem dysfunction. Patients with 
complex middle cerebral artery aneurysms may present with intracranial hemor-
rhage, mass effects, epilepsy, or cerebral ischemia; in addition, the aneurysm may 
be incidentally discovered. A high mortality rate of 65–85% within 2 years has been 
reported, and aneurysm rupture survivors are often left with severe neurological 
deficits [5–9].
In the presence of rupture, aneurysmal SAH may cause coma in 20–30% of 
patients. In “poor-grade” patients, neurologic findings may include extensor pos-
turing and loss of upper brain stem reflexes, and further progression may occur in 
hours from the ictus. A wide light-fixed pupil may indicate oculomotor palsy from 
a ruptured posterior communicating aneurysm or lateral brain stem displacement 
from a hematoma in the temporal or frontal lobe. Pinpoint pupils may indicate the 
presence of an acute hydrocephalus with ventricles often filled with blood. The 
causes of coma after aneurysmal SAH are shown in Table 3.
The severity of SAH is clinically assessed and graded using either the Hunt 
and Hess classification or the World Federation of Neurosurgeons (WFNS) scale 
(Tables 4 and 5). The WFNS, widely used, is a combination of focal neurological  
deficits and the Glasgow coma scale (GCS). Higher grades on both scales are 
• Diffuse ischemic global cortical injury
• Early cerebral edema
• Acute hydrocephalus
• Hematoma in the temporal lobe and brain stem shift
• Hematoma in the pons
• Nonconvulsive status epilepticus
Table 3. 
Causes of coma in aneurysmal subarachnoid hemorrhage.
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associated with the worst outcomes. The WFNS classification provides a more 
objective assessment. The first computerized tomography scan uses the Fisher grad-
ing scale to determine the amount, localization, prognosis, and severity of bleeding 
(Table 6). The risk of vasospasm is high in patients with Grade III and IV SAH.
The overall mortality in patients with SAH is over 30%, and approximately 
10–20% of survivors show functional dependence despite intensive neurological care. 
Several extensive studies have been conducted to improve intensive neurological care 
in patients with SAH [12]. Poor-grade aneurysmal SAH (WFNS Grades IV and V) 
Grade Clinical description
0 Unruptured aneurysm
1 Asymptomatic or minimal headache and slight nuchal rigidity
2 Moderate/severe headache, nuchal rigidity, cranial nerve palsy
3 Drowsiness, confusion, or mild focal deficit
4 Stupor, severe hemiparesis, vegetative disturbance
5 Deep coma, decerebrate rigidity, moribund appearance
Hypertension, diabetes, arteriosclerosis, chronic pulmonary disease, or vasospasm assigns patient to the next less 
favorable category.
Table 4. 
Modified Hunt and Hess classification [13].








World Federation of neurosurgeons scale.








I Focal thin 21% Focal or diffuse 
thin SAH, no IVH
24%
II Diffuse thin SAH 25% Focal or diffuse 
thin SAH, with 
IVH
33%
III Thick SAH present 37% Thick SAH present, 
no IVH
33%
IV Focal or diffuse thin SAH 
with significant ICH or 
IVH





Fisher and modified fisher grading scale.
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reflect 20–30% of all aneurysmal SAH. Mortality is commonly associated with neu-
rological injury resulting from the initial bleeding and rebleeding and from delayed 
cerebral ischemia (DCI). The volume of initial hemorrhage and initial neurological 
status following SAH remain major factors for mortality. Elderly patients and patients 
with coexisting medical conditions are at higher risk. The clinical goal is to prevent 
rebleeding and DCI [13–15].
In general, the prognosis of aneurysmal SAH is considered to be inversely related to 
grading at first presentation. Aggressive early interventions such as emergency surgical 
clip application or endovascular treatment of the aneurysm can lead to positive out-
comes in poor-grade aneurysmal SAH patients. Subarachnoid hemorrhage patients can 
be followed with conservative treatment without invasive intervention. External ven-
tricular drainage is a frequently preferred method in the case of hydrocephalus which 
can be observed during this clinical follow-up. In a multicenter, prospective observa-
tional study conducted with 324 patients, the relationship between the potential clini-
cal risk factors and the prognosis of aneurysmal SAH in intracranial aneurysm patients 
was investigated. Results showed that age, female gender, ventilated respiratory status, 
pupil dilatation, low GCS, WFNS grade, intraventricular hemorrhage, higher Fisher 
grade, higher Modified Fisher grade, and a relatively poor outcome in aneurysmal SAH 
patients receiving conservative treatment play a major role. There are many studies 
showing that age has a strong relationship with clinical outcomes in aneurysmal SAH 
patients [16–23]. Global cerebral edema occurs in up to 57% of patients suffering from 
subarachnoid hemorrhage and is associated with prolonged hospital stay and poor 
outcome. The pathogenesis of brain injury after intracerebral hemorrhage is thought 
to be due to mechanical damage followed by ischemic, cytotoxic, and inflammatory 
changes in the underlying and surrounding tissue. Typically, a sudden rise in intra-
cranial pressure at the moment of rupture reduces cerebral perfusion globally in both 
hemispheres and results in marked ischemic changes. Intraventricular extension of the 
hemorrhage and hydrocephalus may be a cause of coma, and thus, an improvement 
may be seen after ventriculostomy [3, 24, 25].
3. Delayed cerebral ischemia
Rebleeding after SAH remains one of the most serious early complications; 
the reported incidence is up to 15% in the first 24 hours, and the mortality rate is 
approximately 70% [26–28]. Prognosis is closely related to initial bleeding, rebleed-
ing, and DCI. The presence of intraventricular and intracerebral hemorrhage also 
adversely affects prognosis. Cardiac symptoms and neurogenic pulmonary edema 
are considered indicative of SAH severity. Hypernatremia after SAH is considered 
as a poor neurological marker. DCI generally begins approximately 3 days after 
bleeding, and its most severe presence is 1 week after bleeding. Smoking is con-
sidered as a risk factor for the development of DCI. The mechanism of DCI is not 
completely known, but the degree of initial bleeding is likely to be multifactorial 
with the severity of a function. It is also known that DCI occurs in cerebral regions 
without signs of angiographic vasospasm. The general recommendation is that 
angiographic vasospasm should not be treated in the absence of DCI.
DCI is usually treated by administration of nimodipine, via effect of maintenance 
of normal circulating blood volume and induced hypertension. Nimodipine is a cal-
cium antagonist, and its oral administration is useful in the treatment of vasospasm 
and DCI. IV application of nimodipine is not recommended. High-dose IV nicardip-
ine (0.15 mg/kg/hr for 14d) has been shown to reduce symptomatic vasospasm but 
not positively affect the 3-month neurological outcome in a prospective double-blind 
randomized controlled trial [4, 29–35].
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The clinical goal is to prevent rebleeding and DCI, because, in patients with 
SAH, DCI is considered the most important preventable cause of death and poor 
neurological prognosis. Delayed cerebral ischemia affects up to 30% of patients 
and leaves the majority of survivors with motor deficits, cognitive dysfunction, and 
reduced quality of life. The risk of developing DCI is associated with the severity of 
initial bleeding [36].
In patients with GCS 8 or less with intracranial hemorrhage, endotracheal 
intubation should be considered to protect the airway or to clear tracheal secretions. 
Intubation should be performed with a rapid induction with minimal effect on 
hemodynamics and not increasing intracranial pressure. Drugs used in induction 
should be preferred accordingly (e.g., propofol). It should be remembered that 
propofol may cause a drop in blood pressure. Preventive isotonic liquid bolus should 
be applied if necessary. Post-expiratory positive pressure (PEEP) up to 12 mmHg is 
considered safe as long as the mean arterial pressure is maintained [37].
4. Factors determining prognosis in subarachnoid hemorrhage
The prognosis after SAH may vary from severe disability to death, depending 
on the complications usually seen in the first 2 weeks associated with the severity of 
bleeding.
Common causes of this deterioration include neurological events such as hydro-
cephalus, seizures, ischemia, and systemic conditions, such as fever and infections, 
respiratory failure, and electrolyte abnormalities. The level of consciousness is 
considered the most important early predictor of outcome. For these reasons, 
patients presenting with a GCS score of less than 13 have traditionally been defined 
as having poor-grade SAH (classified as grade 4 and 5 according to the Hunt and 
Hess or the WFNS grading scales 5 or more recently as VASOGRADE-Red 6). Brain 
injury refers to the acute consequences of SAH-associated sudden increase of intra-
cranial pressure (ICP), which can cause decreased cerebral perfusion and transient 
global cerebral ischemia. The global cerebral ischemia can result in transient loss of 
consciousness or progressive intracranial hypertension [2, 38–41].
5. Complications and current treatment approaches
During aneurysmal SAH, extravasation of high-pressure arterial blood in the 
subarachnoid space is associated with a sudden ICP increase that, if severe and 
sustained, may compromise cerebral perfusion, causing global cerebral ischemia 
and early brain injury. Recently, the treatment of hypertension in intracranial 
hemorrhage patients has been discussed with INTERACT and ATACH training. The 
American Heart Association/American Stroke Association and Neurocritical Care 
guidelines include mean arterial blood pressure monitor, unsafe aneurysm types, 
and 110 or 160 mm Hg (or both) of the systolic blood bridge. Remember to keep it 
below 180 mm Hg. After aneurysm treatment, these parameters should not be made 
in such a way that spontaneous high blood pressure may be beneficial [29, 42–44].
Intracranial hypertension (ICP of at least 20 mm Hg) is a relatively common 
complication of SAH, especially in patients presenting with poor neurological con-
dition. Multiple factors such as cerebral edema, intraparenchymal hematoma, acute 
communicating hydrocephalus, intraventricular hemorrhage, aneurysm rerupture, 
complications related to aneurysm treatment, early brain injury, and DCI may con-
tribute to the development of intracranial hypertension. High ICP is associated with 
severe regulation of brain metabolism, increased risk of neurological deterioration, 
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and poor outcome, particularly in the absence of medical treatment. An ICP greater 
than 20 mm Hg is considered as an independent predictor of severe disability and 
death in aneurysmal SAH. Critical cerebral perfusion pressure levels (less than 
70 mm Hg) are significantly associated with cerebral infarction after SAH [45–51].
If the autoregulation mechanism is intact when intracranial pressure rises, the 
body tries to keep the cerebral blood flow (CBF) constant. As the ICP rises, the brain 
perfusion pressure drops. Systemic vascular resistance decreases, and vasodilata-
tion occurs at the limits of autoregulation to keep CBF stable. Cerebral blood flow is 
mainly regulated by arterial carbon dioxide tension (PaCO2). Abnormal PaCO2 levels 
are considered to cause major changes in CBF through vasoconstriction and vasodi-
lation, respectively, possibly contributing to further brain injury [52–56].
Main management principles of intracranial hypertension after SAH are tradi-
tionally guided by the literature on traumatic brain injury, due to high numbers. 
It should be noted that pathophysiology is completely different in our scenario. 
The role of therapies such as hyperosmolar agents, hypothermia, barbiturates and 
decompressive craniotomy is not clear in SAH patients with intracranial hyperten-
sion resistant to first-line therapies. The first approach to elevated ICP is cerebral 
venous drainage, normoventilation (PaCO2: 35–40 mm Hg), and positioning bed 
height from 30° to 45°. During sedation and aspiration of tracheal secretions and 
physiotherapy, neuromuscular blocking agents should be added if necessary. 
However, the role of these drugs for ICP management has not been fully estab-
lished, and some authors report that they may be more harmful than useful [57].
The use of hyperosmolar agents, such as mannitol and hypertonic saline, are 
current popular options in the treatment of high ICP in SAH.
Studies have shown that hypertonic saline is effective in controlling ICP and 
improving cerebral blood flow. The last treatment steps at highly resistant ICP 
include barbiturate, induced hypothermia, and decompressive craniectomy. 
Therapeutic hypothermia has been shown to be effective in controlling ICP in SAH 
but has not been shown to be associated with improved functional outcome and low 
mortality rates.
There are studies showing that hypertonic saline is more effective than man-
nitol in lowering ICP in traumatic brain injury. But however, there is no specific 
recommendation to select hypertonic saline or mannitol as the first line for patients 
with high ICP caused by traumatic brain injury [58–66]. Recent literature reports 
effectivity of hypertonic saline like mannitol in reducing of ICP in SAH. However 
further studies are needed to evaluate safest and optimal dose concentration and 
impact on improvement of outcomes.
Decompressive craniectomy, an important approach in refractory ICP in SAH 
patients, is often discussed in patients with poor prognosis. Decompressive crani-
ectomy has been associated with decreased mortality, significant decrease in ICP, 
increased cerebral oxygenation, and increased cerebral metabolism in many stud-
ies. However, severe disability or death was also observed in patients undergoing 
decompressive craniectomy for refractory ICP [67–72].
The hemodynamic approach, known as triple H therapy, has played a very 
important role in SAH treatment for many years. However, its safety and efficacy 
are discussed due to complications that may develop. In patients with SAH, a bolus 
normal saline fluid application is known to increase cerebral blood flow in areas 
of cerebral ischemia. The main purpose of fluid treatment in SAH is to maintain 
euvolemia and normal circulating blood volume. It should be noted that uncon-
trolled hypervolemia and hemodilution do not improve cerebral oxygen formation 
and may cause adverse events [73–77].
Noradrenaline perfusion may be added to the treatment to provide normotension 
in cases where appropriate blood pressure is not achieved despite fluid replacement 
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or in conditions limiting fluid therapy such as heart failure. If the pathology persists 
after blood pressure therapy in neurological examination, intravenous angioplasty 
or salvage therapy with intravenous infusion may be helpful. Prophylactic use of 
angioplasty is not recommended. Cardiac complications after SAH may vary from 
benign electrocardiogram changes to cardiogenic shock. Positive troponin value is 
common after SAH and is considered a good indicator of left ventricular dysfunc-
tion, which increases the risk of hypotension, pulmonary edema, and cerebral 
infarction. Treatment is symptomatic and most patients have spontaneous recovery 
within 2 weeks. However, aggressive ICU management may be necessary for severely 
impaired left ventricular functions. Dobutamine, levosimendan, milrinone, and even 
an intra-aortic balloon pump may be added to the treatment to maintain cerebral 
blood flow. It is known that the risk of heart failure and pulmonary complications is 
much higher in patients with low-grade SAH. Hypovolemia and pulmonary edema 
are known to increase the risk of delayed cerebral ischemia in this patient group. 
Long-term intensive care hospitalization may be required in SAH patients. This may 
result in pulmonary complications such as hospital-acquired pneumonia, cardiogenic 
or neurogenic pulmonary edema, aspiration pneumonia, and pulmonary embolism, 
which occurs in approximately 30% of patients.
Acute respiratory distress syndrome occurs in 27% of SAH patients and is an 
independent predictor of outcome. However, diuretics can be dangerous because 
of the risk of brain ischemia caused by hypovolemia. Early pulmonary edema and 
late pulmonary edema after SAH are caused by heart failure and inflammatory (i.e., 
non-cardiogenic) conditions, respectively.
Measurement of extravascular lung water index, cardiac index, and pulmonary 
vascular permeability index with Pulse Contour Cardiac Output (PiCCO) is consid-
ered to be useful in the identification of pulmonary edema in SAH patients [78–95]. 
Neither statin therapy nor magnesium infusions should be initiated for delayed cere-
bral ischemia. Cerebral vasospasm is just one component of delayed cerebral edema.
Hyponatremia is common in subarachnoid hemorrhage and is associated with 
longer hospitalization time, but not increased mortality. Sodium abnormalities are 
common and carry a risk of poor prognosis in acute SAH patients. We performed a 
10-year observational sodium study. Hyponatremia was defined as serum sodium 
(sNa) concentration below 135 mmol/L, whereas hypernatremia as sNa above 
150 mmol/L. Our 10-year targeted sodium management regimen in acute SAH 
patients showed that dysnatremias were frequent, predominantly hyponatremic 
state, due to cerebral salt wasting syndrome (CSW) and not syndrome of inappro-
priate antidiuretic hormone secretion (SIADH). Hypernatremia was shown to be 
an independent risk factor for inpatient mortality and poor outcome. The standard 
sodium protocol lowered the frequency of SIADH, which was encountered in only 
one patient over 5 years. However, it did not significantly reduce the incidence and 
outcome improvement of hyponatremia. Hypernatremia occurred more often and 
had a higher mortality and worse outcome than hyponatremia, but these patients 
were neurologically worse upon its onset. Hyponatremia is the most common 
electrolyte imbalance that occurs in 50% of patients after SAH. Two mechanisms 
are accepted for hyponatremia after SAH: CSW and SIADH. Cerebral salt wasting 
syndrome and SIADH have different pathogenesis. However, it is not always easy to 
distinguish in the clinic, and they can be observed in the same patient [96–100].
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Abstract
Cerebral arteriovenous malformations (cAVMs) are the rare neurosurgical 
emergency. cAVM is an abnormal vascular web, composed of nidus, feeding artery 
and draining veins. It commonly occurs in the supratentorial area of the brain. The 
common grading system used in cAVM is Spetzler-Martin grading, which takes into 
consideration the size of nidus, the location of cAVM and the venous drainage. The 
cAVMs may develop flow and pressure-related aneurysms, which will increase the 
morbidity and mortality in these patients. cAVMs vary in size and undergo growth, 
remodeling and rarely regression. Most of the cAVMs are asymptomatic, but the 
common presentation are headache, seizure, intracerebral hemorrhage or focal 
neurological deficit. The cerebral angiography remains the gold standard for the 
diagnosis of cAVM. Management of the cAVM includes medical therapy, surgical 
excision, radiosurgery and embolization.
Keywords: cerebral angiography, headache, embolization, focal neurological deficit, 




Cerebral arteriovenous malformations (cAVMs) are the vascular abnormality 
composed of a complex, tangled web of afferent arteries and draining veins linked 
by an abnormal dysplastic intervening capillary bed or no capillary bed (Figure 1). 
The raptured cAVM is a neurosurgical emergency requiring team management 
approach including neurosurgeons, neuro-interventional radiologist, neuro- 
anaesthesiologist and an intensivist.
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2. Epidemiology
Cerebral arteriovenous malformations are rare, found in around 0.1% of the 
population and one-tenth (1/10th) of the incidence of the brain aneurysms. 
About 15% of cAVMs remain asymptomatic based on autopsy series. The 
majority (90%) of cAVMs are found in the supratentorial region, the remain-
ing 10% occur in the posterior fossa. cAVMs commonly occur as single lesions, 
and in 9% of the patients, there are multiple AVMs [1, 2]. cAVM has no gender 
preference.
cAVM causes subarachnoid hemorrhages in 9% of the patients. The mean age of 
presentation is 30–40 years; 3% of young patients had stroke due to cAVM. It also 
causes primary intracerebral hemorrhage in 33% of young adults [3].
3. Classifications
cAVM is classified as follows:
1. Luessenhop-Gennarelli anatomical grading
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3. Nataf grading (Table 3)





Location of cAVM: eloquent areas (sensorimotor, language, visual, thalamus, hypothalamus, internal capsule, 
brain stem, cerebellar peduncles and deep cerebellar nuclei)
Non-eloquent brain area 0




AVM grade = size + eloquence + deep component
Table 1. 
Spetzler-Martin grading scale for cAVM.











Supplementary Spetzler-Martin or Lawton-Young cAVM grading scale.
Grade I No risk factor for bleeding
Grade Ia With venous recruitment
Grade Ib Without venous recruitment grade
Grade II Venous stenosis or venous reflux
Grade III Deep venous drainage only
Grade IV Intra- or juxta-nidal aneurysm
According to this grading system, there is 13% of hemorrhage in grade Ia, in grade Ib 38%, in grade II 48% and in 
grade III and IV risk of hemorrhage 90% [7].
Table 3. 
Nataf grading.
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3.1 Luessenhop-Gennarelli grading
This is the anatomical grading of supratentorial cAVM described in 1977, 
according to the degrees of surgical difficulty for total obliteration, graded into I–IV. 
Luessenhop-Gennarelli grading of cAVM is based upon the number of directly 
participating arteries for which there is a standardized nomenclature [4].
3.2 Spetzler-Martin (S-M) grading
In 1986 Spetzler and Martin graded cAVMs according to location, size and deep 
venous drainage, into the following five grades [5]:
1. Low-grade AVM: Grade I, grade II and grade III
2. High-grade AVM: Grade IV and grade V
3. Inoperable lesions: Grade VI (supplementary Spetzler-Martin (S-M Supp)).
The disadvantages of S-M grading of cAVM are definition of eloquence, lack 
of consideration for nidus compactness, not useful for posterior fossa AVM, only 
applicable for surgical outcome and grade III in homogeneity.
Supplementary Spetzler-Martin or Lawton-Young grading scale for cAVM was 
described in 2010, apart from the risk factors included in S-M grading; this S-M 
Supp grading system includes factors affecting the patient’s outcome, namely, age, 
bleeding or compactness of the cAVMs (Table 2) [6]. Kim et al. from their cohort 
multicentre study concluded that S-M Supp grading system works better than the 
S-M grading for operability decisions and cut-off value for operability is S-M Supp 
scale of 6. S-M Supp also gives better post-operative neurological outcome predict-
ability than the S-M score.
3.3 Nataf grading
In this 4-point grading, five angiographic parameters are used for the determi-
nants of the bleeding risk.
3.4 Vienna classification
This classification is helpful in choosing the mode of treatment.
4. Morphology and type cAVM
Depending on the type and morphology, cAVM (Figure 2) is divided into the 
following (Tables 5 and 6):
Gr 0 Gr I Gr II Gr III
Feeders Pial Pial + perforators Perforator
Number of feeders 1–2 >2
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5. Pathophysiology
The pathogenesis of cAVMs is not well understood; they are considered con-
genital and can undergo growth, remodeling or regression over the period. The 
Figure 2. 
Details of cAVM and associated aneurysms.
Cryptic Absent on angiogram/surgery/pathology
Occult Absent on angiogram/surgery/seen only in pathology examination







Type Nature Pathological features of the 
vessel wall
Treatment modality






arising from the 
arterial trunk
Disruption of IEL, deficiency in 
the smooth muscle layer
The aneurysm and the 
parent artery were occluded 




Segmental ectasia Stretched/fragmented IEL: no 
luminal thrombus
Coiling for symptomatic 
lesion
Unrelated Saccular, arising 
from the Willis 
circle or a site of 
bifurcation
Disruption of the IEL Simply coiling or stent-
assisted coiling
Table 6. 
Classification of aneurysm with cAVM [8].
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size of cAVMs varies widely, and cAVM can remain clinically silent for decades. In 
cAVM blood flows directly between them without capillary bed and not interven-
ing neural parenchyma in nidus. cAVMs is a high-flow and high-pressure system. 
Particularly the small AVMs are having significantly higher pressure in the feeding 
arteries; hence the small AVMs are more lethal than the larger ones and bleed more 
frequently.
Familial cAVMs have been reported, but it is not clear whether these are coin-
cidental or indicate a familial occurrence. Angio-architecture of cAVMs is direct 
arterial to venous connections without an intervening capillary network. Both the 
arterial supply and the venous drainage may be by single or multiple vessels. The 
high-flow arteriovenous communication potentiates a variety of flow-related phe-
nomena such as the development of afferent and efferent pedicle aneurysms, which 
occur in 20–25% of patients, and arterialization of the venous limb. Aneurysms 
can be a source of bleeding with cAVMs and may indicate a grave prognosis [9]. 
Abnormal flow and a vascular steal phenomenon have been suggested to underlie 
some clinical symptoms associated with cAVMs [10]. Histopathological stud-
ies demonstrate areas of chronic ischemia and gliosis in the region of the cAVM 
malformation. Angio-structure of cAVM is typically composed of arterial feeder, 
nidus, draining vein and intervening gliotic neural parenchyma. The arterial feeder 
can be single or multiple originating from pial or perforating or dural arteries, and 
it can be a direct feeder supply as terminal branch or indirect feeder supply en-
passage. Nidus is a compact tangle of dysplastic, thin-walled vessels of varied length 
connecting feeding arteries to draining veins. cAVM nidus can either be globular 
or conical in shape and may be compact or diffuse. Within the nidus, arterial blood 
is shunted directly into draining veins without passage through a normal, high-
resistance arteriolar-capillary network.
6. Clinical presentation
cAVMs commonly present in younger age group ranging from 10 to 40 years. 
The clinical presentation of cAVM depends on the patient’s age, size, location and 
vascular features of the cAVM. These patients commonly present with headache or 
neurological deficit or convulsions or intracerebral hemorrhage.
6.1 Headache
Around 0.2% of patients with headache and normal neurologic examina-
tions were associated with cAVM [11]. Usually headache associated with cAVM 
is incidental, without any specifications. Headaches are the presenting symptom 
in approximately 15% of patients without evidence of rupture. Headache can be 
characterized as similar to migraines with lateralization to one side.
6.2 Focal neurologic deficit
This is quite an unusual presentation of cAVM. A vascular steal syndrome is 
hypothesized to be the cause for focal neurologic deficit [1].
6.3 Seizure (convulsions)
About 11–33% of cAVM patients present with convulsions, and patients with 
cortical-located, large, multiple and superficial-draining cAVMs present with 
convulsions [12]. Convulsions are focal, simple or partial complex with secondary 
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generalization. cAVM-related seizures may occur due to the overt intracranial 
hemorrhage, from the hemosiderin deposition, or secondary to venous hyperten-
sion, ischemia following steal. The cAVM location influences the seizure type and 
semiology. The 5-year seizure risk for cAVMs is found to be 8% [13].
6.4 Intracerebral hemorrhage
About 41–79% of cAVM patients present with intracerebral hemorrhage (ICH) 
(Figure 3). Children more frequently present with intracerebral hemorrhage than 
adults [14]; 23% of patients with ICH or focal neurologic deficits had a 5-year risk 
of seizures. Hemorrhage can be parenchymal, intraventricular or subarachnoid.
Patients with cAVMs can have ICH on initial presentation. The deep venous 
drainage and deep brain location of cAVM had higher incidence of ICH, a recurrent 
AVM hemorrhage of 12% over an average with an average rebleeding rate of 7% 
annually [15]. Pregnancy is not a risk factor for hemorrhage from a cAVM, but the 
data are not definitive [16]; cAVM hemorrhage rate in pregnant women was not 
significantly different compared with the rate for non-pregnant women [17].
7. Diagnosis
Imaging studies are essential for the establishment of the diagnosis of cAVM, to 
make a pre-therapeutic evaluation of the cAVM to help in decision-making, to treat 
the AVM as a sole therapy or a multidisciplinary approach. It also helps in post-
therapeutic evaluation of cAVM.
7.1 Computerized tomography (CT) of the brain
The CT of the brain is the first imaging procedure used to rule out hemorrhage. 
cAVM is suspected in young patients with lobar hematoma without significant 
oedema and calcifications. The parenchymal calcifications are found in 20% 
of cases, related to intravascular thrombosis or evolution of an old hematoma. 
Figure 3. 
Graphic representation of intracerebral hemorrhage.
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The compression of the nidus by hematoma precludes CT diagnosis of cAVM in 
patients with acute intracerebral hemorrhage; in these patients CT angiography and 
magnetic resonance angiography are essential.
7.2 Magnetic resonance imaging (MRI) of the brain
MRI of the brain is highly sensitive for the location of the cAVM nidus and an asso-
ciated draining vein; it also has a unique sensitivity in demonstrating remote bleeding 
related to these lesions. MRI of the brain is particularly valuable in follow-up patients 
after treatment. After radiosurgery MRI is important for the regression of the nidal 
volume. Whereas the MR angiography techniques can characterize the venous drainage 
and other vascular features, the surrounding tissue that is subjected to the radiation 
field can be accurately monitored for post-therapy oedema or radiation necrosis [18].
7.3 Cerebral angiography
It is the gold standard for the diagnosis, treatment planning and follow-up after 
treatment of cAVMs. The anatomical and physiological information of the cAVM 
nidus, its relationship to surrounding vessels and localization of the draining or 
efferent portion of the cAVM are readily obtained with this cerebral angiography. It 
will also help in demonstration of associated aneurysm suggesting a lesion at higher 
risk for subsequent hemorrhage. The contrast transit times provide additional use-
ful information regarding (Figure 4).
8. Treatment
The treatment plans of cAVM are most appropriately made by a multidisci-
plinary team of experienced clinicians with the consideration of size, location and 
vascular features of the AVM [19]. While making the decision, whether a patient 
should undergo AVM treatment, several factors have to be considered including the 
short- and long-term risk of hemorrhage, feasibility, associated aneurysm, patient’s 
age, risks of intervention, availability of interventional radiologist and size and 
compactness of the nidus. The short-term and long-term hemorrhage risk is associ-
ated with a history of raptured cAVM, patient age, AVM location, size and vascular 
morphological features.
Figure 4. 
Cerebral angiogram showing cAVM.
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The three types of modalities of treatment are microsurgery and excision of 
cAVM, embolization and stereotactic radiosurgery. It’s frequent that these modali-
ties are used in combination to achieve the complete treatment. In a systemic 
review, it was found that available treatment modalities were associated with risks 
including 5.1–7.4% of the median rate of permanent neurologic complications or 
death and incomplete efficacy of 13–96% [20]. Medical management of cAVM is 
considered when the patient has suffered a devastating neurological deficit; cAVM 
is very extensive, located deep in the brain, with blood supply primarily from 
deep perforating vessels, which are not amenable to endovascular or radiosurgical 
therapy, advanced age and poorly controlled comorbidities. We will discuss these 
modalities in the following subheadings.
8.1 Microsurgical cAVM excision
Microsurgical AVM excision is the most effective treatment of cAVM; it has 
the longest history of use for the definitive treatment of cAVMs and offers the 
best chance of immediate cure in patients at high risk of hemorrhage [19]. Factors 
associated with increased surgical risk are large size, deep venous drainage, deep 
location, diffuse nidus and feeders from deep perforating system. Surgeons 
should follow few basic surgical principles, cAVM excision should be an elec-
tive procedure, irrespective of the ruptured or unraptured cAVMs, preoperative 
steroids, anticonvulsants and antibiotics to be started, a wider craniotomy and 
dural opening, if the nidus is below the surface, an arterialized draining vein (red 
vein) can be followed to the AVM, localization may be assisted with ultrasound or 
frameless stereotaxic, dura should be open carefully, circumferential dissection 
of the nidus layer by layer, at least one major draining vein should be preserved 
till end of dissection, at end of dissection this vein becomes bluish proving that 
feeders have been eliminated, securing the individual vessels can be done with 
low power bipolar coagulation, but care should be taken as the excessive bipolar 
coagulation usage can cause retraction into eloquent tissue leading to the signifi-
cant neurological morbidity. The complete AVM excision should be documented 
by post-op angiogram. Excision of the whole nidus is necessary to protect against 
rebleeding. If cAVM are high-flow, preoperative embolization should be consid-
ered, and cAVM supplies with multiple vascular territories may require a surgical 
staging. If cAVM are ectatic, high blood flow and irregular vessels will help in the 
identification. The feeding arteries (Table 7) can be distinguished from draining 
veins not by sight or look, as the veins will have arterial blood but by noting if the 
distal vessel collapses with gentle occlusion of the vein. The surgeon should always 
secure the feeding artery as close to the nidus as possible to ensure that this is not 
a passage artery feeding the normal brain, unless there is definite evidence on an 
angiogram that an artery is a direct nidus feeder.
Size Vein dilates considerably, the vessel >4 mm is a vein unless proven otherwise
Color Due to oxygenated blood, both appear red, but on careful view under illumining microscopy, 
the vein appears bright red due to thin muscular layer, and the artery appears light pink
Flow on 
occlusion
Upon gentle compression of the vein, it will collapse distally unlike the artery
Vascular 
course
Arteries dive into sulci and fissure when veins rise to the surface towards sinuses
Table 7. 
Differentiation of the artery from the vein in cAVM.
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8.2 The morbidity and mortality of microsurgical excision of cAVMs
According to Castel and Kantor, morbidity and mortality after microsurgical 
excision of cAVM vary from 1.5 to 18.7% and from 0 to 15%, respectively [21]. 
Morbidity is high (20%) in deep-seated cAVM compared to the smaller cAVM with 
morbidity of up to 9% (Tables 8 and 9).
8.3 Stereotactic radiosurgery for cAVMs
High-energy beams of photons or protons to a defined volume containing 
cAVM nidus are stereotactically focused, and it induces progressive thrombosis of 
lesions by fibrointimal hyperplasia and subsequent luminal obliteration (Figure 5). 
The time between treatment and obliteration is referred to as the latency period, 
and it varies from 1 to 3 years. One has to wait for radiosurgery till the hematoma 
resolves. The factors influencing the obliteration rate of cAVM are cAVM size, 
target determination, angio-architecture and haemodynamics, cAVM location 
(hemispheric better) and radiation dosage. Stereotactic radiosurgery for cAVMs has 
disadvantages of the risk of hemorrhage in latency period and individual variability 
to radiosensitivity and neurological deficit.
The neurological deficit after radiosurgery is observed in 5.37% of the cases, 
and it was permanent in 1.46%. The mortality was 1.6%, and it is mainly due to the 
bleeding in the latency period [24].
The other complications after radiosurgery are radiation necrosis, which causes 
new neurologic deficits and seizures, and around 8% of the patients develop the 
parenchymal lesions, cranial nerve deficits, seizures, headaches and cyst formation 
[25]. The incidence of complications is related to cAVM location and the volume 
treated. Thalamic, basal ganglionic and brainstem locations are prone to develop-




Retrograde thrombosis of feeding vessels
Resection of eloquent brain
Normal perfusion pressure breakthrough (haemorrhage in normal brain tissue surrounding the lesion)
Table 8. 
Complication of microvascular surgery.






(Heros RC, Korusure K, Diebuild PM.  Surgical excision if cerebral arteriovenous malformations. Neurosurgery. 
1990;26:570-577).
Table 9. 
Spetzler-Martin grading and patient’s outcome after microsurgery [22, 23].
51
Cerebral Arteriovenous Malformation from Classification to the Management
DOI: http://dx.doi.org/10.5772/intechopen.86659
the radiation dose directed to the surrounding tissue and is increased in large brain 
AVMs that require larger treatment volumes [27]. Repeated radiosurgery is associ-
ated with increased complications [28].
8.4 Embolization
A rapidly evolving technique uses embolic agents such as silk, Histoacryl with 
Lipiodol and Onyx and delivery systems such as balloons with calibrated leaks, 
flow-guided micro-catheters and over-the-wire micro-catheters (Figure 6). It was 
used initially as an adjunct to microsurgery or radiosurgery; nowadays in selected 
cases, embolization is a sole treatment modality. By embolization less than 5% of 
cAVMs are cured.
Embolization can be an effective adjunct to radiosurgery and surgery. 
Embolization prior to radiosurgery is used to reduce the nidus size of large 
brain AVMs as the large AVMs have a lower cure rate with radiosurgery alone. 
Embolization prior to surgery is employed to reduce blood loss and to occlude 
Figure 5. 
Percentage of cAVM obliteration according to the nidus size (mm) by radiosurgery [25].
Figure 6. 
Embolization process.
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vessels that may be difficult to control during surgery [29]. Pre-embolization ste-
roids and anti-epileptic medications should be started; the procedure is done under 
general anesthesia. The aims of cAVM embolization could be curative or palliative, 
and it could be partial prior to the radio- or microscopic surgery. Careful analyses of 
angiographic information including size, eloquent location, deep versus superficial 
venous drainage and vascular anatomy/number of feeders are considered for the 
suitability for embolization of cAVMs.
The cAVM embolization can be complicated into partial occlusion, intracranial 
hemorrhage, brain ischemia, glueing of micro-catheter or perfusion pressure 
breakthrough syndrome. Perfusion pressure breakthrough syndrome occurs in 
approximately 5% of the patients, thought to be related to the loss of autoregulation 
causing oedema or hemorrhages in the surrounding normal brain tissues [30]. The 
successful cAVM embolization occurs in 10–40% of the patients and may have to be 
done in the multiple settings.
To summarize the treatment of cAVMs, the following factors have to be consid-
ered: the patient’s age and anatomic and vascular morphology of the cAVM.
8.5 Patient’s age
It is an important factor in the decision to treat cAVMs. Those with a longer life 
expectancy will accrue a higher lifetime risk of hemorrhage. Accordingly therapy is 
recommended for children and young adults, whereas the older cAVM patients with 
shorter life expectancies may be managed more conservatively. The cumulative risk 
of hemorrhage in cAVM patients can be calculated by the formula [31]: Lifetime risk 
of hemorrhage = 1 – (1 − P) × N (N is the expected years of life remaining, and P is 
the annual probability of hemorrhage). Another simpler formula is as follows: [32] 
Lifetime risk of hemorrhage = 105 - patient’s age in years.
8.6 cAVM location
cAVM in eloquent brain territories presents a challenge for risk assessment. 
Significant clinical morbidity is likely to result if a surgical complication occurs as 
well as if the cAVM ruptures. Such patients may be more likely to be considered for 
radiosurgery.
8.7 Deep venous drainage
Deep venous drainage is a risk factor for surgical complications as well as for 
AVM rupture. If the lesion is otherwise amenable for treatment, radiosurgery may 
be the best option.
8.8 The cAVM size
Larger lesions are more difficult to treat but are not clearly at higher risk of 
bleeding than smaller lesions. cAVMs greater than 6 cm are managed conserva-
tively. In patients with large lesions, the endovascular treatments may be useful 
to reduce the size of the aneurysm, if the vascular anatomy is determined to be 
amenable to this approach.
8.9 Associated aneurysm
The treatment of aneurysms associated with AVMs varies depending on aneu-
rysm location and diameter [33]. When believed to be the source of hemorrhage, 
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aneurysms are generally treated with surgery or endovascular therapy, depending 
on their location and size, according to the expertise of the available experienced 
clinicians. Aneurysms associated with unruptured cAVMs do not necessarily 
require treatment, depending on their size and other anatomic features.
Spetzler-Martin grading scale: Spetzler-Martin grading scale classifies surgical 
risk of removing cAVM according to its size, location and the presence of deep 
venous drainage. According to S-M grading, surgery is the modality of choice for 
grade I and II lesions, with radiosurgery as an alternative for small lesions based on 
location or other vascular anatomic features, while grade IV and V lesions are gener-
ally managed conservatively. S-M Supp grading gives a cut-off scale of 6 for opera-
bility of cAVM, and it is also a better predictor for post-cAVM excision neurological 
outcome. Hafez et al. [34] nicely described that apart from the S-M Supp grading, 
perforates play an important role in cAVM patient’s outcome (Table 10) [35].
9. Conclusion
Cerebral arteriovenous malformations are rare and 10 times less frequent than 
the cerebral aneurysms. cAVMs are rare in the posterior fossa and account for 33% 
of intracerebral hemorrhage in young patients. They are classified by four differ-
ent ways, but the commonly used classifications are Spetzler-Martin grading and 
supplementary Spetzler-Martin grading, as they also help in deciding the therapeu-
tic approach. But it is not much useful in dealing the posterior fossa cAVMs. cAVMs 
can complicate into the formation of flow-related aneurysms and, according to their 
locations in relation to the cAVM, are classified into intranidal, distal, proximal or 
unrelated aneurysms. Angio-structure of cAVM is the direct connection between 
arterial and venous circulations without any intervening capillary network, and this 
makes cAVM high in flow and pressure structure at the risk of rapture.
The common presentation of cAVM is with intracerebral hemorrhage, with con-
vulsions and rarely with focal neurological deficit. The most commonly used imag-
ing modality for the diagnosis of cAVMs is computerized tomography. MRI scan 
has a unique sensitivity for the detection of remote hemorrhage, and conventional 
catheter cerebral angiography remained a gold standard in diagnosis of cAVMs. 
Multidisciplinary team approach is the best for management of cAVM patients. The 
surgical excision of cAVM gives definitive therapy in cAVM patients, radiosurgery 
is curative in selected cAVM patients and cerebral angiographic embolization is 
Microsurgery Radiosurgery Embolization
Low procedural invasivity 1 3 2
Occlusion capacity 3 2 1–2
Speed of efficacy 3 1 2–3
Long-term reliability 3 3 2–3
Independent from size 2 1 3
Independent from brain functionality 1 2 3
Independent from angio-architecture 2 3
Independent from flow 3 2 1
1: no/low, 2: medium, and 3: yes/high.
Table 10. 
Factors for selecting the modalities of therapy in cAVM patients [34].
Vascular Malformations of the Central Nervous System
54
Author details
Nissar Shaikh1*, Aisha Al-Kubaisi2, Muhammad Mohsin Khan2, Adnan Khan2, 
Zia Mahmood1, Arshad Chanda1, Adel Ganaw1, Gamal Al-Ameri1, Mostafa Rezk1, 
Moad Ehfeda1, Muhammad Zubair1, Jazib Hassan1 and AR Raju Vegesna1
1 Surgical Intensive Care, Hamad Medical Corporation, Doha, Qatar
2 Department of Neurosciences, Hamad Medical Corporation, Doha, Qatar
*Address all correspondence to: nissatfirdous99@gmail.com
rarely a sole therapy and usually in combination with surgical therapy. The medical 
therapies of cAVM are anticonvulsants and steroids. While taking a therapeutic 
decision for cAVMs, it is of vital importance to consider the patient’s age, location, 
deep venous drainage, size of cAVMs and the presence of the associated aneurysms. 
The associated aneurysms must be secured before the interventions for cAVMs.
© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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Arteriovenous malformations (AVM) are vascular malformations composed 
of a network of abnormal vessels connecting directly between the artery and 
vein without an intervening capillary bed. Cerebral arteriovenous malforma-
tions have an incidence of 0.8–1.3 per 100.000 person years. Clinical symptoms 
include intracranial hemorrhage, seizure, headache, and focal neurological 
deficit. Annual mortality rate associated with hemorrhage is 1–5%, and 10–30% 
of survivors will have disability. Treatment options for cerebral AVMs include 
open surgery, embolization, and radiosurgery. Depending on the grade and 
angioarchitectural characteristics, a combination of these modalities can be 
used. Endovascular treatment can be performed for size and grade reduction, 
presurgical devascularization, size reduction before radiosurgery, targeted 
embolization, and as stand-alone treatment for cure. Targeted embolization 
can address intranidal or flow-related aneurysms and high flow arteriovenous 
shunts. Complications of the endovascular treatment include hemorrhage 
related to vessel perforation or normal pressure breakthrough phenomenon, 
ischemia, microcatheter retention, and other general complications associated 
with angiographic procedures. Mortality associated with endovascular treatment 
is less than 2% and permanent neurological deficit can be seen up to 2–8.9% 
of cases. New endovascular techniques include balloon-assisted embolization, 
transvenous embolization, and double microcatheter techniques like pressure 
cooker technique.
Keywords: cerebral arteriovenous malformation, intracranial hemorrhage, 
endovascular, embolization
1. Introduction
Arteriovenous malformations (AVM) are vascular malformations composed 
of a network of abnormal vessels connecting directly between the artery and vein 
without an intervening capillary bed. AVMs are thought to be congenital lesions 
originated from persistence of primitive arteriovenous connections [1].
1.1 Epidemiology
According to epidemiological studies, including Netherland Antilles [2], 
Olmsted county Minnesota [3], and New York islands [4], incidence of cerebral 
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arteriovenous malformations is between 0.8 and 1.3 per 100.000 person years. In 
addition to sporadic cases, brain AVMs can be associated with syndromes including 
hereditary hemorrhagic telangiectasia, Wyburn-Mason syndrome, and Sturge-
Weber syndrome [5, 6].
1.2 Clinical presentation
Symptomatic brain AVMs may present with intracranial hemorrhage (50%), 
seizure (33%), headache (16%), or focal neurologic deficit (6%) [7]. Annual risk 
of bleeding of due to brain AVMs is approximately 2–4%. Risk factors increasing 
the odds of bleeding include prior history of intracranial bleeding due to AVM, 
deep location, exclusive deep venous drainage and single draining vein, intrani-
dal aneurysm, and high intranidal pressure [7–9]. When there are three factors, 
risk may increase up to 34%. In patients presenting with hemorrhage, rebleeding 
risk in the first year is approximately 32% that decrease to 11% in subsequent 
years [10]. Annual mortality rate is approximately 1.5% and 10–30% of survivors 
have long-term disability. Neurological disability is more common in ruptured 
AVMs compared to aneurysm rupture due to higher likelihood of a lobar hema-
toma [11]. Although there is conflictive data, smaller AVMs have a higher ten-
dency to present with hemorrhage. Spetzler et al. [12] found that 82% of smaller 
AVMs (<3 cm) present with hemorrhage compared to 21% of hemorrhage seen 
in larger AVMs (>6 cm). Ondra et al. [13] published a series of 160 symptomatic 
untreated AVM cases and found that 23% of the patients died during a mean 
follow-up of 23.7 years.
1.3 Therapeutic strategies
AVM treatment includes medical management, surgical, endovascular, and 
radiosurgical modalities. ARUBA, largest multicenter randomized trial to date, 
showed that medical management alone is superior to interventional therapy for 
the prevention of death and stroke in patients with unruptured AVMs [14, 15]. 
However, the follow-up period in this study was only 33 months, and 5-year 
follow-up results that will prove whether these results are persistent are yet to 
be published. Nevertheless, ruptured AVMs, unruptured AVMs with significant 
risk factors, and some symptomatic AVMs in young patients must be treated. 
These treatment modalities can be used as stand-alone treatment for cure, or a 
combination of different techniques can be used to increase the efficiency and 
minimize the risks associated with treatment. Although there is still no consen-
sus on the ideal treatment, every case is evaluated specifically for its rupture 
risk and risks associated with its treatment. The most common grading system 
used to stratify the risks of surgical treatment of AVMs is the Spetzler-Martin 
system [16]. This system classifies the AVMs according to size, location, and 
venous drainage. Larger lesions, AVMs with deep venous drainage, and lesions in 
eloquent locations have higher surgical risk. Eloquent locations include senso-
rimotor cortex, visual cortex, thalamus, internal capsule, brainstem, cerebellar 
peduncles, and deep cerebellar nuclei. Deep venous drainage sites are straight 
sinus, internal cerebral veins, basal veins of Rosenthal, and precentral cerebellar 
veins. Spetzler and Ponce proposed a modified version of the grading system in 
2011 [17].
AVMs larger than 3 cm in a non-eloquent and superficial location can be safely 
treated with embolization followed by surgery. AVMs larger than 3 cm with a deep 
or eloquent location can be embolized and then radiosurgery can be used for the 
ultimate cure. Smaller lesions (<3 cm) can be safely treated with surgery alone or 
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radiosurgery can be used as stand-alone treatment in case of eloquent or deep loca-
tion. For ruptured small deeply located surgically inaccessible AVMs, embolization 
can be used as a stand-alone treatment for cure.
2. Endovascular treatment
The first report of embolization of an AVM was published by Luessenhop and 
Spence et al. in 1960 [18] who used methyl methacrylate pellets after a direct 
carotid puncture. Selective catheterization of the intracranial circulation with 
microcatheters was first described by Serbinenko et al. [19] and Kerber. Further 
evolution has occurred with the use of new liquid embolic agents like cyanoacry-
late by Drake et al. [20] and Debrun et al. [21]. After years of embolization with 
N-butyl cyanoacrylate, introduction of a new agent composed of ethylene vinyl 
alcohol polymer (Onyx, Medtronic, Irvine, CA, USA) has changed the practice 
of AVMs once more.
Endovascular treatment of cerebral AVMs can be used before open surgery, 
before radiosurgery, for cure as a stand-alone treatment, to target the weak 
angioarchitectural points, or for palliative purposes. The advantages of endo-
vascular treatment include minimally invasiveness, immediate angiographic 
evaluation during and after the treatment, and immediate occlusive effect. 
Angiography is the gold standard for the diagnosis and treatment planning for 
AVMs. Angiograms show the location, size, and number of arterial feeders and 
draining veins and locate weak points such as intranidal aneurysms, flow-related 
aneurysms, venous drainage stenosis, ectasia, or aneurysm of the draining 
veins. These angioarchitectural characteristics lead to decision on the treatment 
strategy for a specific AVM including surgical, endovascular, or radiosurgical 
techniques.
2.1 Embolization before surgical resection
Preoperative embolization reduces the blood loss during surgery and decreases 
surgery times. By decreasing the size of an AVM, the Spetzler-Martin grade and 
eventually surgical morbidity-mortality are decreased (Figure 1). Grade 1 and 
grade 2 AVMs, which are amenable to stand-alone surgery, may benefit from the 
embolization of the deeply located feeders. Grade 3 AVMs with deep and eloquent 
location can be treated with embolization preoperatively and surgical morbidity 
and mortality can be reduced significantly [22]. Presurgical embolization is the 
most beneficial for grade 3 AVMs.
2.2 Embolization before radiosurgery
Obliteration rates after radiosurgery decreases as the size of an arteriovenous 
malformation increases. Obliteration rate decreases from 80 to 50% when the 
size of the AVM increases from 2.5 to 3 cm [23]. The main aim of embolization 
before radiosurgery is to decrease the size of the lesion before radiosurgery [24] 
(Figure 2). AVMs larger than 3 cm can benefit significantly by embolization. A 
successful embolization obliterating the periphery of an AVM can help to decrease 
the required dose for obliteration and negative effects of the radiosurgery on the 
neighboring tissues [25]. If an AVM has intranidal aneurysms, these aneurysms can 
be embolized to decrease the bleeding risk during the latency period. Additionally, 
targeted embolization can be used to obliterate direct arteriovenous shunts in the 
arteriovenous malformations to increase the efficiency of the radiosurgery [26]. 
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Figure 1. 
(A–D) A ruptured choroidal AVM that caused intraventricular and subarachnoid hemorrhage in a 26-year-
old male. AVM is supplied by the right posterior cerebral artery (PCA), parietooccipital branch, medial and 
lateral posterior choroidal arteries, and right pericallosal artery from anterior cerebral artery (ACA).  
(E and F) Residual AVM supplied by en passage arterial feeders (arrows) from the posterior choroidal 
arteries and more than 90% size reduction after embolization. These en passage feeders were not amenable to 
embolization and patient went to surgery for AVM resection on the following day after embolization. Control 
angiogram after surgical resection does not demonstrate any evidence of a residual AVM (G and H).
Figure 2. 
(A and B) An unruptured left perirolandic AVM supplied by middle cerebral artery branches in a 46-year-
old female with headaches. (C) Superselective catheterization and angiogram during preradiosurgical 
embolization. Postembolization angiograms (D) show at least 90% size reduction with a small residual lesion 
in the Rolandic region. Stereotactic surgery is planned (E) following embolization due to eloquent location. 
Follow-up angiograms 2 years after radiosurgery (F and G) demonstrate complete obliteration of the AVM 
without any residual or recurrent lesion.
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There are conflictive reports in the literature regarding the efficiency of embolization 
before radiosurgery. Whereas some studies have recently mentioned decreased oblit-
eration rates after embolization [27, 28], other studies have demonstrated increased 
efficacy of radiosurgery with better obliteration rates after embolization [29].  
Figure 3. 
(A–C) An unruptured frontopolar AVM supplied by the orbitofrontal and frontopolar branches of the right ACA 
and drained by a single frontal cortical vein into the superior sagittal sinus. (D) The ETOH cast after embolization 
of two feeders in the same session with a curative intent. ETOH cast completely matches with the angioarchitecture 
of the AVM. Final angiograms (E and F) show complete obliteration of the AVM without any residual filling.
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In our practice, we recommend embolization before radiosurgery for cases with 
a volume larger than 10 cc, fistulous arteriovenous shunting, and intranidal 
aneurysms.
2.3 Curative embolization
Complete obliteration rates with embolization have been reported between 9.7 
and 14% with NBCA (N-butyl cyanoacrylate) [30]. During the Onyx era, complete 
obliteration rates with stand-alone embolization rose up to 18–51% [31]. Even 
higher cure rates up to 94% has been reported in smaller series with selective cases 
[32]. There were higher rates in AVMs with smaller size and a smaller number of 
arterial feeders (Figure 3). AVMs that have less prominent angiogenic nidus and 
predominantly fistulous AVMs compared to pure plexiform lesions were also more 
prone to complete obliteration. Small AVMs with single or less than two feeders 
with deep and central location are good candidates for stand-alone endovascular 
treatment. Larger size of the feeding artery also increases the chance of complete 
angiographic obliteration [33]. According to Valavanis and Yasargil, sulcal AVMs 
fed by pial arteries are more amenable to safe and effective embolization [34]. 
Most recent meta-analysis by Wu et al. [31] found an overall complication rate of 
Figure 4. 
(A) Ruptured cerebellar AVM supplied by the left anterior inferior cerebellar artery (AICA) branches and 
with drainage into the left transverse sinus. (B) A flow-related aneurysm on the left AICA and multiple 
intranidal aneurysms. Unsubtracted angiogram (C) after targeted embolization of the left AICA shows 
NBCA cast within the aneurysm that was most likely the culprit for the previous rupture and hemorrhage. 
Postembolization angiogram before surgery (D) shows occlusion of multiple aneurysms with residual AVM.
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24.1% including hemorrhage occurring in 9.7% of patients and procedure-related 
mortality rate of 1.5%. These rates are slightly higher compared with studies where 
the goal was adjunctive embolization before surgery or stereotactic radiotherapy. 
Even though stand-alone embolization with intent to cure has the potential to be 
a safe and efficient treatment, it must be preserved for select AVM cases or can be 
welcomed as an unanticipated result of an adjunctive endovascular treatment.
2.4 Targeted embolization
Intranidal aneurysm that may cause recurrent bleeding is the main target for 
embolization if a complete or near complete obliteration is not feasible (Figure 4). 
Aneurysms are more frequently seen in AVMs located in the frontal and occipital 
lobes. Deep arterial feeders not accessible by surgery are also a good target for 
embolization. Obliteration of the fistulous component of an AVM and decreasing 
AVM size by embolization may improve the cure rates after radiosurgery.
2.5 Palliative embolization
Although there is significant debate on the management of unruptured arterio-
venous malformations, intractable seizures or intractable headaches may dictate 
further treatment rather than medical management. Embolization can decrease the 
severity of these symptoms by theoretically reducing the steal phenomenon and 
venous hypertension [35, 36]. Embolization of the meningeal supply can relieve 
intractable headaches. Resolution of trigeminal neuralgia after embolization has 
been reported [37]. One must always consider risk-benefit balance when considering 
embolization for symptom relief because partial treatment of large AVMs by emboli-
zation or surgery may increase the risk of intracranial hemorrhage [27]. On the other 
hand, Meisel et al. [38] found that partially embolized AVMs have a lower risk of 
hemorrhage than the risk expected during the natural course of an untreated AVM.
3. Endovascular technique
3.1 Embolization procedure
Operator needs to know the goal of the endovascular treatment whether it is 
aiming a complete obliteration, presurgical grade reduction, size reduction before 
radiosurgery, or a targeted treatment to obliterate weak angioarchitectural points 
like flow-related aneurysms or intranidal aneurysm causing recurrent hemorrhage. 
Accordingly, with the specific aims, a game plan can be organized.
In most of the institutions, AVM embolization is performed under general 
anesthesia. Although some centers advocate conscious sedation over general 
anesthesia, we do not find it practical to perform embolization in awake patients 
considering potentially lengthy procedures and absolute need for immobilization 
during embolysate injection. Triaxial systems with intermediate distal access cath-
eters provide the advantage of much needed stability and momentum in distal and 
tortuous arterial feeders. A distal access catheter can be navigated to the level of the 
supraclinoid internal carotid artery, basilar artery, and even in the middle cerebral 
artery M1 or posterior cerebral artery P1 segments to have a better support.
If the aim is cure or significant size reduction, the ideal position of the micro-
catheter will be as distal as possible and close to the nidus of the AVM. One must 
be very careful during microcatheter navigation within the arterial feeders that are 
prone to dissection or perforation. The safest navigation technique is pushing the 
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leading microcatheter with a microwire inside and without microwire coming off. 
Microwire can lead the microcatheter if there is a kink or tortuosity preventing the 
microcatheter to move forward alone. As soon as the kink or tortuosity is over-
come, microwire is withdrawn inside. Navigation technique is different for flow- 
dependent microcatheters like Magic microcatheter (Balt, Montmorency, France). 
These microcatheters can be pushed with injection of saline and contrast mixtures 
and gentle pushing. One must pay attention to avoid kinking of these microcath-
eters because of poor visibility of the microcatheter shaft that tends to fold on itself 
when there is too much forward momentum. Gentle superselective microcatheter 
injections demonstrate the component supplied by the pedicle, venous drainage, 
and speed of shunting. If there is normal parenchymal blush from the same pedicle, 
another pedicle is chosen to prevent nontargeted embolization. En passage feeders 
are challenging because it can be difficult to choose them selectively, and distance 
to the normal main branch is usually very short for a safe injection. Microcatheter is 
flushed with saline after contrast injection and before introducing the D5 for NBCA 
or DMSO for ETOH. The working angle with the longest and straightest view of the 
microcatheter avoiding overlapping of the nidus and microcatheter must be chosen 
for the superselective angiogram and liquid embolic injection.
Ideal liquid embolic injection aims to penetrate into the nidus, completely 
obliterate the nidus, and reach to the very proximal portion of the venous outflow 
(Figure 5). This can be challenging in AVMs with multiple feeders and single drain-
ing vein. If the venous outflow is occluded with remaining arterial feeders and a 
Figure 5. 
(A–C) A previously ruptured cerebellar AVM in a 57-year-old-male with prior history of surgery for 
hematoma evacuation and partial resection of the AVM. (D and E) Complete obliteration of the AVM after 
embolization.
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large residual nidal component, a normal pressure breakthrough may occur leading 
to intracranial hemorrhage. Early venous stagnation with a residual persistent AVM 
can be an ominous sign and may require complete endovascular obliteration of the 
AVM if possible or immediate surgical resection (Figure 6).
Depending on the angioarchitectural characteristics and preferences and experi-
ence of the operator, EVOH or NBCA can be chosen. Although ETOH is used more 
frequently with the advantages of longer injection times or possibility of halting 
injections with intermittent angiographic control, NBCA is still preferred by some 
institutions [39]. Loh and Duckwiler [40] did not find significant differences between 
two agents in their capacity for at least 50% volume reduction, complication rates, 
and intraoperative blood loss. NBCA works through polymerization and requires 
meticulous preparation in order to prevent contamination with blood or saline that 
may cause premature polymerization. NBCA is prepared in a separate table or in an 
isolated part of the main table [40]. Operators change their gloves before preparation 
to prevent contamination and contact of blood with embolic agents. Microcatheter is 
flushed with D5 before NBCA injection. NBCA mixture can be tailored depending on 
the arteriovenous shunting. Most common mixture ratios of NBCA to Ethiodol are 1:3 
or 1:2 (NBCA:Ethiodol). Denser mixtures can be used if there is a fistulous compo-
nent with fast flow into the veins. More diluted mixtures can penetrate better into the 
nidus with the drawback of higher chance of reflux. Another technique to improve the 
NBCA penetration into the lesion is flushing the guiding catheter continuously with 
D5 dextrose solution while injecting the glue [41]. Penetration of the NCBA can be 
Figure 6. 
(A and B) An unruptured posterior fossa AVM. Final angiogram (C and D) after balloon microcatheter-
assisted embolization shows the onyx cast almost entirely matching with the AVM. (E and F) A tiny residual 
filling (arrow) without obvious early venous filling. Patient had surgery following embolization for complete 
resection of the AVM.
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stopped by stopping the D5 perfusion. NBCA is an adhesive agent and microcatheter 
must be removed briskly as soon as the reflux begins. In both NBCA and ETOH injec-
tions, microcatheter is removed while applying negative pressure by gentle aspiration.
ETOH (Onyx, Medtronic, Irvine, CA, USA or Squid, Emboflu, Gland, 
Switzerland) is a nonadhesive liquid embolic agent, which does not polymerize but 
precipitates when dissolved with dimethyl sulfoxide (DMSO). ETOH laminates 
along the venous wall without immediate occlusion of the vessel. Most frequently 
used ETOH-based liquid embolic agent is Onyx (Medtronic, Irvine, CA, USA). 
Dead space of the microcatheter is filled with the exact amount of DMSO before 
ETOH injection. Before injection, we usually mark the screen with a pen showing 
the landmarks including the most proximal tolerable reflux point on the microcath-
eter, boundaries of the AVM, and beginning of the venous drainage. Under blank 
roadmap, ETOH is injected slowly and reflux is watched. In the most popular “plug 
and push technique,” reflux forms a plug of ETOH at the tip of the microcatheter. 
Some institutions prefer the denser version of ETOH like Onyx 34 (Medtronic, 
Irvine, CA, USA) to form a plug. After the precipitation of ETOH forming a plug, 
antegrade penetration into the nidus with new injections is expected. Whenever 
there is further reflux, penetration into another arterial branch, or early venous 
penetration, injection is stopped for approximately 90 s. Halting injection for more 
than 2 min may cause clogging of the microcatheter. If there is no ETOH coming 
off the microcatheter tip or appearing under blank roadmap 60–90 s after starting 
injection, injection must be stopped and microcatheter is removed. Clogging of the 
microcatheter can result in rupture of the microcatheter shaft and extravasation 
of ETOH [42]. Intermittent angiograms can be done to control the obliteration of 
the AVM and the status of venous drainage while halting ETOH injections. After 
a satisfying obliteration is achieved, microcatheter is removed from the system. In 
ETOH cases, microcatheter is removed by applying constant gentle tension on the 
microcatheter. If there is a stubborn microcatheter stuck in the ETOH cast, patience 
with repetitive pulling with constant tension will remove the microcatheter in most 
of the cases.
Advances in microcatheter technology, development of detachable tip micro-
catheters, ETOH compatible dual lumen microballoon catheters, and evolution of 
liquid embolic agents have changed the paradigms in the endovascular treatment.
3.2 New trends in embolization techniques
3.2.1 Balloon-assisted embolization
DMSO compatible balloon microcatheters with double lumen (Scepter, 
Microvention Terumo, Aliso Viejo, CA, USA and Eclipse, Balt, Montmorency, 
France) allow injection of ETOH or NBCA while balloon is inflated within the 
feeding artery [43, 44]. This creates a wedge positioning of the microcatheter like 
situation or forms a transient plug to increase the penetration of liquid embolic 
with minimal or no reflux. This will theoretically decrease the fluoroscopy time and 
radiation dose and increase the ease of microcatheter removal after injection. This 
technique is especially effective in fistulous AVMs with large caliber feeders. Balloon 
inflation prevents reflux and allows a more controlled injection in flow arrest condi-
tions. Special attention must be paid during inflation in order to prevent rupture of 
the feeder. If there is a problem with balloon inflation, uninflated balloon should be 
replaced as it may increase the chance of catheter entrapment [45]. If there is reflux 
along the inflated balloon, further gentle inflation usually prevents reflux. Extreme 
caution must be paid during inflation of the balloon within the arterial feeders to 
prevent overinflation and rupture.
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3.2.2 Transvenous embolization
Although this technique recalls the venous outflow occlusion, one of the most 
fearful situations for a neuroendovascular specialist during AVM embolization, 
there is increasing use of transvenous embolization in selective cases [45–47]. 
Deeply located hemorrhagic AVMs with small tortuous feeders or en passage feed-
ers may have complex anatomy precluding the use of transarterial embolization. 
Transvenous embolization have theoretical advantages of better penetration of 
the AVM nidus, less risk of ischemic events due to arterial occlusion, and relatively 
easier navigation through enlarged and usually straighter veins. Significantly high 
complete obliteration rates between 80 and 100% [47, 48] were reported in the 
literature. A transjugular venous access with a triaxial system including a sturdy 
guiding system of an 8F sheath and distal access catheter is crucial for safe and 
efficient practice of transvenous embolization. Alternatively, a 6F transjugular 
access with a 6F distal access catheter can be used. Detachable tip microcatheters 
or balloon microcatheters in feasible anatomy may prevent reflux and occlusion 
of the venous drainage. Some centers intentionally let an approximately 3 cm 
reflux after a longer injection and leave the microcatheter inside the system after 
cutting the microcatheter shaft at the skin incision site. Mendes et al. [47] did not 
report any thromboembolism associated with transvenous embolization cases 
with transjugular access where all microcatheters were left intentionally within 
the venous system. Arterial access and arterial flow arrest with transient balloon 
occlusion or simultaneous transarterial embolization should be used if techni-
cally feasible. Although there is no established standard practice of transvenous 
embolization, theoretical criteria to select cases include small lesions with a nidus 
of <2 cm, hemorrhagic AVMs, patients who are not good surgical candidates, 
arterial feeders that are not amenable to transarterial embolization like en passage 
feeders, lenticulostriate arteries or choroidal arteries, and AVMs preferably with a 
single drainage vein [46, 48]. Nonadhesive ETOH should be used for transvenous 
embolization [49]. Systemic hypotension during and after transvenous emboliza-
tion is also crucial for decreasing the arterial pressure that must be overcome for 
better nidal penetration. Another technical challenge for transvenous emboliza-
tion arises from frequently encountered venous anatomical variations and fragile 
structure of the cerebral veins that may lead to disastrous consequences in case of 
vessel injury. One must pay extreme caution for safe transvenous navigation of the 
microcatheter without leading microwire. Aneurysms, ectasia, or stenosis in the 
draining vein may preclude transvenous embolization due to high risk of vessel 
injury during navigation.
3.2.3 Pressure cooker technique
Pressure cooker technique (PCT), first described by Chapot et al. [50], applies 
a plug composed of coils and glue instead of the usual ETOH plug used in the 
regular plug and push technique. Coils are deployed and NBCA is injected to form 
a plug. A microcatheter for ETOH injection is placed in the optimal position in the 
feeding artery followed by a second microcatheter placed in between the tip of the 
first microcatheter and detachment zone. As described by the sheeping technique, 
placement of the first microcatheter usually facilitates the navigation of the second 
security microcatheter [32, 51]. A 1.2F Magic (Balt, Montmorency, France) micro-
catheter is used in small caliber vessels and Echelon 10 (Medtronic, Irvine, CA, 
USA) is used as a second microcatheter in relatively larger caliber arterial feeders. 
Since detachable coils are not compatible with Magic 1.2F microcatheter, injectable 
flow coils (SPIF, Balt, Montmorency, France) are used. In case of larger caliber 
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vessels with high flow arteriovenous shunts, injectable coils may flow unintention-
ally toward the tip of the first microcatheter. Detachable coils are deployed through 
a regular 1.7F like Echelon 10 (Medtronic, Irvine, CA, USA) for precise placement 
of the coil and glue plug. This type of plug is more resistant to ETOH reflux and 
facilitates a more forceful and continuous ETOH injection. It creates a wedge-like 
position similar to ETOH injection through the balloon microcatheters. The theo-
retical advantages compared to balloon-assisted embolization are better navigability 
of flow-directed microcatheters and avoidance of risk of vessel perforation during 
balloon inflation.
4. Complications of the endovascular treatment
Overall morbidity and mortality rates from the largest series of AVM embo-
lization range from 0 to 22% and 0 to 3%, respectively [52–56]. Intracranial 
hemorrhage during or after the embolization can be seen in between 2 and 4.7%. 
Most common reason for hemorrhage is vessel perforation due to microcatheter 
or microwire manipulations. Venous outflow obstruction and normal perfu-
sion pressure breakthrough are other mechanisms that may cause bleeding after 
embolization. Normal perfusion pressure breakthrough is believed to occur due 
to overdilated capillaries in the parenchyma surrounding the AVM in the setting 
of steal phenomenon or ischemia. After embolization or resection of the AVM, 
increased pressure or perfusion in the surrounding parenchyma may cause rupture 
of the maximally dilated capillaries [57]. Staged embolization is preferred in large 
AVMs in order to prevent normal perfusion breakthrough phenomenon [58]. If the 
surgical resection is not planned to immediately follow the embolization, a staged 
embolization in several sessions is performed. Although there is no established rule, 
less than 50% size reduction is aimed in every session in order to prevent postembo-
lization hemorrhage. About 4–6 weeks can be waited in between every session for 
hemodynamic stabilization. If there is significant slowing of the venous drainage 
during any moment of embolization, either complete obliteration must be achieved 
by embolization or surgical resection must be performed urgently following 
embolization. Therefore, it is utmost important to evaluate the venous drainage pat-
tern before and immediately after the embolization. In rare cases, perforation and 
bleeding may occur during superselective microcatheter injection in a small branch. 
If there is any concern for intraoperative rupture or postprocedural neurological 
deterioration happens, a brain computerized tomography must be obtained to rule 
out hemorrhage. In case of hematoma with mass effect or impending expansion 
risk, emergent craniotomy for hematoma evacuation helps minimize neurological 
deficit and may avoid mortal consequences [59].
Ischemic complications can occur due to thromboembolism from the embolic 
material or thrombus formation within or along the guiding catheter or microcath-
eter. Mechanisms or thromboembolism are reflux or nontargeted flow of the liquid 
embolic into a normal branch during embolization. Heparinization is routinely used 
during AVM embolizations. Other general complications related to angiographic 
procedure include groin hematoma, retroperitoneal hematoma, arteriovenous 
fistula, and contrast nephropathy with similar frequencies compared to other 
neurointerventional procedures.
Buffalo grading system [60] is used to stratify the risks associated with endovas-
cular treatment with curative intent. Risk of the endovascular treatment increases 
with number of arterial feeders, smaller diameter of the feeders, and eloquent loca-
tion. One point is given for AVMs with one or two arterial feeders, 2 points is given 
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for three or four arterial feeders, and 3 points is assigned for four or more pedicles. 
If the diameter of the most feeders is less than 1 mm or AVM is in an eloquent loca-
tion, an additional point is given. Starke et al. [61] proposed another scale to predict 
various factors increasing complication risk in AVM embolizations. This scale is 
very similar to Spetzler-Martin grading system for surgical morbidity-mortality 
and includes same factors including size (1 point for <3 cm and 2 points for >6 cm), 
eloquent location, and deep venous drainage. They proposed the need for more than 
one session of embolization as an additional risk factor with increased complica-
tion rate. However, Crowley et al. [56] did not find any significant difference in 
the complication and morbidity/mortality rates depending on the Spetzler-Martin 
grades. The same study did neither show a significant difference in complication 
rates between the ETOH versus NBCA cases.
Microcatheter retention may occur between 3 and 8% of cases [42]. Risk of 
microcatheter retention increases after longer injections with long reflux, in 
smaller branches and branches with significant curves and tortuosity. If the vessel 
accommodating the microcatheter has tortuosity, long refluxes must be avoided. 
Safe reflux for an efficient push and plug technique is usually between 15 and 
20 mm. Smaller vessels with or without tortuosity require a smaller reflux of less 
than 10 mm [50]. Although ETOH is nonadhesive and initially microcatheter 
retention was expected to decrease with ETOH use, clinical practice and experi-
ence demonstrated the contrary. The risk increased due to longer injection times 
and the need for a significant reflux to form a plug for efficient ETOH injection. 
Loh and Duckwiler [40] found higher incidence of microcatheter retention and 
difficulty in removing the delivery microcatheter in the first trial comparing 
Onyx to NBCA, which led to FDA approval of the Onyx. ETOH is less throm-
bogenic than NBCA and does not cause immediate occlusion in case of an unin-
tended flux.
Development of detachable tip microcatheters including Apollo (Medtronic, 
Irvine, CA, USA) and Sonic (Balt, Montmorency, France) has substantially 
decreased the incidences of microcatheter retention [62]. These microcatheters 
have variable lengths (1.5 or 3 cm) of detachable tip segment that allows better 
estimate of tolerable reflux thanks to markers, and detachment will occur if there is 
enough reflux to create a tension point. Sonic (Balt, Montmorency, France) micro-
catheter usually detaches after a long injection with substantial reflux; whereas 
Apollo (Ev3) microcatheter may not detach in many cases and can be retrieved as a 
whole without detachment.
Introduction of distal access catheters helped better navigation of very distal 
tortuous feeders and facilitated retrieval of microcatheters after a long injection. 
The use of distal access catheters is almost the standard of practice especially for 
cases with superficial lesions with distal and tortuous feeders. Distal location of 
a guide catheter eliminates the need for repeated navigation of a microcatheter 
through a tortuous supraclinoid internal carotid, anterior, middle cerebral artery, or 
basilar artery.
Although recanalization after complete obliteration of an AVM is extremely 
rare, there is still risk of recanalization that mandates angiographic follow-up 
after complete obliteration. Potts et al. [63] in their extensive review of multiple 
series of AVMs cured with embolization found 4.5% recurrence rate on follow-up 
angiography. However, there was not any case of recurrence with rupture or any 
adverse event during follow-up period. Mechanisms that may lead to recurrence 
include incomplete embolization due to nonvisualization of a component during 
initial embolization, mass effect from a hematoma, or recanalization of an initially 
thrombosed compartment.
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Abstract
In 2014, ARUBA (a randomized trial on cerebral Arteriovenous Malformation – 
AVM) found patients treated using prevalent interventional strategies are three 
times more likely to suffer a stroke/die compared with those treated conserva-
tively (blood pressure reduction). Subsequent controversy led the European 
societies dealing with AVM to organize a consensus conference. Among the 
statements made was: “There may be indications for treating patients with higher 
Spetzler-Martin (SM) grades, based on a case-to-case consensus decision of the 
experienced team”. Thus, a clear accord emerges. There is a lacuna/weakness of 
interventional modalities when addressing high SM grade AVMs. This lack of a 
clear treatment choice originated our review. We attempt to identify the advan-
tages and challenges of each present treatment/evaluation modality and highlight 
core requirements for future strategies. We conclude that existing modalities pro-
vide substantial recent improvements, yet the core challenge persists. Finally, we 
advocate testing a novel modality – intraluminal radiotherapy (active implants) by 
exploiting the “candy wrapper” or edge effect. If proven effective, this approach 
could offer gradual vessel occlusion with minimal abrupt hemodynamic changes 
known to induce hemorrhage, the lowest recurring session number (reduced 
costs), minimally invasive attributes and very low radiation (dose/dose rate) 
kinetics minimizing potential Adverse Radiation Effects (AREs).
Keywords: arteriovenous malformation, hemorrhage, embolization, radiosurgery, 
gamma knife, surgical resection, intraluminal radiation therapy
1. Introduction
AVM is a tangled web of blood vessels, in which arteries directly transition 
into veins without intermediate microcirculation elements that provide perfusion 
to surrounding tissue. The AVM blood vessels are called a nidus and have little 
resistance to flow compared with a normal capillary bed. Such structure manifests 
violent flows which result in increased hemorrhage risks. Due to growing use of 
advanced imaging modalities, there has been increased incidental detection of 
cerebral AVMs. When detected, there is impending need for treatment since stroke 
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chance for an unruptured and untreated AVM is ~20–40% per decade [1]. About 
38–71% of patients presenting brain AVM suffer intracranial hemorrhage [2]. Given 
these statistics, interventional treatment appears vital. Currently, three prevalent 
modalities exist: endovascular embolization, stereotactic radiosurgery (SRS), and 
surgical resection. Each modality conveys a wide risk array (safety/efficacy). Thus, 
many AVMs ultimately remain untreated (see further data below). Unfortunately, 
these are typically the larger AVMs that could better benefit from intervention 
(~76% of AVMs having a nidus <30 mm are treated; compared with ~57% of those 
having a nidus of 30–59 mm and only ~14% of those having a nidus >60 mm) [3]. 
Moreover, embolization typically necessitates a series of interventional procedures/
sessions (up to 11, on average 2.6) [4]. Each procedure involves patient hospitaliza-
tion, advanced imaging, general anesthesia, and a high-risk operation but, most 
importantly, exhibits a 3.2% chance of significant complications [4]. Finally, due 
to a low obliteration likelihood (11–40%), embolization is not recommended as a 
single-modality therapy and is usually combined with radiosurgery. Radiosurgery 
(if successful) takes 1–3 years to achieve obliteration. Thus, patients remain at 
hemorrhage risk for a lengthy treatment period [5]. To conclude, many patients 
with cerebral AVM benefit less from current prevalent treatment modalities that 
carry high risks, costs, and intensive procedures and, even if eventually effective, 
take years to complete. In 2014, the largest randomized trial on AVMs (ARUBA 
trial) found that patients treated using the prevalent interventional strategies were 
three times more likely to suffer a stroke or die compared with those treated only 
for blood pressure reduction [6]. ARUBA elicited a plethora of reactions. Some were 
relatively supportive, but many more criticized the study methods and outcomes. 
Eventually, the controversy led the European societies dealing with AVM to orga-
nize a consensus conference. A clear accord emerges. There is, indeed, a lacuna 
or at least weakness of interventional modalities when addressing high SM grade 
AVMs. The lack of clear treatment choice for a pathology with a point prevalence of 
~18/100,000 in adults responsible for 4% of all primary intracerebral hemorrhages 
is the motivation for this review [7].
1.1 Definitions and angioarchitecture
AVM features a vascular region lacking transition hierarchy, where arteries 
change directly into veins (Figure 1) [13]. AVM physical appearance is a well-
defined enclosed volume of entangled blood vessels mostly known as a “nidus.” 
Arteries entering the nidus are termed “feeding arteries” and veins leaving it are 
termed “draining veins” (Figure 2) [9].
AVMs may appear in virtually every vascular body region. Clinically, signifi-
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hepatic, and peripheral [8–16]. This chapter focuses on cerebral AVMs due to the 
high risks and challenging treatment involved with this class. Nidus sizes vary 
in diameter between 1 and 10 cm. AVMs <3 cm are classified as “small.” AVMs 
between 3 and 6 cm are classified as “medium.” AVMs >6 cm are considered as 
“large” [8]. The majority of AVMs are medium sized (~55%), followed by small 
(~38%) and then large (~7%) [17, 18]. The nidus structure does not typically 
obstruct blood flow; in fact, the opposite is true (see below). Thus, the organ 
function is usually preserved. However, in rare cases (especially large AVMs), the 
nidus is orientated or structured in a way that impedes perfusion (steal phe-
nomena) [9]. Here, clinical features of ischemia or lack of brain function may be 
present [17].
1.2 Pathophysiology
AVMs are considered as a major cause of intracerebral hemorrhage, particu-
larly in the young population (33.5% for age<20years) [19]. From a fluid mechan-
ics perspective, arterioles constitute the main flow resistance/drop of the vascular 
tree (Figure 3, OpenStax CNX) via a mechanism of rapid increase of surface 
contact between the blood and the endothelial surface and thus shear stress induc-
tion. Lack of arterioles causes minor pressure drops across the nidus. The mean 
arterial blood pressure difference between normal and AVM cases is ~40 mmHg 
Figure 2. 
AVM nidus. Physical location (left), angiogram (center), and pre-surgical anatomy (right) [9].
Figure 3. 
Pressure drop along the vascular tree.
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and has become an indicator for potential hemorrhages [20]. These findings are 
confirmed by modern 4D flow magnetic resonance imaging (MRI) and high-
resolution magnetic resonance angiography (HR 3D MRA) [21, 22]. The CNS 
vascular network is not equipped to endure pressure drops exceeding 10 mmHg, 
particularly not the structurally thin veins. Thus, the biomechanical aspects of 
AVM pressures, flows, and shear stresses play a major part in the structural failure 
of its vessels’ vascular walls.
1.3 Pathogenesis
AVM is generally considered congenital and/or of developmental origin. Beneš 
and Bradác describe several genetic pathways associated with AVM pathogenesis, 
such as hereditary hemorrhagic telangiectasia (HHT, an autosomal dominant genetic 
disease) [23]. Typically, the genes Endoglin, ALK-1 (ACVRL1, TGF-β related), and 
SMAD4 are implicated [24]. These genes also participate in angiogenesis and vas-
cular remodeling. The main signaling pathways disrupted are: (i) TGF-β—cellular 
growth, communication, and inflammatory processes; (ii) NOTCH—angiogenesis, 
considered critical for arterial fate determination; (iii) MAPK(1/3)—physiological 
and pathological cell proliferation; and (iv) PI3K/Akt—cell cycle regulation.
1.4 Epidemiology, natural history, and clinical features
Fast-flow lesions’ prevalence is estimated to be 1–2 out of 10,000 people or 
1.2–1.3 in 100,000 per person-year [23]. AVMs are found in 0.05% of all brain 
MRIs [25]. In the USA and Canada, 5000 new cases are detected yearly [26]. 
Demographic, morphological, and clinical (particularly age-related) charac-
teristics do vary, but many important pathology-related statistics (e.g., rate of 
incident hemorrhages) remain roughly similar worldwide [17]. In South Africa, 
male gender and African-black origin were found to be strong indicators for 
AVM seizure development [27]. Frontal (20.4%), parietal (22.2%), temporal 
(16.6%), and cerebellar (14.0%) are the most common anatomical brain regions 
to present AVMs [17, 27]. Supratentorial lesions account for 90% of brain 
AVMs [28]. Intracranial hemorrhage is the most common clinical presentation 
(30–82% of lesions) [29]. AVMs account for 1–2% of all strokes and 2–4% of all 
non-traumatic intracerebral hemorrhages [23]. However, the unique age distri-
bution among stroke etiologies (the median age for an AVM patient is 32 years 
old [30]) suggests that AVMs are responsible for more than a third of hemor-
rhagic strokes in young adults [19]. Furthermore, some studies suggest that 
higher hemorrhage risk values of 4.6% [31] and 30% of lesions are subarachnoid 
[32]. These are considered highly catastrophic and present the mortality rates 
of 25–50% [33]. Main factors influencing hemorrhage risk statistics are initial 
hemorrhagic (7.48%) or seizure (4.16%) presentations, associated aneurysms 
(6.93%), and deep venous drainage (5.42%) [31]. Other clinical representations 
are neurological deficits (24%), chronic headaches (19%), and focal or general-
ized seizures (46%) [17]. The American Association of Neurological Surgeons 
(AANS) provides a wide symptoms list—seizures, muscle weakness or  
paralysis, loss of coordination, difficulties carrying out organizational tasks, 
dizziness, headaches, visual disturbances, language problems, abnormal 
sensations, memory deficits, mental confusion, hallucinations, and dementia 
[34]. Annual mortality rates vary between 0.7 and 2.9% [23]. Considering an 
estimated number of 300,000 US patients, this results in ~2100–8700 annual 
mortalities in the USA alone.
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1.5 Brief history
Early AVM descriptions may date back to ~1500 BC, evidenced in the Ebers 
Papyrus description of hemorrhoids, varicose veins, and aneurysms. Vessel mal-
formations were apparently also familiar throughout the Roman and early Arabic 
empires. However, the first modern documented AVM procedure was performed 
by Hunter during the eighteenth century, the first official clinical diagnosis was 
described in 1895, and the first surgery (a feeding artery ligation) was performed 
by Giordano in 1889 and was immediately followed by a full AVM resection in Paris 
[23]. The early era of AVM microsurgery is traditionally attributed to Kunc et al. 
who suggested the whole AVM obliteration as a standalone fully efficient treatment 
strategy in 1965 [35]. The interventional radiology approach and radio-surgical 
techniques emerged during the 1980s and eventually paved the way for present 
treatment modalities. The 1980s were also pivotal regarding treatment strategies. 
Up to then, recommendations for AVM treatment were mainly institution/physi-
cian based. However, during the 1980s, Spetzler and Martin (based on vast surgical 
work) developed the first well-established AVM classification and treatment scale. 
This grading scale is considered the “gold standard” decision-making tool in the 
field to date [36].
2. Main diagnosis and imaging tools
Though AVM prevalence is estimated to reach up to 0.2% of the population, actual 
confirmed diagnosis rate is only ~0.02% [23, 37]. This significant gap is attributed to 
the fact that AVMs are congenital pathologies remaining generally mildly symptom-
atic until clinical presentation appears (unfortunately, this is typically hemorrhagic 
stroke) [23]. AVMs are mostly diagnosed and confirmed using radiology. The imaging 
findings also greatly influence treatment evaluations. Two strict AVM diagnostic cri-
teria are: indication of a nidus and clear venous drainage [38]. Angiographic elements 
evaluated as indications for AVMs’ clinical significance, and risk assessments include: 
arterial supply and venous drainage identification, nidus position, geometry, and 
size, presence of intracranial hemorrhage, and related pathologies [39]. The presence 
of aneurysms is associated with 26% of AVM patients [27].
2.1 Digital subtraction angiography
DSA is a vascular mapping technique based on conventional angiography. DSA 
involves an additional pre-processing step that removes non-vascular anatomical 
data [40]. Angiography is the gold standard methodology for the characterization 
and delineation of cerebral AVMs and in the evaluation of cerebrovascular diseases 
[41, 42]. The method dynamically displays vascular transitions and is uniquely 
able to delineate the size and number of feeding arteries and their origins, measure 
the nidus size and compactness, and evaluate venous drainage locations [42]. In 
addition to its significant diagnostic role, angiography is the main technique used 
by interventional radiologists to accurately navigate through the neurovascular 
environment and assess treatment progression and related events through inter-
ventional sessions [43, 44]. DSA is performed using selective (the catheter used for 
contrast administration is only advanced to the AVM vicinity) or super-selective 
(the catheter is further advanced to the AVM feeding arteries) approaches [23]. 
DSA is increasingly being supplanted by the less invasive computed tomography 
angiography (CTA) and the X-ray and nephrotoxic contrast-devoid MRA.
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2.2 Computed tomography
CT comprises a limited diagnostic tool for unruptured AVMs [45]. Lower density 
areas may (potentially) indicate the AVM in CT scans [46]. The great contribu-
tion of CT scanning in AVM diagnosis lies in its high sensitivity for acute bleeding 
detection, which makes it a front-end diagnostic tool when patients present acute 
symptoms related to the pathology [47]. CT is also used to assess efficacy and 
complications of embolization interventional treatments [47].
2.3 Computed tomography angiography
CTA combines the CT imaging procedure with contrast agent injection. This 
enables real-time (RT) structural presentation of neurovascular angioarchitecture 
(e.g., nidus, arterial feeders, and draining veins) and identifying associated pathol-
ogies such as fistulas and aneurysms [38]. Gupta et al. demonstrated that it is even 
possible to obtain good quality intranidal angiograms using RT CTA for anatomic 
localization of a specific catheterized (embolized) AVM region [48].
2.4 Magnetic resonance imaging
Smith et al. found MRI which is superior to CT and angiography in determining 
nidus size and location, detecting AVM effects on adjacent brain tissue, and show-
ing the obliteration extent following embolization [49]. MRI also facilitates AVM 
classification into base categories (e.g., sulcal/gyral) [23]. Use of flow turbulence 
and velocities as benchmarks has been shown to increase MRI diagnosis efficacy 
[23, 50]. MRI is considered highly efficient in detecting and delineating hemor-
rhagic episodes [23]. In addition, it can detect damage and atrophies in surrounding 
brain tissue and related pathologies such as aneurysms and fistulas. The latter are 
considered challenging for early detection and feature high annual risks for hemor-
rhagic events (7.5%) [41].
2.5 Functional MRI
fMRI is used to detect abnormalities in brain areas adjacent to AVM borders or 
deficits in specific cognitive tasks correlated with regions affected by it [41]. fMRI 
can help to evaluate AVM margins and aid in preventing damage to surrounding 
brain tissue during interventional sessions. AVMs are congenital pathologies. Thus, 
it is suggested that the developing brain neuroplasticity will present different fMRI 
images for healthy and pathologic cases. Caramia et al. used fMRI and transcranial 
magnetic stimulation (TMS)—which directly explore cortical neurons’ electrical 
activity—and showed cortical motor areas reorganized in the AVM containing 
hemisphere [51]. The main limitation of fMRI is that it does not directly detect 
AVMs as MRI does. Therefore, it should be used as a treatment planning tool rather 
than for standard diagnostics [23].
2.6 Magnetic resonance angiography
MRA is valuable in providing AVMs with 3D angiographic images and hemody-
namic data [23]. MRA techniques are characterized by two main parameters—flow 
and contrast. State-of-the-art MRA techniques are:
• Time-of-flight (TOF) MRA: TOF-MRA or inflow angiography enhances blood 
flow areas by shortening the MRI echo time (TE) parameter, thus reducing the 
85
Advocating Intraluminal Radiation Therapy in Cerebral Arteriovenous Malformation Treatment
DOI: http://dx.doi.org/10.5772/intechopen.89662
execution number in each flow-related voxel in comparison with stationary 
voxels. This results in flow patterns appearing brighter. The technique can also 
aid in finding residual AVMs [41]. However, Lee et al. report the accuracy and 
specificity rates of only 75–78 and 68% respectively, which leaves DSA at the 
front-end [52].
• Phase contrast (PC) MRA (Figure 4): In PC-MRA, phase shift differences 
between stationary tissue and flowing blood results from the application of 
a bipolar phase-encoding gradient and a velocity-encoding factor [23]. Since 
phase change is coupled with velocity vectors, the technique is considered 
superior to TOF-MRA (better detecting flow directions, minor velocity 
changes, and slow regions). Chang et al. used PC-MRA post-processing 
computational fluid dynamics to calculate shear stresses at vascular walls [22]. 
Wu et al. used PC-MRA to identify peak flows, velocities, and their exact loca-
tion within the nidus and feeders [53]. To conclude, PC-MRA is a promising 
technology but is still not comparable with conventional angiography [23].
• Time-resolved imaging of contrast kinetics (TRICKS) MRA: Here, continuous 
imaging is employed during the passage of a contrast agent yielding a movie 
with an acquisition rate of up to three frames per second [41]. These improve-
ments enable the visualization and calculation of flow through regions of 
the AVM (also selectively), enabling confirmation of suspected findings on 
conventional imaging tools [41]. The technique findings correlate well with 
DSA with regard to nidus size and location, venous drainage pattern, and 
arterial feeders in multiple studies but still lag DSA in spatial and temporal 
resolutions.
2.7 Diffusion-weighted MRI
These methods are based on the diffusive anisotropy of water molecules along 
nerve axons and plexus, where axial motion takes precedence [41, 54]. Here, we 
can find techniques such as diffusion tensor imaging (DTI), diffusion spectrum 
imaging (DSI), and high angular resolution diffusion imaging (HARDI). These 
more recent techniques serve as a valuable non-invasive pre-operative and pre-
radiosurgery tool to evaluate the involvement and proximity of cerebral AVMs to 
white matter tracts [41]. Using these methods, it provides clinicians with strong 
risk assessment capabilities, particularly regarding the microsurgery approach and 
track planning [55]. dwMRI can be used with other technologies for presenting a 
combined vascular and neuroanatomical image [55]. It might also enable very early 
identification of ischemic areas [46]. dwMRI is limited mainly to white matter 
tracts and presents high sensitivity to protocol operation parameters (e.g., TR/TE/
spatial resolution) and artifacts from inadvertent sources.
Figure 4. 
(A) PC-MRA original image of right temporal AVM, with (B) velocity, (C) whole brain, and (D) feeding 
arteries shear stresses data [22].
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2.8 Summary
AVM analysis is based on the findings of multiple modalities—vascular anatomy 
of nidus and feeders, acute/chronic brain matter pathological presentations, flow 
and velocity rates, and surrounding tissue anatomical and functional attributes 
(e.g., connectometractography). Each modality presents specific strengths and 
weaknesses. CT is extremely sensitive to hematomas and offers several AVM 
anatomical finding capabilities. CTA is used to diagnose AVM in patients with acute 
hematomas. MRI presents improved topography and the detection of subacute and 
chronic hematomas and surrounding brain tissue pathologies. PC-MRA is used 
for high-resolution vascular imaging and provides biomechanical data (e.g., shear 
stresses), that is, highly beneficial in clinical assessment. Functional-anatomical 
relations data are effectively gathered using fMRI and dwMRI which provide strong 
clinical decision-making tools. Finally, DSA remains the gold standard for both 
diagnostic and procedural purposes due to its high-resolution real-time imaging of 
cerebral angioarchitecture. To conclude, brain imaging is a prolific field constantly 
presenting the development of promising improved and new modalities.
3. Grading and classification
3.1 The SM grading system
In 1986, Spetzler and Martin published a relatively simple AVM classification 
system called “SM Grading” [36]. SM is considered as the gold standard to date. 
The system requires three parameters, evaluated using angiography, CT, and MRI 
(Table 1): size, venous drainage pattern (“superficial” if all drainage is via corti-
cal veins and “deep” if some or all drainage is via deep veins), and neurological 
eloquence of adjacent brain regions (“eloquent” regions are those well-defined 
by a neurological function, while the regions of less defined function or disabling 
effects when disrupted such as temporal lobes and cerebellar cortex are considered 
“non-eloquent”). SM eventually sorts AVMs into five grades. Inoperable AVMs are 
considered grade six. Spetzler and Martin correlated their grading with the surgical 
outcomes of 100 patients and found it to be well-correlated with both minor and 
major post-operative neurological deficits. Further validations were later performed 
by both the authors and peers [56].
3.2 Modifications of SM
Several modifications of the SM grading system have been suggested over the 
years. Following are some key examples. De Olivera et al. suggested including 
Graded 
feature
AVM size (cm) Eloquence of adjacent 
brain












assigned 1 2 3 0 1 0 1
Grade = [size] + [eloquence] + [venous drainage]; that is (1, 2, or 3) + (0 or 1) + (0 or 1).
Table 1. 
Determination of AVM grade [36].
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two Grade 3 subgroups with different patient management [57]: 3a (large size, 
pre-operative endovascular embolization followed by microsurgical resection) 
and 3b (venous drainage and/or eloquence, generally treated with radiosurgery). 
They found their modified classification a useful guide for the best treatment but 
indicated that it has many exceptions. Lawton et al. suggested further subcatego-
rizing Grade 3 AVMs into four classes for better correlating the SM grading with 
associated surgical risks (− less risk, + more risk) [58]: Grade 3−AVMs (small nidus 
size, deep venous drainage, and eloquent adjacent brain tissue) have a surgical risk 
similar to that of low grade AVMs and can be safely treated with microsurgical 
resection, Grade 3+ AVMs (medium size, superficial drainage, and eloquent) have 
a surgical risk similar to that of high-grade AVMs and are best managed conser-
vatively. Grade 3 AVMs (medium, deep, and non-eloquent) have intermediate 
surgical risks and require judicious selection for surgery. Grade 3* AVMs (large, 
superficial, and non-eloquent) are either exceedingly rare, with a surgical risk that 
is unclear, or theoretical lesions with no clinical relevance. Finally, fairly recently in 
2016, Neidert et al. suggested a grading system for patients with ruptured AVM-
related IntraCerebral Hemorrhage (AVICH) to predict clinical outcome [59]. Their 
system extended SM with parameters such as age, diffuse nidus (from the Lawton-
Young grading system, that added patient age, hemorrhagic presentation, nidal 
diffuseness, and deep perforating artery supply in 2010 to improve neurological 
outcome prediction and refine patient selection [60]), intracerebral hemorrhage 
volume (30 CC threshold), and intraventricular hemorrhage (derived from the 
intracerebral hemorrhage score). They demonstrated that their score predicts the 
outcome of patients with ruptured AVM and associated ICH better than previ-
ous grading systems (SM included). They cautioned that an external validation is 
needed before this score is tested in a prospective multicenter cohort. To date, no 
modified grading system has become as well-established as the SM grading.
3.3 SRS grading scales
Schwartz et al. tried to predict the AVM obliteration success of single-dose 
photon SRS for individual patients [61]. They defined the obliteration prediction 
index (OPI ≡ marginal dose of radiation given at the edge of the target lesion in 
gray/lesion diameter in centimeters). They concluded that the exponential func-
tion  P = 1 − A  e −B⋅OPI (where  P is the obliteration probability and  A, B are constants) 
is well-correlated with successive chance, partly describes the biological effect of 
radiation, and is independent of the device (marginal dose) used. They suggested 
that radiosurgery centers use this model to facilitate successful treatment prediction.
Pollock-Flickinger developed a grading system to predict excellent patient out-
come (complete AVM obliteration without any new neurological deficit) following 
single session AVM radiosurgery [62]:
 AVM score  =  0.1  AVM volume [ cm 3 ] + 0.02 Patient age  [years]  
+ 0.3  AVM location ∗  (1)
where * indicates: frontal or temporal = 0; parietal, occipital, intraventricular, 
corpus callosum, or cerebellar = 1; basal ganglia, thalamic, or brainstem = 2.
They concluded that their proposed AVM grading system strongly correlates 
(R2 = 0.88) with patient outcomes but cautioned that further testing by indepen-
dent centers using prospective methodology is still required.
In 2016, Pollock et al. compared five AVM grading scales—SM, radiosurgery-
based AVM score (RBAS), Heidelberg score, Virginia Radiosurgery AVM Scale 
(VRAS), and proton radiosurgery AVM scale (PRAS)—at predicting SRS outcomes 
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(Table 2) [63]. Their criterion was AVM obliteration without a decline in modified 
Rankin Scale (mRS) score (excellent outcome). They concluded that continuous 
scores AVM grading scales (RBAS and PRAS) outperformed integer-based grading 
systems in the prediction of AVM obliteration outcomes since they directly correlate 
with patients’ existing physical attributes.
3.4 Grading systems for embolization
Even though endovascular embolization widely differs from surgical or SRS 
approaches, dedicated grading was not considered as a broad/general tool until 
fairly recently. In 2010, Feliciano et al. conducted an extensive literature survey 
and correlated endovascular treatment with AVM characteristics. Points were given 
according to feeding vessels, eloquence, and fistulae presence (Table 3) [64]. They 
concluded that a grading scale similar to SM for use in risk assessment and outcome 
determination in brain AVM patients treated by endovascular techniques seems 
adequate and clinically feasible.
3.5 Summary
Though posited in 1986, the SM AVM grading system remains the gold standard 
in predicting surgical treatment success. The development and assimilation of SRS 
led to uniquely dedicated grading. The future probably lies with “continuous” grad-
ing, where scores are directly correlated with AVM and patients’ actual features and 
properties. Endovascular dedicated grading has just recently emerged, mostly based 
on large literature surveys and meta-analyses, but apparently shows real promise 
(though it still necessitates firmer actual validation).
4. Embolization
Embolization is intended to physically block blood flow to the AVM. It is a mini-
mally invasive endovascular procedure carried out by an interventional radiologist. 
AVM embolization is considered among the most challenging in the field due to 
the vasculature target tortuous hemodynamic formation but, more so, due to its 
high-pressure arteries directly connecting with low-pressure veins (AV shunts). If 
arteries are proximally occluded, anastomoses develop from nearby vessels creat-
ing new shunts. Thus, proximal arterial occlusion has no curative effect and is 
restricted to pre-surgical situations [23]. In contrast, direct AVM treatment requires 
AVM feature Points
Number of feeding vessels <3 1
3–5 2
≥6 3
Eloquence of adjacent areas Non-eloquent 0
Eloquent 1
Presence of AVFa No AVF 0
AVF 1
aAVF = arteriovenous fistula or fistulous component.
Table 3. 
Classification scheme for risk assessment during embolization procedures for brain AVMs [64].
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distal (transarterial) embolization. First, navigation is performed all the way to 
the venous section. Then, an embolic agent is super-selectively introduced into the 
draining veins via microcatheters that are retracted backwards as the vasculature 
fills up (all the way to the arterial feeders). Vessel selection tract is traditionally 
based on DSA.
In 1995, Frizzel et al. reviewed the cure, morbidity, and mortality associated 
with the embolization of 1246 brain AVMs during the previous 35 years [65]. Cure 
rates were 4–5%. Temporary and permanent morbidities were 10 and 8–9%, respec-
tively. Mortality was 1–2%. These statistics improved over the years. However, to 
date, embolization is generally considered a pre-operative (pre-SRS) adjunctive 
procedure because: (I) as a sole modality, it is assumed effective only in a minority 
of cases [66]; (II) proximal occlusion of feeding arteries appears to be associated 
with recurrence [66]; and (III) it appears to increase hemorrhagic risk compared 
with conservative management, especially in unruptured AVMs [67].
Currently, the two most common embolization agents in cerebral AVM treat-
ment are N-butyl cyanoacrylate (NBCA) and ethyl-vinyl alcohol copolymer 
(EVOH)-DMSO solvent (Onyx) [68, 69]. These materials are delivered in liquid 
form and are, hence, injectable through very narrow diameter microcatheters.
4.1 Cyanoacrylates
Cyanoacrylates solidify by polymerization initiated once they contact an anionic 
environment such as blood [69]. The process is very rapid but can be delayed by 
dilution using Lipiodol (Ethiodol in the USA) vehicle retardant. The more Lipiodol 
the mixture contains, the longer the delay. Optimizing dilution is a very empirical 
process that greatly depends on operator experience level. Cyanoacrylates’ main 
advantages are that they: facilitate nearly instant occlusion; induce an inflammatory 
response within the embolized vessel walls that are believed to play an important 
role in the occlusion durability; are compatible in case of vascular rupture; are 
injectable via many microcatheter types (even the thinnest and most flexible ones 
currently available); have a non-glued microcatheter withdrawal that gives rise 
to minimal vascular network traction, so they are highly compatible with narrow 
diameter arterial vessels (very sensitive to traction-induced mechanical trauma); 
and facilitate surgical resection by helping to identify embolized vessels (compress-
ible and easily cut with micro-scissors). Cyanoacrylates’ main drawbacks are: 
catheter can become entrapped in the occluded vessel; difficulty in controlling the 
occlusion position; highly local occlusion; they can only be used by operators with 
extensive training; must be opacified to monitor flow during injection; and catheter 
position must be abandoned.
4.2 EVOH copolymer-DMSO solvent (Onyx)
Here, small polymer particles are suspended in solution using a DMSO solvent 
[69, 70]. Following mixture injection, DMSO diffuses to surrounding tissue, 
resulting in particle aggregation occluding the lumen. Flow is omnidirectional and 
typically includes artery reflux along the microcatheter tip. Following injections 
progressively colonize adjacent arteries, only then traveling towards the drain-
ing veins. Consequently, microcatheter tip trapping is a typical feature. This led 
manufacturers to develop catheters with detachable tips. Onyx’s main advantages 
are: relatively high complete obliteration rate with the evidence of stability over 
time [70]; slow solidification facilitates prolonged/controlled injection with deeper 
nidus penetration; and mid-procedure angiography and reduced catheter adherence 
even during reflux. Onyx’s main drawbacks are: DMSO is toxic—rapid injection can 
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cause vasospasm, necrosis, and acute respiratory distress syndrome (ARDS) [71]; 
DMSO-compatible catheters and syringes must be used; high radiopacity causes 
poor visualization during reflux in very small vessels and masking by previously 
embolized regions potentially leading to subsequent healthy vasculature emboliza-
tion; over-reflux can potentially harm adjacent functional healthy arteries; and 
mixture must be shaken for at least 20 min prior to usage in order to homogenize 
the tantalum powder used for opacity.
4.3 Precipitating hydrophobic injectable liquid
PHIL is a recent liquid agent composed of a non-adhesive copolymer 
(polylactide-co-glycolide and polyhydroxyethylmethacrylate) dissolved in 
DMSO. Triiodophenol is used as an iodine component, being covalently bound to 
the copolymer for radiopacity [72]. Initial studies show embolization characteristics, 
embolization extent, and biocompatibility to be comparable with those of Onyx 
[72–74]. However, further studies are required to fully evaluate its safety and efficacy 
[74]. PHIL main advantages are: shorter pause times that result in significantly 
higher embolization success compared with Onyx; lower volumes required for the 
same extent of embolization compared with Onyx; it comes ready for use (does not 
require preliminary preparation); and improved visibility compared with Onyx. 
PHIL’s main drawbacks are: still necessitates DMSO; embolization performance (effi-
cacy) is only comparable with that of Onyx but does not improve on it; and could 
result in the exertion of traction on the vascular network upon catheter extraction.
4.4 AVM embolization complications
Post-embolization hemorrhage is the most severe, dramatic, and morbidity-
mortality-related complication [75]. Up to 14% of patients exhibit neurological 
deficits [75, 76]. The combined death and permanent disabling neurological deficit 
rate is below 3.9% per patient [77, 78]. Risk predictors for endovascular treatment 
differ from those for AVM surgery [76]. Some studies report no morphological 
AVM characteristics test predict treatment complications [76]. Others suggest AVM 
location in an eloquent brain part, and fistula presence and a venous glue deposi-
tion are associated with complications [77]. Yet, others consider that basal ganglia 
location is weakly associated with new post-embolization neurologic deficits [78]. 
This topic is controversial. It appears that extensive devascularization and the 
absence of post-procedure hypotension increase hemorrhage risk [75]. Thus, partial 
(25–30%) devascularization per session and post-procedure hypotension induction 
were recommended [75]. Overall, there is a consensus that brain AVMs’ emboliza-
tion is associated with low overall mortality and disabling morbidity rates [77, 78]. 
The hemorrhage mechanisms are typically: artery perforation by a microguide/
microcatheter during navigation; excessive pulling on a stuck microcatheter; and 
hemodynamics-related rupture due to changes in flow patterns and commination 
(size reduction) in venous drainage. These are typically the most severe and occur 
within 48 h following embolization. Finally, thrombus formation and its migration 
from the carrier catheter leading to ischemic complications is a feasible though 
non-frequent scenario.
Embolization complications dictate clear design recommendations for future 
endovascular devices: gradual blood vessel closure in which no abrupt flow changes 
take place inside the nidus; the ability to treat small and big blood vessels, easier 
to operate when treating patients—requiring reasonable training and experience 
(and skills); and avoiding exerting significant mechanical stresses on the delicate 
vasculature.
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5. Stereotactic radiosurgery
SRS is a leading alternative to surgery or embolization, especially for AVMs 
located in deep or eloquent brain regions, where invasive treatment is not optional 
[79]. SRS employs ionizing radiation for gradually occluding AVM blood vessels. 
Its application was adopted from oncology during 1970–1980s [80, 81]. During the 
next decades, SRS (or “gamma-knife”) rapidly evolved as a standalone modality 
and following embolization. SRS systems typically comprise a spherical array of 
high-focused gamma ray generators (Figure 5), a mechanical system that precisely 
positions and immobilizes patients’ heads and a 3D imaging, and tracking system 
for treatment (i.e., dose delivery) design and real-time management (Figure 6). 
The chief benefit of radiosurgery is that it can eliminate the threat of spontaneous 
intracranial hemorrhage by gradual obliteration of the AVM over 2–3 years [81].
5.1 Histopathological response
Radiation induces endothelial damage (lasting biochemical changes and apoptosis), 
thrombocyte aggregation/development of fibrin microthrombi, and subendothelial/
perivascular spindle cell proliferation (contractile myofibroblasts formed in vascular 
walls and AVM connective tissue—stroma) [23, 82, 83]. Both degenerative and 
proliferative changes are dose- and time-dependent. Degeneration expressions are 
tissue granulation and inflammatory cell presence in the stroma followed by type IV 
collagen-producing fibroblasts and fibrocytes and eventually hyaline phenotypics 
and obliterated vessels. Proliferation is expressed by the formation and accumulation 
of myofibroblasts (neointima) assumed as the canonical shrinking and occlusion 
factor in irradiated AVMs [23, 82, 83]. Importantly, normal vessels do not exhibit 
propensity to obliterate. Apparently, due to the connective tissue (stroma) surround-
ing the AVM nidus, pathological vessels playing a key role in the obliteration process 
[23, 84]. Obliteration is often followed by new vessel formation, occasionally visible 
on MRI [23, 82]. Radiation-induced necrosis, neural loss, myelin fragmentation, and 
gliosis have been detected in the surrounding brain tissue 1–10 mm from the lesion 
Figure 5. 
Schematic illustration of a stereotactic radiosurgery procedure [© Mayo clinic].
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border [23]. Histopathology is typically elicited and efficacy-controlled by focused 
irradiation of marginal doses of ~10–35 Gy (median ~20) (Figure 6)—delivered in a 
single or fractionated (higher doses) protocol [81, 82]. It has become a consensus that a 
better understanding of irradiation response physiology may facilitate the targeting of 
individual enzyme systems and open up new SRS opportunities [84].
5.2 Widely used systems
Gamma-knife systems consist of up to ~200 cobalt-60 sources arranged in 
circular arrays within a spherical mechanism [79]. The arrays’ geometry and source 
strength (typically ~30 curies each) result in a 3D energy field of isodoses at any 
defined volume within the sphere. While each source beam dose is very low, the 
converged irradiation at any pre-chosen focus position adds up to clinical values. 
The targeted volume can be varied using different sized collimators. These systems 
Figure 6. 
Top: SRS treatment planning (dosimetry). Using imaging scans and specialized software, the treatment team 
determines the best combination of radiation beams to target the lesion [© Mayo clinic]. Bottom: marginal 
dose versus efficacy (following [81]).
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traditionally required complete patient immobilization—which involves direct 
mechanical fixation of patients’ skulls using a stereotactic frame. The fixation is 
an invasive procedure that can be highly painful and stressful. Newer models can 
perform frameless treatment (thermoplastic mask for immobilization and advanced 
imaging for stereotactic orientation), thus supporting a less invasive patient experi-
ence. Gantry and robotic arms systems employ gantry-mounted linear accelera-
tors (“LINACS”) to generate the energy beam and rely on either fixed circular or 
multi-leaf collimators (MLCs) for its shaping. This allows a conformal scheme—
which aids in treating irregular nidus geometries. Alternatively, the system can be 
mounted on a robotic platform (arm vs. gantry) that adds mechanical degrees of 
freedom. Patient positioning can also be achieved using imaging (cone beam CT) or 
laser systems, so frame-based immobilization systems are becoming obsolete. Less 
common are proton beam systems that accelerate protons (using a synchrotron or 
cyclotron) in order to generate the therapeutic beam. An advantage of proton treat-
ment is the minimal target-exiting dose safeguarding the lesion surrounding tissue. 
The proton beam is typically delivered to the target volume via a gantry mechanism. 
Patient immobilization can be achieved invasively and non-invasively. Proton 
systems’ main disadvantage is that they are scarce and expensive.
5.3 Treatment selection
Since radiosurgery/therapy equipment is scarce and extremely expensive, 
many centers and physicians have adopted particular patient selection and treat-
ment protocols. The availability of different systems per hospital/clinic has further 
contributed to this diversity. The result has been that there are many controversies 
regarding patient and modality selection in general, and with respect to radiosur-
gery/therapy in particular [85]. During the last two decades, this trend has been 
changing as more physicians and researchers are attempting to standardize score-
based radiotherapy grading and patient selection systems (see Section 4.3) [59]. 
A treatment selection scheme established at Pittsburgh University is presented in 
Figure 7 [81]. Selection relies on AVM volume and location as well as the existence 
of post-treatment (residual) lesions.
Unlike SM grading in surgery, to date, there has been no distinct established 
treatment selection criterion for radiosurgery/therapy. Even recent advanced grad-
ing systems are not widely considered a sufficiently standardized basis for designat-
ing a patient for radiation modality. Common factors are bleeding history, patient 
age, existing comorbidities, anatomical location, and clinical history [81].
5.4 Outcomes and complications
Standard protocol for AVM obliteration typically involves clinical diagnostics 
and a half-yearly MRI, followed by annual MRI imaging. Final validation (classi-
cally at 3 years) is DSA-based, as the latter constitutes the gold standard [81]. A 
meta-analysis, performed by Badra et al. in 2018 [79], found that: obliteration rates 
are ~70–80% at 2–4 years post-treatment; annual bleeding rates are 1.1–8%; AREs 
are 12–38%; and overall morbidity is 4–12%. Another study showed [81]: the oblit-
eration rates of 78% at 3-year follow-up, repeated radiosurgery needed in 12.5% of 
cases, post-surgery annual bleeding rates in 4.1% of cases, and AREs in 16.3%. Thus, 
while radiation treatment is relatively effective, it is not risk- and complication-free. 
Several categories merit particular attention: acute complications are typically 
related to the post-procedural presentation of neurological deficits after 2 years or 
more. Yen et al. studied 1426 Gamma Knife Surgeries (GKS) and found radiation-
induced imaging changes (RICs, visualized as increased T2 signal surrounding the 
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treated nidi on MRI) that are the most common adverse effects following GKS—in 
33.8% of lesions [86]. Patients with a relatively healthy brain and large nidi or with 
a single draining vein were more susceptible to RICs. Few RICs were symptomatic 
(8.6%), and most symptoms were reversible (only 1.8% had permanent deficit). 
About 7.7% of RICs were acute—causing a midline shift of the brain. Late AREs 
typically occur many years following SRS (6.9% of patients after a median of 
8.7 years. The 5-, 10-, and 15-year incidence is 0.4, 7.7, and 12.5%, respectively). 
They are characterized by perilesional edema or cyst formation and are distinct 
from short-term (1–2 years post-surgery) AREs, often labeled as RICs [87]. About 
3.4% of Late AREs are symptomatic at detection. Many that are asymptomatic later 
present with cyst progression. The overall symptomatic rate of late AREs is 4.7% 
[87]. Another study included radiation necrosis and cystic vessel formations in late 
ARE diagnosis and found the incidence at 2–6% [79]. Finally, since radiotherapy 
for AVM is based on ionizing radiation, the concern for carcinogenicity arises. 
However, little evidence has been found to support radiation induced tumors 
(RITs). A late retrospective analysis performed by Pollock et al. found no RITs in 
471 patients observed between 1990 and 2009 (with very few others out of the total 
1837 patients presenting malignant transformation) [88]. The authors concluded 
that the risk of RITs or malignant transformation after SRS is very low and should 
not be used as a justification for choosing alternative treatments. Lunsford et al. 
corroborate these findings [81].
5.5 Fractionated radiation/treatment
FR strategy is intended for treating large lesions that carry increased mortality 
and morbidity using interventional methods and lower obliteration rates or longer 
obliteration time when treated using radiotherapy. Unfortunately, large AVM is 
not a well-defined or accepted criterion in the literature. SM refer to >6 cm along 
the nidus largest diameter. Other studies define a volumetric condition >10 (cm3) 
[62]. However, there is a consensus that high single-fraction doses as used in small 
AVMs increase radiation injury risks and associated neurological deficits when 
Figure 7. 
AVM treatment selection scheme (following [81]).
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large normal brain volume is exposed to high doses [89]. Two approaches exist to 
improve safety and efficacy in these cases: (1) fractionation radiosurgery (FR) 
where total dose is equally divided into fractions delivered over multiple sessions 
(days scale), so brain tissue adjacent to the lesion can tolerate higher integral doses. 
(2) Volume staged radiosurgery where the AVM is typically divided into 2–4 
spatial regions each treated separately using a high single-fraction dose. Between 
treatments, a rest period (3–9 months) is imposed. Here, each AVM part is instantly 
treated with a clinically effective dose. Normal brain tissue recovers between treat-
ments. This makes it possible to tackle the main disadvantage of FR—low fractional 
doses are relatively less effective at treating AVM and result in reduced obliteration 
rates unless the total dose is substantially increased [89]. However, a main concern 
of this approach is that partial AVM obliteration apparently alters blood flow 
patterns and increases hemorrhage risks [89]. Currently, there is a little evidence 
for the superiority of one approach over the other [89]. In general, it is highly 
recommended to minimize the integral dose to the normal brain of asymptomatic 
patients. Recently, Unkelbach et al. elegantly demonstrated that by boosting 
complementary parts of the target volume in different fractions, it may be possible 
to achieve a therapeutic advantage in FR since this approach facilitates mean dose 
reduction in the normal brain [89]. To date, FR has not been widely accepted as 
presenting a compelling advantage over multi-modality treatments such as initial 
size reduction using embolization.
5.6 Summary
While gaining popularity and presenting impressive treatment success rates of 
~80%, radiosurgery still has distinct limitations that must be faced. Obliteration 
typically takes 2–3 years during which patients remain exposed to significant annual 
bleeding risks of 4–5% (twice that of conventional treatment) and overall morbid-
ity rates reaching 12%. Large (SM grade ≥ 3) AVMs necessitate multi-modality 
or fractionated treatment. The latter shows promise but requires further study if 
efficient management is desired.
6. Surgical resection
6.1 Patient selection and outcome predictors
The SM grading system for predicting patient outcome is microsurgery-based 
and remains the gold standard in the field [36]. Though the physiological origins 
of each AVM’s clinical presentation are unknown, SM and supplemental grading 
systems have been validated on numerous occasions (see above). These systems 
apply to both patient selection and outcome prediction. Recently, Kim et al. demon-
strated, in a cohort study performed on 1009 AVM patients at four institutions, that 
supplemented SM grades (SM-Supp, also considering the patient age, bleeding his-
tory, and compact anatomy indication) have greater predictive accuracy than stand-
alone SM grades [90]. Their findings are not unique in that they show improvement 
over SM. They also rightfully conclude that “current grading systems are imperfect 
and evolving and that as the pathophysiology, hemodynamics, and genetics of 
AVMs are elucidated through research, grading systems will incorporate these 
advances.” We, however, believe that there is a great difference between academic 
and clinical settings. We acknowledge that complex grading schemes may present 
improved predictability and selection capability. However, we believe practitioners 
must be provided with simple, intuitive, and relatively easy-to-use schemes. Only 
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such schemes will be readily accepted and rapidly/easily implemented in clinical 
settings, particularly in emergency cases. We, therefore, recommend that the fac-
tors incorporated into future grading schemes remain relatively accessible (direct) 
and limited in number.
6.2 Standard microsurgery protocol
We briefly (and humbly) review key steps involved with AVM microsurgery 
[23, 37]. Once a patient is designated for microsurgery, treatment planning and 
evaluation begins. Often, additional imaging is performed to provide maximal 
data for a solid operating plan. Here, 3D reconstruction can prove very helpful and 
emphasis should be given to study the AVM main feeders. Pre-operative steps 
include patient positioning (one that provides a good venous return and preferably 
has the AVM surface aspect horizontal at the top of the approach and the longest 
axis of the nidus vertical) and craniotomy (removal of part of the skull to expose 
the brain), which provides exposure to the lesion area. Here, caution must be 
exerted to ensure the craniotomy is larger than the AVM surface while safeguard-
ing the delicate dilated and exposed draining veins during dura opening (against 
adhesion). Only then can AVM resection be performed. The procedure in general 
is directed from the arterial towards the venous side of the nidus. All vessels must 
be coagulated or clipped. It is customary to leave true feeders to the end since their 
earlier occlusion can lead to the recruitment of blood flow from deep feeders and 
may cause their rupture [23]. It is important to ensure that draining veins present 
no evident flow. Eventually, the nidus is gently rolled out of the resection cavity. 
Post-operative management includes admitting the patient (while completely 
sedated) to the Intensive Care Unit for close observation for evidence of post-
operative bleeding or swelling. A post-operative CT is typically performed shortly 
after the procedure to rule out any such complication followed by a mandatory 
angiography performed on day 2–3 after surgery.
6.3 Results and complications
The main advantage of AVM microsurgery is its “straightforward” approach, which 
allows relatively definite lesion resection and rapid clear follow-up. Microsurgery is 
considered the gold standard in AVM obliteration. It presents a high success (cure) 
rate reaching 99% in small SM 1–2 grades [91–93]. Treatment challenges include 
limitations regarding accessibility (deep locations) and a high risk of severe complica-
tions that contribute to the mortality and permanent morbidity rates of 3.3 and 8.6%, 
respectively, as seen in a meta-analysis performed in 2425 patients between 1990 and 
2000 [8]. A more recent study found permanent mortality and morbidity rates of 1.7 
and 4.8% (2.2% permanent significant morbidity) [91], and yet, another study found 
the permanent mortality and morbidity rates of 7.9 and 14.8% (though obliteration 
rate was 87.2%) [92]. Additional studies present early and permanent disabling deficits 
in 12.3 and 4.5%, respectively, permanent neurological deficit in 16.1% [93], periop-
erative neurological deficits of 17%, annual hemorrhage rate of 0.3%, and a recurrence 
rate of 0.9% in children [94]. These findings and others clearly demonstrate the 
pronounced variations in the modality outcomes depending on surgeons’ expertise, 
patients’ AVM grading distribution (e.g., 7% neurological deficits at SM Grade 1 
compared with 50% at SM 5 in [90]), prior bleeding presentations, multi-modality 
protocol (e.g., surgery following embolization or radiosurgery as in [95]), and so 
forth. A review of the literature indicates that the leading risks of surgical resection 
are intraoperative rupture, post-operative hemorrhage, and post-operative edema. 
These hemodynamic events can become life threatening and disabling. Additional 
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complications of reduced risk are neurologic deficits from over-dissection or ischemia, 
seizures, hydrocephalus, and infections [23, 37]. The subject of lesion recurrence 
following microsurgery has been controversial. Different centers report highly varied 
outcomes. Recently, Aboukaïs et al. analyzed the subject and reported the recurrence 
as a fairly rare case (7/138 cases) affecting mostly pediatric patients. They recommend 
particularly long-term angiographic follow-up in children to detect AVM recurrence or 
remnants [96].
6.4 Emerging trends
Brain microsurgery is a proliferating field presenting many interesting develop-
ments in imaging, treatment management, surgical approach, and so forth. We very 
briefly mention a few promising directions. Molecular imaging employs specific 
antibodies combined with detectable agents such as gadolinium [55]. This tech-
nique was used to image particular receptors on tumors and could non-invasively 
detect biological markers in AVM vessels. If an appropriate biomarker imaging 
probe for AVM is discovered, it will facilitate highly selective lesion diagnosis and 
analysis. Specific conditional biomarkers (activated by physiological occupancy 
of enzymes, ions, and metabolites) can possibly even support super-selective 
procedures. Rad et al. demonstrated that vessels within the mature rat AVM exhibit 
elevated phosphatidylserine (PS) externalization compared with normal vessels 
[97]. Ionizing radiation increased PS externalization in a time-dependent manner. 
They concluded that the AVM localization of PS externalization may function as 
a tool in future SRS treatment. Image guidance provides a promising technique, 
particularly when incorporated into patient intraoperative 3D viewing and simulat-
ing systems [98]. It facilitates improved AVM localization, clearer venous anatomy, 
better definition of craniotomy, and so forth for the surgeons, and may reduce 
intraoperative risks. Spetzler and Sanai used dynamic retraction (retractorless 
surgery) and a variety of advanced handheld instruments with considerable success 
and suggest that fixed retraction can be supplanted by this approach, thus limiting 
the risk of retractor-induced tissue edema and injury [99]. There are additional 
promising directions outside the scope of this chapter. However, most of those 
mentioned (as well as those not discussed here) still lack a large enough database 
for establishing clinical superiority.
6.5 Summary
The neurosurgical aspect of AVM treatment presents a versatile picture. While 
SM Grade 1–2 lesions are treated with good efficacy and low risks (as well as a few 
Grade 3 cases), successful outcome rapidly declines in medium-to-large lesions, 
demonstrating high risk for adverse outcomes (transient and permanent neurological 
deficits as well as mortality). These high risks do not markedly decline when address-
ing large AVMs using a multi-modality approach. Perhaps because such procedures 
are not yet sufficiently established, we cannot currently provide this statement with 
distinct supporting evidence. Small AVMs constitute a large portion (~40% or so 
based on our literature observations) of all lesions. This leaves many cases without 
direct surgical solutions and greatly limits the use of this approach as a single modal-
ity. Future developments include further advancements in imaging methods, aug-
mented reality and simulation systems, and innovative tools and approach methods. 
These will certainly facilitate continuous improvement in efficacy and safety with 
regard to small lesions and an increased ability to effectively treat medium lesions. 
However, we fear that treating the majority of medium-to-large lesions will continue 
to necessitate multi-modal, fractionated, or novel approaches.
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7. Discussion and recommendations
The ARUBA trial, published in 2014, compared interventional therapy with 
medical management of unruptured brain AVMs. It was a broad trial involving 39 
active clinical sites in nine countries. The study recruited 223 patients during the 
period from April 2007 to April 2013. About 114 of the patients were assigned to 
interventional therapy and 109 to medical management. The conclusions were that 
the risk of death or stroke is significantly lower in the medical management group 
than in the interventional therapy group (hazard ratio 0.27). Naturally, the study 
elicited a plethora of reactions that we will not fully cover since they are outside the 
scope of this review. Some, that were relatively more supportive, identified ARUBA 
as the only randomized trial at that time (2010) with clear clinical outcomes com-
paring different interventional treatments for brain AVMs with conservative medi-
cal therapy [100]. More reactions were less supportive, criticizing the pragmatic 
design, the patients’ heterogeneity, the lack of standardization of the treatment 
arm, the choice of outcome measures, the short follow-up period, the small popula-
tion, and so forth [87, 101, 102]. The controversy also led the European societies 
dealing with the treatment of AVMs to conduct a consensus conference at the 
European level [104]. Among the statements made were two key points which we 
quote: “There are sufficient indications to treat unruptured AVMs Grade 1–2 SM” 
and “There may be indications for treating patients with higher SM grades, based 
on a case-to-case consensus decision of the experienced team.” One clear consensus 
emerges—further research is advocated to delineate the optimal management 
of unruptured AVMs, particularly those with SM grade≥3 [103]. Furthermore, 
judicious observation of the literature since ARUBA indicates that there may be a 
lacuna or at least weakness in interventional modalities when addressing high SM 
grade AVMs. This fact has not traversed the community unnoticed. All three main 
interventional modalities present a similar line—advancement in existing treatment 
paradigms, treatment planning, and intra-operative measures. However, to date, the 
core challenge persists. We feel that one possible cause is the limitations inherent in 
present approaches that lead to diminishing returns with every new improvement 
(necessitating ever-increasing technological and financial investments). The two 
leading avenues of interventional choice for medium-to-large lesions are currently 
multi-modal and staged treatment. When considering multi-modal treatment, we 
must take into account other factors besides medical outcomes. Multi-disciplinary 
AVM treatment suffers from a fundamental market/commercial flaw. Every manu-
facturer focuses on its core technologies (whether they are embolic agents, radiation 
therapy equipment, etc.), and these typically do not complement one another. 
This considerably impedes R&D of novel multi-modal techniques and protocols 
by leaving them in the hands of mostly research endeavors that lack the financial 
resources of commercial companies. Interestingly, this fact is clearly reflected in the 
literature. The number of papers we reviewed dealing with single modality treat-
ment is an order of magnitude larger (speaking cautiously…) than those adopting 
a multi-modal approach. This trend continues for the number of patients treated. 
To conclude, we fear that multi-modal treatment faces inherent financial and 
technical limitations that strongly impede its chances of reaching full potential and 
will continue to do so in the near future. Fractionated radiation and multi-session 
(staged) embolization also suffer similar logistic and economic flaws. It is very 
challenging to repeatedly admit patients to very complex and expensive procedures 
also requiring highly experienced medical experts who are typically in “short sup-
ply,” and advanced facilities, particularly in radiation treatment. Considering this 
state of affairs, we conclude that it could be advantageous to consider a treatment 
approach that has not been used to address AVM in the past—continuous mild 
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irradiation provided via an implantable active source. The use of such implants in 
Brachytherapy is very well established and dates back decades (if not a century). 
Much knowledge has been accumulated in the field (we will not review the subject 
due to lack of space). Such an implant has the potential to elicit a hyperproliferative 
effect facilitating lumen closure by thickening of the vascular wall by exploiting the 
“candy wrapper” or edge effect (see further data below).
First, let us attempt to convince the readers that this approach merits medical 
investigation. In Section 6.1, we explained that there are two major changes in tissue 
when exposed to radiation—degeneration and proliferation. Both changes are 
dose- and time-dependent. Therefore, there is room for adjusting and augmenting 
each by controlling radiation kinetics and spatial distribution patterns. Active stent 
studies show proliferation and restenosis reduction (typically in-stent) but also 
induction (typically at the stent edges). Albiero et al. implanted 122 32P radioactive 
β-emitting stents (activity levels of 0.75–12.0 μCi) in 91 lesions in 82 patients [105]. 
After 6-month follow-up, they found that intrastent restenosis was 0–16% (depend-
ing on implant activity; high activity stents showed no restenosis). However, they 
also found that restenosis at stent edges was 41–52% (maximal for the lowest activ-
ity stents!). They concluded that the use of active stents in patients with coronary 
artery disease is feasible and named this edge effect as the “candy wrapper.” They 
speculated that the effect was a result of low radiation at the stent edges combined 
with an aggressive approach to stenting (pre-dilatation with an oversized balloon). 
Shortly after, they also demonstrated that stents with higher initial activity levels 
of 12–21 μCi (54 lesions) reduced intrastent neointimal hyperplasia compared 
with stents of 3–12 μCi (42 lesions) [106]. However, they did not eliminate edge 
restenosis (38% for the lower activity stents were reduced just to 30% for the 
higher activity stents). Since they used a non-aggressive stent implantation strategy 
(pre-dilatation with a non-oversized balloon) in the second study, they also ruled 
out that the edge effect is attributable to the implantation procedure. Wardeh et al. 
implanted 31 stents in 26 patients [107]. They corroborated this deduction (also 
attributing the edge effect to low radiation levels) and concluded that the use of low 
activity radioactive stents is safe and feasible. Sianos et al. analyzed 175 human ves-
sels (131 were eventually eligible) treated according to the beta-radiation in Europe 
(BRIE) study protocol [108]. They wanted to evaluate the impact of Geographical 
Miss (GM—a situation in which the radiation source does not fully cover the injured 
vessel segment) on edge restenosis after intracoronary beta-radiation therapy. The 
injured edges of the effective irradiated segment (EIRS) constituted the GM edges. 
Restenosis was defined as diameter stenosis >50% at follow-up (6 months). They 
found GM affected 41.2% of the edges and significantly increased edge restenosis to 
16.3% compared with 4.3% in non-GM edges (for both proximal and distal edges). 
GM associated with stent injury increased edge restenosis more than that associated 
with balloon injury (from 3.6% with no GM to 18.75% compared with from 5.36 to 
10.71%, respectively). However, EIRS restenosis was similar between vessels with 
and without GM (24.3 and 21.6%, respectively), thus indicating a dominant effect 
for radiation fall origins. Van der Giessen et al. investigated the edge effect in the 
coronary arteries of Yucatan micropigs [109]. They fabricated half radioactive and 
half non-radioactive stents (n = 20, with 10 regular stent controls). Their design 
introduced a mid-stent radioactive dose falloff zone next to a non-radioactive 
stent-artery transition at one side and a radioactive stent-artery transition at the 
other side. They demonstrated a significant mid-stent stenosis at 4 weeks follow-
up. Two animals died suddenly because of coronary occlusion at this mid-zone at 
8 and 10 weeks. At 12 weeks, there was a significant neointimal thickening at the 
mid-stent dose-falloff zone of the half-radioactive stents but not at the stent-to-
artery transitions at both extremities. No mid-stent response was observed in the 
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non-radioactive stents. They concluded that the edge effect is associated with the 
combination of stent injury and radioactive dose falloff. Studies performed on 
both human subjects and animal models found a significant neointimal increase 
at low activity stents edges [110]. These findings seem clinically significant since 
low-dose-related neointimal hyperproliferation, when compared with conventional 
radiosurgery, does not appear to be associated with damage to the Tunica Adventitia 
or Vasa Vasorum, hyaline phenotypes, or any endothelial disfunction (degeneration 
traits). Desouky et al. recently reviewed the targeted and non-targeted effects of 
ionizing radiation [111]. They describe cell and tissue response to low-dose/dose 
rate ionizing radiation. Cells exposed to such radiation exhibit increased cellular 
communication and resistance to future irradiation. They conclude that exposure 
of human cells to low radiation induces molecular processes that are different 
from those induced by high dose radiation. Furthermore, the effects of ionizing 
radiation are not restricted to irradiated cells but also affect non-irradiated cells via 
mechanisms termed “Radiation Bystander Effects” and “Radioadaptive Response” 
[111]. This suggests that a low-dose/dose rate source can potentially affect a larger 
volume than that anticipated from direct energy absorbance evaluations based on 
our experience with high-energy treatments.
The edge effect has always been treated as an adverse phenomenon. However, in 
AVM treatment, the objective is precisely the opposite of most traditional vascular 
procedures—obliteration rather than revascularization. Here, we suggest that 
if exploited properly, this effect may prove highly beneficial. Let us explain its 
potential advantages:
• An implant can be introduced in a minimally invasive manner by an interven-
tional neuroradiologist alongside embolization or standalone. The expertise 
required for these procedures overlaps considerably.
• Gradual closure of the blood vessels will not elicit rapid hemodynamic irregu-
larities that are well known to induce adverse effects such as hemorrhage.
• A single implantation procedure yields short overall operative/hospitalization 
time with FT or staged embolization. No recurrent patient admittance also 
ensures adequate costs compared with staged interventional procedures (also 
considering hospitalization charges).
• The literature indicates that lumen occlusion in these settings requires months. 
This can possibly lead to a shorter overall treatment period compared with FT 
or staged embolization (that can take up to years) and thus reduce hemorrhage 
risks.
• Treatment time for SRS is typically up to ~2 h. For FT, let us multiply it by 
up to 5 which is a common session number—indicating ~10 h. Let us now 
assume that the continuous source is decaying over a period of just 3 months 
~3*30 day/month*24 h/day = 2160 h. This indicates that a dose rate more than 
a 1000 times smaller compared with that which is used in SRS or more than 
200 times smaller compared with FT could eventually provide the same overall 
absorbed energy. This is clearly not a sufficient medical proof since we know 
FT is less efficient than radiosurgery in obliteration rates and we certainly 
have no evidence of the effectiveness of such a source type and radiation levels 
in the AVM context. However, it does clearly indicate the potential for dose-
rate reduction. Many AREs that originally motivated FT could be inherently 
circumvented when mild constant radiation is employed instead of short-lived 
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high-intensity energy doses/rates. Mild radiation also ensures a much better 
contained isodose distribution compared with the target volume and thus 
affected brain volume (Figure 8).
• A mammalian cell cycle typically lasts around a day (~24 h). A treatment 
lasting up to 2 h will not overlap with each of the cell cycle stages. However, a 
continuous source will expose the lesion cells to radiation during each of their 
cell cycle stages. We know from cancer treatment experience that this can 
prove highly beneficial. No data is available to indicate this also applies in the 
case of AVM treatment. However, this is certainly a point to consider.
• There is a mature and experienced medical device/implant industry that can 
reasonably rapidly adjust to develop and fine-tune such implants to AVM clini-
cal requirements.
• Device/implant procedures are relatively easily attuned to qualify for reim-
bursement regulations, so insurance companies and medical centers can adopt 
the treatment modality.
• In contrast with embolic agents, a radiation source does not have to occupy 
each and every AVM blood vessel because it inherently supports a collateral 
effect. This leaves a very wide and flexible working range for the physicians 
regarding the final implantation position.
To conclude, if proven feasible, low-radiation implants could add several unique 
benefits to AVM treatment and we advocate studying their use.
Figure 8. 
Illustration of the conceptual differences between the presumed radiation traits required from a continuous 
source and those required from the current two predominant treatment modalities—radiosurgery and FT. Left: 
radiation dose/rate kinetics. Right: isodose map (the same dashing indicates equal radiation levels). The 
continuous source is constantly effective, thus necessitating significantly reduced doses/rates and facilitating a 
much better contained radiation distribution field, reduced affected brain volume, and potentially reduced 
AREs.
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Abstract
Blister aneurysms are rare carotid lesions characterized by a thornlike appear-
ance in combination with prominent fragility. Comprising less than 2% of all intra-
cranial aneurysms, they are considered to be either dissecting or false aneurysms. 
Etiogenesis remains poorly understood, though atherosclerosis seems to be playing 
a prominent role. Although many approaches have been tried throughout the years, 
treatment of blister lesions remains debatable. Both surgical and endovascular 
modalities can be used, with every technique having though its own limitations and 
pitfalls. In this context, when confronted with such a lesion, physicians should con-
sider all available alternatives in order to maximize the chances of a good outcome.
Keywords: blister aneurysms, blister-like aneurysms, carotid aneurysms
1. Introduction
Blister aneurysms are a rare but well-recognized form of cerebral vascular 
lesions. Comprising less than 2% of all intracranial aneurysms, they are typically 
found on the dorsal or dorsomedial wall of the internal carotid artery (ICA). With 
a characteristic thornlike appearance on angiography, blister aneurysms’ most 
prominent feature is the fragility of their wall. This explains for their aggressive 
clinical course and grave prognosis.
Although most authors agree that blister aneurysms are either dissecting or false 
lesions, their exact nature as well as their optimal management remains unknown. 
Traditionally, surgery has been advocated as the first-line treatment. Primary 
clipping, wrapping, wrap-clipping or even carotid artery sacrifice (with or without 
a bypass) have all been tried. However, results have always been far from satisfying, 
often making neurosurgeons reluctant to operate on such cases.
During the past few years, clinicians’ interest in blister aneurysm has been 
renewed with the introduction of endovascular modalities in everyday practice. 
Among all the different available approaches, flow diversion seems lately to be 
gaining ground, showing promising results. Of course, until consensus has been 
reached, blister aneurysms are still to be treated on a case-by-case basis.
2. General features and clinical presentation
Blister aneurysms are a distinct form of cerebral vascular lesions with often 
mixed characteristics and uncertain pathogenesis. They comprise less than 2% of all 
intracranial aneurysms [1]. Originally described by Sundt and Murphey more than 
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40 years ago [2], the typical configuration of blister aneurysms consists of a shallow 
and broad-based or even semifusiform focal protrusion located on the internal carotid 
artery [3]. Arising from the anteromedial carotid wall in up to 65% of cases [4], these 
lesions seem to be unrelated to major arterial junctions, although very fine branches 
such as those supplying the optic nerve may sometimes be involved [5]. Rarely, blister 
aneurysms can be found on the anterior communicating artery or even the basilar 
trunk [6, 7], while in a recent case report, the posterior inferior cerebellar artery has 
also been implicated as another potential site of origin for such a lesion [8].
A prominent characteristic of blister aneurysms is the marked weakness of their 
wall, a feature that not only reflects the unique pathology of these lesions but also 
predetermines their high rupture risk, aggressive clinical course, and tendency for 
rapid growth and progression. In the most common scenario, a blister aneurysm 
will be diagnosed after an episode of subarachnoid hemorrhage (WFNS grade > 3 in 
68% of cases) [9]. Being initially small and sessile, it will substantially enlarge 
within days of presentation, reaching finally a shape much similar to that of its 
saccular counterparts [4]. Commonly, the end result is a rerupture with potentially 
catastrophic consequences for the patient.
On a side note, and regarding terminology, blister aneurysms were originally 
known as dorsal, anterior or superior carotid wall lesions, a nomenclature though 
that soon became obsolete failing to recognize the presence of such anomalies on 
the medial, posteromedial or lateral surface of the internal carotid artery [10]. 
Additionally, intracranial vessels have never—by tradition—been designated as 
dorsal or ventral, adding another reason to abandon at least the first of these denom-
inations [11]. An alternative, broader term used mainly by Japanese authors was 
carotid trunk aneurysms [4]. Still, confusion remained since bleb-like but essentially 
stable carotid lesions have been encountered during surgery, an observation that 
clearly indicates that not all such morphological entities fulfill the requirements to be 
considered as true blister aneurysms, and as a matter of fact, some of them may even 
be the precursors of typical berry lesions [12, 13]. Whatever the case, the term blister 
(or blister-like) aneurysms seems to be by now the dominant one within the relevant 
literature and as such will be used throughout the present manuscript.
3. Epidemiology and demographics
Blister aneurysms are rare lesions comprising less than 2% of all intracranial 
aneurysms [1] and 0.9–6.6% of internal carotid artery lesions [14]. In the three larg-
est series published to date, Yaşargil et al. reported 3 blister aneurysms in a total of 
319 carotid lesions [15], Nakagawa et al. reported 8 cases in a series of 460 surgical 
patients [3] and Meling et al. reported 14 lesions in a total of 912 aneurysms [16].
Having a slight female preponderance and occurring more frequently on the 
right side, blister aneurysms tend to affect patients at a rather younger age than their 
saccular counterparts [17, 18]. In a series of six patients, Abe et al. found a mean 
presentation age of 56 years [11], while Park et al. calculated this in their own cases at 
35.4 years [19]. Risk factors include arterial hypertension [6] and atherosclerosis [16].
4. Pathological considerations
Due to the rarity of blister aneurysms, our understanding of the relevant pathol-
ogy is only limited. For most authors these lesions are of a dissecting nature [20], and, 
as such, they are considered to be the consequence of a tear in the affected artery’s 




covered by only the adventitial layer. At this point, it should be noted that the adven-
titia of intracranial arteries is well known to be thicker over bifurcation sites, partially 
compensating for the underlying medial defect. Arising exclusively at nonbranching 
arterial segments, blister aneurysms lack this relatively rigid coverage and are thus 
much more fragile than their saccular counterparts [23]. This difference between 
the two accounts for the prominently aggressive clinical course of blister lesions (i.e. 
increased risk of bleeding and tendency for rapid subsequent growth and rerupture). 
In their series of 40 blister aneurysms, Ogawa et al. found signs of dissection (double 
lumen, arterial narrowing or dilation, etc.) in 10 cases [4], while Satoh et al. reported 
a similar association in as many as 16 out of their 18 in total patients [13].
An alternative hypothesis on the pathology of blister aneurysms is that they are in 
fact false lesions, essentially representing a focal arterial wall defect [8]. In this direc-
tion, Abe et al. suggested a few years back that the characteristic bleb-like protrusion 
seen by surgeons in such cases is nothing more than an organized blood clot covering 
the diseased arterial site [11]. Removal of this clot during surgical preparation of 
the aneurysmal dome is highly likely to cause a rerupture [4]. The pseudoaneurysm 
theory was initially based on macroscopic intraoperative findings but was later 
confirmed in at least two cases reported by Charbel et al. [24]. According to these 
authors, pathological examination of the aneurysmal sacs, which were resected in 
both cases, in their entirety revealed only blood clot and no fibrous, elastic or smooth 
muscle tissue (Verhoeff-vanGieson staining plus immunostaining) [24].
The first-ever complete microscopic description of a blister aneurysm has been 
delivered by Ishikawa et al. in their, classic by now, publication in neurosurgery in 
1997. To do this, the authors of the article applied an Elastica Masson stain on cross 
section specimens of the internal carotid artery of a patient who sustained a fatal 
rupture of such a lesion [25]. According to their report, the examined blood vessel 
was heavily atherosclerotic with prominent underlying thickening of the intima. 
Near the edge of the atheromatous plaque, both the internal elastic lamina and the 
tunica media were abruptly terminated, and the resultant gap (i.e. the aneurysm 
sac) was covered only with fibrinous tissue and adventitia. The latter was neither 
thickened nor rich in collagen as is usually seen in a saccular aneurysm. At the 
rupture point, the adventitia was lacerated and fragmented. Notably, and contrary 
to what it would be expected in a dissecting lesion, no inflammatory infiltration or 
dissection of the artery outside the actual aneurysm was observed.
In a more recent publication, Kim et al. reported a blister aneurysm with a 
typical clinical course whose dome was resected during surgery for histologic 
examination. Their conclusions, although interesting, seem to have only added to 
the confusion: immunohistochemical staining for smooth muscle actin proved to 
be positive, a finding compatible with an intact tunica media and thus a true lesion. 
Medial fibroblast proliferation and laminar thrombosis were also noted [26].
It is obvious that the literature on pathology of blister aneurysms has been, up 
until now, far from conclusive. Speculations stray widely with data supporting 
each theory being only limited. A possible explanation is that we are dealing with 
different stages of a rapidly evolving disease or, alternatively, that there is no single 
entity but a whole range of these. Our only certainty seems to be that morphological 
changes taking place in blister aneurysms are much more destructive than those 
seen in berry lesions.
5. Etiogenesis
Similar to their pathology, etiogenesis of blister aneurysms remains, despite our 
best efforts, unclear. Both Stehbens and Ohara have traditionally associated such 
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lesions with atherosclerosis, a concept that has by now gained wide acceptance 
[12, 27]. Atheromatous changes affecting the carotid artery lead to degeneration 
of the internal elastic lamina [28]. The latter is reported to be the major anatomic 
structure resisting the pressure of blood flow within a given vessel [29]. The 
end result is an overall weakening and subsequent laceration of the arterial wall 
(penetrating ulceration) [30]. Focal subadventitial dissection leads to the formula-
tion of a blister aneurysm [14]. For reasons not yet fully understood, this whole 
process usually takes place at the periphery of an atherosclerotic plaque where its 
stiff degenerated wall borders that of a normal elastic vessel segment [25]. Further 
research is needed to explain carotid vulnerability at these locations.
Apart from atherosclerosis, another factor that seems to play an important role 
in the formation of blister aneurysms is hemodynamics. The anteromedial surface 
of the supraclinoid carotid segment, where most of blister lesions arise, is curved 
in such a way that blood flow directly impinges on the arterial wall [4, 11]. In the 
most probable scenario, increased hemodynamic stress acts on an already diseased, 
sclerotic arterial segment, and it is the combination of these two that finally results 
in an aneurysm formation.
6. Diagnosis
Given that the vast majority of blister aneurysms presents with subarachnoid hem-
orrhage, the diagnostic evaluation of such a lesion usually starts with a brain CT scan. 
Hemorrhage is typically lateralized and mainly involves the carotid and suprasellar 
cisterns as well as the Sylvian fissure. Of note is that, when performed within 24 hours 
after ictus, CT scans detect subarachnoid blood with a sensitivity of up to 95%, a figure 
though that quickly drops to less than 50% a week later [31]. This is attributed to the 
rapid decrease of the hemorrhage density due to dilution by cerebrospinal fluid [32].
The second step in the diagnostic triage of subarachnoid hemorrhage is, for most cen-
ters nowadays, a CT angiogram. Blister aneurysms appear, initially at least, as shallow, 
broad-based lesions, usually less than 2 mm and with a characteristic triangular or thorn-
like shape (Figure 1) [33, 34]. Unfortunately, their small size in combination with their 
unusual location (i.e. nonbranching arterial sites) and close proximity to the skull base 
often makes detection of these lesions obscure [35]. Adding to the difficulty, the aneu-
rysmal dome presumably collapses right after rupture, while its parent artery contracts 
as a reaction to the presence of subarachnoid blood. The end result can be a significant 
delay in diagnosis and initiation of treatment. Sensitivity of single slice CT angiography 
in the investigation of intracranial aneurysms smaller than 3 mm has been reported to 
be 25–64% [36]. Better results with improved image quality and spatial resolution have 
been achieved with the introduction of multidetector row technology [37]. Blister lesion 
diagnosis can be also greatly facilitated through the application of a meticulous technique 
(decreased section thickness, increased pitch, proper bolus timing and elimination of 
venous contamination) along with appropriate postprocessing of CTA scans (maximum 
intensity projections, multiplanar reconstructions and volume-rendered 3D images) 
[33]. Notably, most false-negative CT angiograms, when evaluated in retrospect, do 
reveal suspicious anomalies that could be well associated with a blister aneurysm. This 
observation underlines the significance in such cases of a high index of suspicion.
Despite advances in the field of CT angiography, conventional DSA with its 
excellent spatial resolution remains the gold standard for the detection of cerebral 
aneurysms, and, as such, it should be performed whenever initial investigations 
prove to be negative. The appearance of blister lesions on a DSA closely resembles 
that of their CTA counterparts, but luminar irregularities related to atherosclerosis 




oblique views or even rotational 3D scans significantly increase the sensitivity of the 
method [38]. Signs of dissection have been reported in up to 89% of blister aneu-
rysm cases and include a false lumen, an intimal flap, a filling defect or contrast 
pooling [39]. Should the presence of a blister aneurysm be suspected on the basis of 
DSA findings, the evaluation of collateral flow through the circle of Willis is always 
advisable in case an occlusion procedure is to be carried out [18, 33].  
Cross-compression carotid injections may help demonstrate the anterior communi-
cating artery, while patency, size and collateral potential of its posterior counterpart 
can be assessed through an Alcock test (vertebral injections with carotid artery 
compression). For a more detailed study, temporary balloon occlusion will be 
required [31].
Figure 1. 
Reconstructed CTA showing a blister-like aneurysm on the dorsal wall of the internal carotid artery (ICA).
Figure 2. 
Internal carotid injection, AP view. A characteristic thornlike blister aneurysm is noted opposite to the anterior 
choroidal artery origin. Large posterior communicating artery supplying the posterior circulation noted.
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Another important aspect of imaging in cases of blister aneurysms is that, on 
short-term follow-up angiography after initial presentation, these lesions usually 
show rapid growth to a saccular configuration [19]. Being at least partially related 
to lysis of an intra-aneurysmal clot [26], this progression is considered to be a good 
indicator of a blister lesion even though the only real way to authenticate such a 
diagnosis is through direct intraoperative inspection [1, 40].
7. Treatment
Management of blister aneurysms is associated with a high overall rate of 
mortality and morbidity [35]. The main causes for this include the small size and 
broad neck morphology along with the prominent fragility of such lesions, features 
that often lead to intraprocedural rupture when traditional surgical or endo-
vascular techniques such as clipping or primary coiling are to be applied [6, 19]. 
Additionally, and even if an initial intervention proves successful, subsequent 
regrowth requiring further treatment has been commonly reported [9]. Other 
factors contributing to the grim prognosis of blister aneurysms include a commonly 
grave clinical presentation as well as delays in an appropriate diagnosis.
Given the lack of universal consensus in blister aneurysm treatment, a wide 
variety of approaches and methods has been employed up to date and will be dis-
cussed below. These have included both reconstructive and deconstructive surgical 
and endovascular techniques, with different authors competing for best results in 
an ever-changing field. In any case, attention should be given to specific measures 
to prevent rerupture while awaiting final treatment (tight arterial blood pressure 
control, cautious cerebrospinal fluid drainage in patients with a ventricular drainage 
in place and selective use of aminocaproic acid) [41]. The latter must be instituted as 
soon as possible to secure the aneurysm and to allow aggressive management of sub-
arachnoid hemorrhage-related complications such as vasospasm and hydrocephalus.
The alternative treatment modalities for blister aneurysms are:
a. Reconstructive techniques
• Surgery: primary clipping (including encircling clips), wrapping,  
clip-wrapping, wrap-clipping and direct suturing
• Endovascular therapy: primary coiling, stent-assisted coiling, telescopic 
stenting (stent-in-stent technique) and flow diverters
b. Deconstructive techniques
• Parent artery occlusion with surgical or endovascular means with or without 
bypass surgery
7.1 Surgical treatment
7.1.1 Clipping procedures (primary clipping and wrap-clipping)
7.1.1.1 Technique
Traditionally, surgical clipping has been the preferred mode of treatment for 
all forms of cerebral aneurysms, including blister lesions. In a typical case, the 




proximal control in case of an intraprocedural rupture. This is usually achieved with 
an incision along the medial border of the ipsilateral sternocleidomastoid muscle 
[42]. Subsequently, a standard pterional craniotomy with generous sphenoid ridge 
drilling is carried out, and through this, the Sylvian fissure is opened widely. Gentle 
retraction of the frontal lobe provides access to the supraclinoid internal carotid 
artery which, in most cases, is found to be prominently sclerotic [43]. The aneurysm 
itself is usually seen protruding from the dorsomedial carotid wall. Careful prepara-
tion of the aneurysmal dome is crucial. As a matter of fact, should the frontal lobe 
be attached to it, most authors propose a subpial dissection in order to minimize 
direct manipulation of the lesion [44]. Special care is needed to avoid removing the 
platelet plug that typically covers the aneurysm as this may result in a large wall 
defect and uncontrollable bleeding [4].
Direct clipping of a blister aneurysm is performed under temporary trapping 
and in such a way that the blades of a usually angled or curved Sugita clip are 
parallel to the longitudinal axis of the carotid artery [19, 45]. This has been shown 
to lower the risk of intraprocedural rupture [17]. Given that the underlying patho-
logical process seems to extend well beyond the limits of the aneurysm itself, the 
surgeon should try, when closing the clip, to include part of the “normal” arterial 
wall outside the lesion in order to avoid breakage of the transitional zone found in 
between them [4]. A valid alternative is to envelope the entire diseased arterial seg-
ment with a wrapping material such as gauze, cotton or Gore-Tex on top of which 
the clip can be applied to obliterate the lesion [46]. Wrap-clipping not only rein-
forces the carotid wall as a whole but also helps avoid slippage of the clip, a compli-
cation not uncommonly seen in blister aneurysms surgery [47]. One yet alternative 
is to wrap the lesion after the clip has been applied (clip-wrapping). Whatever the 
exact technique, induced hypotension [11], burst suppression with desflurane or 
thiopental, cooling of the patient or even transient flow arrest with adenosine can 
all prove useful adjuncts [11, 24, 41, 48].
7.1.1.2 Results of clipping procedures, associated complications and rescue measures
Primary clipping of blister lesions is known to carry an up to 30% risk of 
complications, both intraoperative and postoperative [9, 49]. In the former group, 
aneurysm avulsion and internal carotid artery laceration seem to be our major 
concerns, while progression of the lesion often accompanied by rerupture seems to 
be the main danger during the postoperative period [50].
When confronted with a laceration of the carotid artery during surgery, the 
most commonly used rescue technique has traditionally been sacrifice of the vessel 
to control bleeding. As proven by numerous studies, this is associated with a high 
risk of cerebral ischemia, not only because collaterals may be inadequate in the first 
place but also due to hemorrhage-related vasospasm that often further aggravates 
the whole situation [16]. Other alternatives include direct suturing, placement of 
an encircling clip graft and reapplication of the originally placed clip to intention-
ally narrow the carotid artery and thus achieve hemostasis [4, 43]. In every case, 
surgeons must be always prepared for such an event, and large aspirators need to be 
available throughout the procedure. Initial hemorrhage control is usually achieved 
by applying direct pressure on the artery with oxidized cellulose and a small cot-
tonoid. Brief periods of cardiac arrest with the aid of adenosine are also useful to 
improve visibility and help gain control of the situation [41].
Direct suturing of an arterial tear during surgery for a blister aneurysm is made 
possible because the edge of the lesion is relatively well outlined [51]. It entails 
removal of the original clip, trimming of the aneurysmal sac with microscissors (to 
prevent tissue buckling into the lumen) and repair of the arterial wall defect with 
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8/0 nylon stitches [43]. Suturing in the acute stage is usually extremely difficult due 
to the deep and narrow surgical field. As a result, initial attempts at this required 
prolonged trapping of the diseased segment invariably led to cerebral ischemia [52, 
53]. To avoid this, recent studies propose reformation of the arterial wall with only 
a few stitches rather than its complete restoration [43]. Subsequent circumferential 
wrapping of the artery or, alternatively, placement of an encircling clip graft should 
be enough to stop oozing and stabilize the end result [54].
Encircling clip grafts have been developed by Sundt almost 40 years ago and spe-
cifically to address the problem of repairing the wall defect associated with a blister 
aneurysm [2, 55]. They can be used either as a primary modality (instead of the 
classic clip) or in cases of intraoperative rupture. Applied typically with the aid of a 
straight or right angle clip holder, Sundt clips provide a rigid sleeve and a soft woven 
fabric lining, allowing surgeons to essentially reconstruct the lacerated arterial wall 
[56]. Produced in various sizes, the appropriate clip for each case can be estimated 
on the basis of preoperative angiographic studies with a 3–4 mms diameter and 
a 3–5 mms length being the most widely used options [42]. Major disadvantages 
associated with these devices are that they cannot be used in cases of lesions close or 
opposite to carotid branches (i.e. posterior communicating and anterior choroidal 
arteries) and also that they come in certain fixed diameters that may or may not fit 
the vessel involved [48]. The latter limitation occasionally leads to postprocedural 
stenosis, a risk that surgeons must always be aware of and act accordingly [6]. Of 
note is a recent publication by Cho et al. who used a Sundt clip in combination with 
an endovascularly placed carotid stent to treat a ruptured blister aneurysm with 
good results [42]. Being a valuable adjunct in blister lesion surgery, encircling clip 
grafts should be readily available in all such procedures. Sadly, these adjuncts are 
rarely part of the modern day aneurysm clip tray, and young neurosurgeons are 
often not even aware of their existence.
Despite all efforts, intraoperative rupture of a blister aneurysm carries a mortal-
ity rate of up to 25% [57]. On this basis, and with surgeons trying for improved 
results, novel techniques continue to emerge. An interesting addition to our arma-
torium has been recently proposed by Kazumata et al. in the form of a protective 
bypass concept. According to these authors, when dealing with a blister aneurysm, 
and knowing the fragility of such a lesion, surgeons should at least contemplate 
an STA-MCA bypass prior to any attempted clipping. Ensuring adequate cerebral 
perfusion, this technique allows, in case of an intraoperative laceration, time for 
corrective measures to be applied accordingly. The duration of temporary occlusion 
for direct suturing or clip reapplication seizes to be a limiting factor, while, should 
the need for a carotid occlusion arise, this can be done safely, combined with a 
proper high-flow, radial artery graft bypass [58].
7.1.2 Wrapping procedures
In an effort to limit intraoperative manipulation of the lesion, neurosurgeons, 
especially in the past, have widely used wrapping of blister aneurysms as an alter-
native to clipping mode of treatment. In this context, wrapping is undertaken when 
a traditional clip cannot be properly applied due to either the morphology of the 
aneurysm itself or the underlying sclerotic changes of the parent vessel (i.e. the 
carotid artery) [46]. The technique entails encasing of the entire diseased segment 
of the carotid artery with an appropriately sized thin sheet of—usually—cotton. 
On occasions, cuts along its longitudinal axis are made to accommodate for branch 
vessels and perforators. Creation of ample room to allow free movement of surgical 
instruments and circumferential dissection of the aneurysm dome can prove dan-




the aid of microforceps, and an angled clip is used to fit it snugly around the artery. 
Once the wrapping is secured, any excess length is cut and removed [39, 41].
The concept behind wrapping is that mechanical reinforcement of the diseased 
carotid artery provides protection from a potential rerupture during the immediate 
postoperative period while, in the long term, induced inflammatory changes even-
tually lead to connective tissue formation and remodeling of the weak arterial wall 
into a histologically competent structure [47, 59, 60]. Wrapping materials that have 
been tried out include muscle, muslin gauze, Teflon, silicon, collagen-impregnated 
Dacron fabric and cotton [46]. The latter seems to dominate today the relevant 
literature with most authors proposing it as the most effective option. Notably, 
Biobond, a cyanoacrylate glue widely used in the past, is by now obsolete due to its 
toxicity [60–62].
Complications associated with wrapping are rare. Perforator injury or parent 
vessel narrowing following placement of whichever material has been chosen make 
postoperative angiography an absolute necessity [63]. Delayed development of a 
granuloma or arachnoiditis has also been reported resulting in cranial neuropathies 
[64, 65], an observation that has led many authors to suggest that cotton must be 
used with the utmost care and never be placed in contact with adjacent cranial 
nerves, especially the chiasm [46, 63].
In the premicrosurgery era, numerous studies have been published on the 
efficacy and safety of wrapping. Among these, the largest series has been the one 
presented by Todd et al. in 1989. According to it, the risk of early (within 6 months) 
rehemorrhage after wrapping of an aneurysm has been calculated to be 8.6%, while 
late incidents were at 1.5% per year [66]. Results seem to have been significantly 
better after the introduction of the surgical microscope although only few rel-
evant articles exist. Characteristically, Cudlip et al. reported in 1998 a series of 15 
wrapped aneurysms with no rehemorrhages within 1 year after surgery [67].
Wrapping is unquestionably inferior to clip ligation for the treatment of rup-
tured aneurysms. However, it does offer a degree of protection during the immedi-
ate postoperative period, and, by doing so, it remains today a valid—even though 
last resort—therapeutic option when confronted with a blister aneurysm [47].
7.2 Endovascular treatment
Initial attempts at endovascular treatment with primary coiling of blister 
aneurysms (Figure 3) have returned, in most cases, disappointing results [68]. A 
high risk of intraprocedural rupture and coil protrusion or migration were prob-
lems commonly encountered due to the small size and shallow morphology of such 
lesions, their fragile nature and their proximity to vascular curves on the carotid 
wall (the latter, in combination with the typical orientation of blister aneurysms, 
has been known to necessitate a difficult and extremely gentle catheterization 
maneuver in order to gain access to the sac while avoiding a potential perforation) 
[19, 35]. Additionally, the lack, in many cases, of a true wall often allowed for post-
treatment progression and—possibly—rebleeding [40]. As a consequence, most 
authors advocated that blister aneurysms are unsuitable for endovascular treatment 
and should therefore be left to surgery [69].
With the introduction of intracranial stents in clinical practice, our concep-
tion of blister lesion management has gradually changed. Surgical techniques are 
increasingly looked down upon as outdated and old-fashioned while stent-assisted 
coiling (Figure 4) became, initially at least, the new trend in the field. The proce-
dure is carried out either by first placing the stent (e.g. Neuroform or Enterprise 
stents) and then introducing coils through its struts (trans-stent coiling) or by 
catheterizing the aneurysm sac and deploying the stent over the microcatheter 
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Figure 4. 
Intraprocedural images showing stent-assisted coiling of a left ICA blister lesion.
prior to coiling (jailing technique). Facilitating stable intrasaccular coil deploy-
ment while at the same time reinforcing the underlying diseased arterial wall, 
stent-assisted coiling promised to provide a safe and reliable therapeutic alternative 
[20, 70]. However, it was soon realized that results, even though better than those 
of surgery, were far from optimal. Intraoperative complications, mainly bleeding, 
were encountered in up to 17% of cases, while the risk for recurrence of the lesion, 
need for further treatment and postoperative repeat hemorrhage were reported 
at 65, 50 and 13%, respectively [9, 35, 71]. Notably, Meckel et al. found that the 
latter, a potentially catastrophic and fatal event, is seen only in cases that show 
incomplete occlusion (i.e. neck remnant or residual sac) by the end of the initial 
already procedure and especially if the patient receives full double antiplatelet 
treatment postoperatively or if the aneurysm in question is atypically large or 
partially thrombosed [35]. In this context, early and tight angiographic follow-up of 
partially obliterated lesions is essential, while any signs of regrowth should prompt 
complementary treatment. In the face of all these, most authors are by now mov-
ing away from stent-assisted coiling being the preferred primary and sole mode of 
treatment. Instead, they are using it, if possible, as a preliminary means to achieve 
a certain degree of protection until definite treatments, in the form of some other 
techniques, can be instituted.
Prior to moving on, and in order to close the discussion of stent-assisted coiling, 
it should be noted that one more major argument against it is the need for subse-
quent antiplatelet therapy [72]. This, combined with a potentially still unsecure 
aneurysm, requires careful consideration. Additional risks include the frequent 
Figure 3. 




need for a surgical intervention at a later time (e.g. extraventricular drainage or 
shunting procedures) [73, 74] and delayed spontaneous intraparenchymal bleed-
ing with the rate of the later though not being affected by the initial subarachnoid 
hemorrhage [75, 76]. The exact therapeutic antiplatelet regimen that should be used 
in such a setting is still debatable. Some authors suggest that a similar to elective 
case scheme should be followed: loading with full doses of aspirin and clopidogrel 
just prior to the procedure, double antiplatelets for 3–6 months (usually 75 mg 
aspirin and 75 mg clopidogrel daily) and then continuation of only aspirin for 
another 6 months to life [77]. Going even further, Lee et al. augmented this regimen 
by a full-dose heparinization for 24–48 hours postoperatively [1]. On the contrary, 
other authors favor a reduced or even single-drug scheme. The rationale for this is 
that in the presence of a high-flow state within the stented lumen of large-size ves-
sels (e.g. internal carotid artery), fibrin formation or clotting is relatively unlikely. 
Moreover, the risk of and the consequences of a potential intraprocedural rerupture 
are minimized, while at the same time occlusion of the aneurysm through thrombus 
formation is significantly facilitated. Using such an approach, Meckel et al. reported 
in 2011 only 1 fatal rehemorrhage in between 11 patients who were primarily treated 
with stent-assisted coiling of blister aneurysms. In other reports, stent-assisted 
coiling under systemic heparinization and loading with dual antiplatelets only after 
the procedure was found to be associated with a cumulative risk of thrombotic and 
hemorrhagic complications as low as 2% [78], while the intraprocedural use of 
aspirin and later introduction of clopidogrel carried a 21% overall risk of periopera-
tive complications [79]. In any case, and because of significant heterogeneity of 
response to antiplatelet drugs, platelet function should be performed prior to any 
intervention as well as during the postoperative period (a patient’s response may be 
found to change over time) [80, 81].
A recent development in blister aneurysm treatment and a welcome addition to 
our armatorium has been flow diversion. According to advocates of such a concept, 
and given that blister lesions are regarded by many as pseudoaneurysms, flow 
diversion is the only endovascular technique capable of actually reconstructing the 
vessel wall and sealing off any underlying defect [8, 82]. This can be achieved either 
through a stent-in-stent technique or with the aid of devices such as the pipeline or 
the Silk flow diversion systems. The former typically entails telescopic deployment 
of multiple overlapping stents within the diseased vessel in an effort to increase 
the total mesh density and thus restore proper parent artery laminar flow [8]. This 
results in thrombosis of the lesion, an effect augmented by endothelial prolifera-
tion along the length of the implanted stents. In the same direction, and specifi-
cally designed with this in mind, proper flow diverters like the Silk or the pipeline 
systems provide significantly better hemodynamic results at the expense however 
of increased perioperative complications due to their stiffness and thrombogenicity 
[83–85]. Notably, and regardless of the technique selected, flow diversion allows 
for preservation of branching vessels, an important feature when it comes to blister 
aneurysms since such lesions are usually located close to the posterior communicat-
ing or the anterior choroidal arteries [86].
Major concerns with the use of flow diversion for the treatment of blister lesions 
include an even more prominent need for antiplatelets as well as the fact that such 
an approach does not guarantee protection from postoperative progression and 
rerupture. Regarding the latter, and despite reports of a marked decrease in intra-
aneurysmal flow on the intraoperative already angiogram, hemodynamic stress 
upon the lesion theoretically remains at least for a few days [40]. Rasskazoff et al. 
recently reported that even with the use of double SILK flow diverters, complete 
occlusion of a blister aneurysm they treated did not occur till 18 days after the 
intervention, while Consoli et al. verified obliteration of a similar lesion no less than 
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6 months postprocedurally [8, 75]. A valid alternative possibly addressing the whole 
issue is the combination of flow diversion with coiling. On this basis, Kim et al. 
have reported favorable results with stent-assisted coiling as a primary treatment 
augmented by deployment of a second flow diverting stent if needed (i.e. postop-
erative progression of the lesion) [39]. In cases with extremely small lesions where 
coil deployment is perceived as carrying a significant risk, the reverse route can 
also be followed: telescopic stenting and subsequent trans-stent coiling should the 
lesion further grow to allow that [40]. Another attractive option involves covered 
stents; their use however is still limited due—mainly—to their stiffness, a feature 
that makes their intracranial delivery not only difficult but also dangerous since 
they may impinge on the fragile aneurysm neck portion resulting in intraoperative 
rupture. In addition, they often prove impossible to fully conform to the curved 
supraclinoid carotid wall, and, in this way, they can potentially leave an underlying 
aneurysm essentially open [39]. Whatever the case, further experience is needed 
should such devices gain a significant role in blister aneurysm treatment.
7.3 Parent artery occlusion
Although often considered as inherently inferior, deconstructive techniques 
allow for definitive occlusion of a blister aneurysm with minimal direct manipula-
tion of its walls. In this context, carotid artery sacrifice and trapping of blister 
lesions significantly reduce the overall risk of rerupture during the perioperative 
period [19, 87].
Should carotid artery occlusion be contemplated as a final treatment, endovas-
cular rather than surgical trapping is recommended due to its convenience, rapidity 
and safety. In an often cited article, Park et al. have described an elegant technique 
entailing the use of two microcatheters and a proximal balloon to control blood flow 
intraoperatively [19]. The first microcatheter is placed distal to the aneurysm, while 
the second is positioned just at the level of its neck. With the aid of the latter, and 
after inflation of the balloon, a framing coil is deployed inside the carotid artery. 
Prior to detachment, the distal microcatheter is retrieved and repositioned within 
the coil mess. Additional coils are deployed till a stable result is achieved. The use of 
trapping coils instead of detachable balloons is perceived as having a lesser risk of 
intraprocedural rupture.
When occlusion of the carotid artery is suggested, postoperative patency of its 
cardinal branches requires careful consideration. A detailed study of the ophthal-
mic, the posterior communicating and the anterior choroidal arteries as well as their 
collaterals is essential:
i. Ophthalmic artery
Blister aneurysms arise on the communicating segment of the internal carotid 
artery, and therefore the ophthalmic artery does not usually present a problem 
when dealing with such a lesion. If a choroidal blush via the external carotid 
circulation is visualized on preoperative angiograms, the trapped segment of the 
carotid artery is typically extended to include the origin of the ophthalmic artery 
as well, achieving thus a more robust result. As an additional precaution, proximal 
occlusion of the cervical internal carotid artery may also be performed. If, on the 
other hand, no ophthalmic collateral vessels are visualized, preservation of the 
ophthalmic artery is absolutely essential, and carotid trapping should be kept short. 
Accordingly, the proximal carotid artery cannot be occluded, and, as a consequence, 




ii. Posterior communicating artery
Due to its proximity to blister lesions, the posterior communicating artery often 
needs to be included in the trapped carotid segment. In most cases this is safe with 
the only exception being a fetal-type vessel. In the latter case, an alternative thera-
peutic strategy should be considered.
iii. Anterior choroidal artery
Preservation of the anterior choroidal artery is essential in order to avoid post-
operative hemiplegia. On this basis, precision of segmental occlusion offers obvious 
advantages. Should the origin of the anterior choroidal artery prove impossible to 
save, the procedure should be abandoned.
Apart from carotid side branches, another important concern with all decon-
structive procedures is postoperative early or late ischemia. Unselective, abrupt 
occlusion of the internal carotid artery is known to carry a 26% risk of cerebral 
infarction and 12% risk of death [88]. A balloon occlusion test should always 
be performed when such an approach is contemplated. This entails inflation of a 
nondetachable balloon at the site of the intended occlusion and subsequent clini-
cal and angiographic evaluation of hemispheric collateral circulation [89, 90]. 
However, one should always keep in mind that—in the setting of a subarachnoid 
 hemorrhage—results of a balloon occlusion test can be misleading. This is due 
to the fact that a balloon occlusion test does not take into account the hemodynamic 
effects of a posthemorrhagic vasospasm which may complicate such cases [16].
For patients who fail a balloon test occlusion, surgical bypass should be contem-
plated. Traditionally, this is in the form of an artificial communication between the 
superficial temporal and the middle cerebral artery with or without an interposed 
vascular graft (radial artery or saphenous vein) (STA-MCA bypass) [16, 58]. In the 
case a graft is to be used, this is termed as a high-flow bypass and ensures signifi-
cantly better results [91]. As a matter of fact, there are authors recommending 
high-flow bypasses as a primary mode of treatment for blister aneurysms. However, 
experts in the field seem skeptical advocating that a high-flow bypass should never 
be thought of as complete substitute for normal carotid artery supply, quoting an 
80% rate of postoperative complications, including graft occlusion and vasospasm-
related cerebral infarction [41]. Additionally, surgical bypass in patients with 
severely atherosclerotic vessels typically requires antiplatelets, a feature that only 
adds to the overall risk.
8. Conclusion
Our understanding of blister aneurysms is still today incomplete. Having a 
relatively wide spectrum of pathological differentiations, they can be classified as 
either true or false lesions. Whether this represents consecutive stages of the same 
entity or a different, in each case, disease remains to be clarified. Further research 
on the field is an absolute necessity, and young physicians should thus be encour-
aged toward this direction by their senior colleagues.
A direct consequence of our limited knowledge on the nature of blister aneu-
rysms is the lack of an established and universally accepted treatment modality. 
This lack of consensus has led to numerous attempts at novel and often promising 
therapies. However, and with the sole exception of the recently introduced flow 
diverters, all previous options have invariably failed to rise to initial expectations. 
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Flow diversion, despite its limitations, arises today as probably the most attractive 
future prospect. However, until our technology reaches that point, blister aneu-
rysms are still to be treated on a case-by-case basis. In this context, when confronted 
with such a lesion, physicians should consider all available alternatives, both surgi-
cal and endovascular, in order to maximize the chances of a good outcome.
Whichever end treatment modality is to be used, an important point when deal-
ing with a patient that has suffered rupture of a blister aneurysm is amelioration of 
perihemorrhage management in its entity. Careful consideration of all measures to 
prevent and, if needed, manage rebleeding or any other related complications (i.e. 
vasospasm, hydrocephalus, seizures) is essential. All these issues would preferably 
be addressed within a multidisciplinary team consisting of neurosurgeons, inter-
ventionists and ICU specialists should the best possible result be achieved.
As with every other such case, and despite initial enthusiasm, each new thera-
peutic approach proposed for blister lesions needs careful consideration and long 
periods of follow-up to evaluate its efficacy, safety and durability of results. It is 
obvious that further research in the field is an absolute necessity and young physi-
cians should be encouraged toward this direction.
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Arteriovenous Fistulas: The 
Pathological Bridge
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Abstract
An intracranial dural arteriovenous fistula (DAVF) is a type of intracranial 
vascular malformation in which there is a connection between an intracranial 
artery and a dural venous sinus. It accounts for 10–15% of all intracranial arte-
riovenous malformations. This malformation derives its arterial supply primarily 
from meningeal vessels, and the venous drainage is either via dural venous sinuses 
or through the cortical veins. DAVFs have a reported association with dural sinus 
thrombosis, venous hypertension, previous craniotomy, and trauma, though many 
lesions are idiopathic. Digital subtraction angiography remains the gold standard 
for diagnosing these fistulas. Endovascular treatment is one of the first line options 
available for their management. In this chapter, we will discuss and review the etio-
pathogenesis, natural history, common classification systems, and various available 
diagnostic options.
Keywords: angiography, fistula, intervention, pathophysiology
1. Introduction
DAVFs are arteriovenous shunts from a dural arterial supply to a dural venous 
channel, typically supplied by pachy-meningeal arteries and located near a major 
venous sinus. The etiology of these lesions is not fully understood; some are 
congenital, and others are acquired. DAVFs in the pediatric population are associ-
ated with structural venous abnormalities [1], but most DAVFs are thought to be 
acquired. Different etiologies have been implicated in this phenomenon, namely 
sinus thrombosis, trauma, or surgery [2–6].
Yasargill noted that Rizzoli, in 1881, was the first to describe an arteriovenous 
malformation (AVM) that involved the dura mater and Sachs reported the first, 
angiographic description in 1931. Subsequently cranial dural fistulas have been most 
frequently described at the transverse sinus and cavernous sinus, although they 
occur at every cranial dural sinus. Dural arteriovenous fistulas (DAVFs) can occur 
anywhere within the intracranial dura mater. DAVFs are rare vascular abnormalities. 
They consist of numerous tiny connections between branches of dural arteries and 
veins or a venous sinus [7]. The true incidence of DAVFs is unknown [8]. However, 
the reported incidence of intracranial DAVFs is approximately 10–15% of all intra-
cranial vascular abnormalities. A good percentage of DAVFs are asymptomatic or 
undergo spontaneous involution therefore the true incidence may be much more [9]. 
DAVFs are acquired lesions; that is why they present later in life than AVMs [10].
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2. Pathogenesis
Many factors have been involved in the pathogenesis of DAVFs; however, the 
exact pathophysiology remains unclear.
Some patients with DAVFs have been found to have venous sinus occlusion, 
which was proposed to be the direct cause for the development of the fistula. While 
others were found to have venous sinus thrombosis which resulted in the formation 
of small dural arteriovenous shunts by the invasion of angiogenic factors, released 
from the organizing thrombus, to a group of small dural arteries. However, it has 
been noted that DAVF can precede either venous sinus occlusion or thrombosis, 
because of its association with venous hypertension [11, 12].
Venous hypertension may lead to chronic focal decrease in both regional cerebral 
blood flow and cerebral perfusion pressure. The decrease in the cerebral blood flow 
will cause cerebral ischemia, which increases the expression of vascular endothelial 
growth factor (VEGF) via hypoxia-inducible factor-1α (HIF-1α) upregulation, 
leading eventually to the formation of DAVF. Also, some theories suggest that if 
venous hypertension was present, a small arteriovenous anastomosis might open up 
and generates DAVF when the shunting enlarges [13].
Besides occurring incidentally, the development of DAVFs has been caused by a wide 
range of events with head trauma, with or without skull fractures, being the most com-
mon one. Other preceding events include surgical operations like craniotomy, hormonal 
alterations like what happens in cases of pregnancy and menopause, infections like 
cases of otitis and sinusitis, and tumors, particularly meningiomas [14].
3. Classification
The Borden-Shucart and Cognard systems are both known to be the most com-
monly used systems to classify DAVFs. However, there have been many classifica-
tion schemes submitted for DAVF [10]. The Borden classification system (Table 1) 
classified DAVFs into three main types according to the presence or absence of 
cortical venous drainage (CVD) and the location of venous drainage [15]. In type 
I lesion, the drainage goes to the dural sinus or meningeal vein in an anterograde 
fashion. In type II lesion, the drainage to dural sinus goes in an anterograde fashion, 
however, the high pressure within the DAVF causes blood to flow in a retrograde 
way to subarachnoid veins. In type III lesions, the drainage goes directly and com-
pletely to subarachnoid veins [11].
The Cognard grading scale (Table 2) classifies DAVFs into five main types based 
on the direction of the flow whether anterograde or retrograde, presence or absence 
of a CVD, presence of venous ectasia whether ectatic or nonectatic cortical vein and 
the location of the fistula [14].
The presence of a CVD (Borden type II and III, Cognard types IIb–V) or absence 
(Borden type I, Cognard types I, IIa) and the pattern of the venous drainage all are 
considered major factors by the previous classification systems and were used to 
assess the risk of hemorrhage or any neurologic deficits [16]. The absence of a CVD 
Type 1 Venous drainage into a dural sinus without CVD
Type 2 Venous drainage into a dural sinus with associated CVD
Type 3 Drainage into cortical veins (CVD)
Table 1. 
Borden classification of DAVF.
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has been recognized as a favorable factor and the patients are usually asymptomatic 
or have symptoms like pulsatile tinnitus or exophthalmos [15]. On the other hand, 
presence of a CVD is an unfavorable factor that puts the dural fistula in a higher 
Type I Venous drainage into dural sinus with antegrade flow
Type II a Venous drainage into dural sinus with retrograde flow
Type II b Venous drainage into dural sinus with antegrade flow and CVD
Type II a + b Venous drainage into dural sinus with retrograde flow & CVD
Type III Venous drainage into cortical veins (CVD)
Type IV CVD with associated venous ectasia(s)
Type V Venous drainage into spinal perimedullary veins
Table 2. 
Cognard classification of DAVF.
Figure 1. 
Magnetic resonance angiography demonstrating the arteriovenous fistula.
Figure 2. 
Digital subtraction angiography showed dural arterio-venous fistula with pseudo aneurysm at the abnormal 
anastomoses between the right temporal artery and the superior sagittal sinus and the facial vein.
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risk group. DAVF has a higher chance of being symptomatic if the type of either 
classification systems was higher. Also, symptomatic lesions have a higher risk of 
hemorrhage than asymptomatic lesions [16] (Figures 1 and 2).
4. Clinical presentation
Patients with DAVFs may be discovered incidentally and be totally asymp-
tomatic. However, if symptoms are present, they can range widely from mild to 
fatal in severe cases. The site of DAVF and the direction of the venous drainage 
(anterograde or retrograde) are two of the factors that will determine the nature of 
symptoms [17].
Benign symptoms like headache and pulsatile tinnitus present when DAVF 
drains into dural sinus in an anterograde pattern without CVD. Aggressive symp-
toms of pseudotumor cerebri, papilledema and dementia present when DAVF 
drains in a retrograde pattern leading to an increase in the intracranial pressure, 
hence the severe presentation [11].
According to location, ophthalmic symptoms like chemosis, exophthalmos, 
double vision and low visual acuity occur if the DAVF is located in the cavern-
ous sinus because the ophthalmic venous drainage may get compromised with 
subsequent increase in the intraocular pressure and periorbital edema [13]. Ear 
symptoms like pulsatile tinnitus and retroauricular pain present if DAVF involves 
transverse and sigmoid sinuses. Pulsatile tinnitus can be heard over the mastoid 
area with auscultation [16].
Tentorial and anterior cranial fossa DAVFs usually present with hemorrhage 
because both can obtain retrograde CVD. Exophthalmos and chemosis are also present 
in cases of anterior cranial fossa DAVFs if they obtain cavernous sinus drainage [11].
In severe cases, patients suffer from intracranial hemorrhage and neurological 
deficits like seizures, parkinsonism, and cerebellar symptoms [15].
Other presentations include brainstem infarction and cervical myelopathy if 
DAVF is located around the brainstem. Also, these lesions can cause cranial neu-
ropathy because of the compression on cranial nerves [13].
5. Diagnosis
Catheter angiography is the gold standard technique for the diagnosis and clas-
sification of DAVFs. Based on the site of DAVF, this method is usually performed by 
using the four-vessel technique injections with an injection into the external carotid 
arteries. Several dural arterial feeders with early drainage into a dural sinus or corti-
cal vein are mostly revealed on angiograms. Also, conventional angiograms are used 
to classify DAVFs based on the venous architecture and the extent of cortical venous 
reflux.
Among all the used methods for the diagnosis of DAVFs like CT, CT angiog-
raphy, MRI and MR angiography, CT has been the initial neuroimaging method. 
Although it can reveal areas of ischemia, edema and ICH, it could not identify 
DAVF ideally. On the other hand, CTA has been a better method for identifying 
DAVFs, because it can show a dilated vessel associated with an ICH or calcification 
with chronically congested veins. Also, MRA has the same ability of CTA of show-
ing dilated vessels.
As both MRA and CTA can show the site of DAVFs in relation to normal brain 
structures, they are both used as adjuvant methods to catheter angiography, which 
allows both techniques to be used in intraoperative navigation [14, 15].
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This is the first case of a DAVF causing isolated intraventricular hemorrhage 
with radiographic evidence of several cortical venous refluxes into the subependy-
mal venous network. Also, it is the first case of DAVF that was successfully cured 
using multimodality transvenous and trans-arterial embolization techniques. A 
hypertensive, diabetic 84-year-old woman whose modified Rankin scale score is 0, 
presented to the emergency room complaining of headache for 4 days, nausea, 
vomiting and worsening confusion with episodes of severe drowsiness. Non-
contrast CT scan of the head, CT angiogram of the brain, and digital subtraction 
cerebral angiogram were performed. She was treated by transvenous coil emboliza-
tion of the right transverse/sigmoid sinus using POD5 and penumbra −400 coils 
and trans-arterial onyx-18 embolization of the right middle meningeal artery. She 
had 4- and 6-week follow-up by diagnostic angiogram and 6-week follow-up by 
clinical examination. The angiogram 6-week follow-up revealed that the DAVF 
went through complete resolution; the clinical 6-week follow-up showed that the 
patient mental status returned to normal and her headache resolved [18].
6.2 Case 2
A rare case of dural arteriovenous fistula at the cranio-cervical junction 
presented as cerebellar hemorrhage, which made physicians struggle with the 
diagnosis. A 77-year-old woman came to the emergency department complain-
ing of dizziness, she had no history of arterial hypertension. A small cerebellar 
hemorrhage was revealed on imaging studies. Her diagnosis was hypertensive 
intracerebral hemorrhage and was treated conservatively. She developed subarach-
noid hemorrhage 4 months later, and imaging studies detected dural arteriovenous 
fistula at the left C1 dural sleeve. Intracerebral hemorrhage and subarachnoid 
hemorrhage both occurred because of the disruption of a distended cerebellar vein 
due to venous hypertension caused by the dural arteriovenous fistula. Surgical liga-
tion of a feeding artery and a draining vein was performed which cured the dural 
arteriovenous fistula [19].
6.3 Case 3
A report of delayed and progressive spontaneous closure of a DAVF after 
massive intracerebral hemorrhage documented by angiographic studies before and 
after bleeding. This is the first report to document gradual closure of a DAVF by 
serial angiographic studies. A 73-year-old woman who had an attack of general-
ized epileptic seizure was referred to a local hospital. Investigations like MRI and 
transfemoral cerebral angiography were done and revealed a DAVF Cognard type 
IIa + b of the left transverse sinus with feeders from the left occipital artery, left 
pharyngeal artery, left middle meningeal artery, and branches of the meningohy-
pophyseal artery. There was reflux into the cerebral veins and the ipsilateral sigmoid 
sinus was not filled. She had conservative treatment and was discharged home on 
antiepileptic medications 3 days after admission. Also, she was planned a future 
endovascular therapy. She was admitted 1 week later after an episode of severe 
headache. Her neurological examination showed that her pupils were asymmetric 
and she was somnolent. A large and disseminated intracerebral hemorrhage in 
the left temporal, occipital, and parietal lobes was revealed on CT that was done 
upon admission. Her hematoma was evacuated surgically and she went through 
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decompressive craniotomy 2 days later to treat her generalized brain edema and 
increased intracerebral pressure refractory to conservative therapy. The patient was 
sent for rehabilitation for hemiparesis and her recovery was slow. The DAVF closed 
completely 8 weeks after the hemorrhage. One year after the bleeding the patient 
was followed up, she was independent and had recovered but with mild aphasia and 
a slight hemiparesis on the right side [20].
7. Conclusion
Much has been learned in recent years about the pathoanatomy, pathophysiol-
ogy, natural history, and therapeutic options for DAVFs. A better understanding of 
these lesions has allowed more prompt and precise diagnosis, in addition, a realistic 
assessment of features predisposing to aggressive clinical course. Clinical symptoms 
other than hemorrhage and progressive neurological deficits rarely warrants aggres-
sive treatment of a DAVF, unless the lesion is particularly accessible or is associated 
with features predisposing to subsequent aggressive clinical behavior. Patient 
reassurance, symptomatic treatment, or palliative therapy is frequently sufficient. 
In DAVFs with features predisposing to an aggressive clinical course, a more defini-
tive treatment strategy should be adopted. It is obvious that the myriad of clinical 
manifestations of DAVFs and the wide spectrum of possible angiographic and 
pathophysiologic scenarios call for highly individualized management strategies. 
The diagnostic investigation should be thorough to identify DAVFs with features 
predisposing to aggressive clinical behavior such as retrograde and leptomeningeal 
CVD, associated aneurysms, or venous ectasia.
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Abstract
Moyamoya disease (MMD) is a rare disease affecting the cerebral vasculature 
of the central nervous system (CNS) with a reported incidence of 0.35–0.94 per 
100,000 populations. It was first reported from Japan and later from other parts of 
the world. The pathology is narrowing of blood vessels supplying anterior circula-
tion and rarely posterior circulation. It was believed that the disease is genetic in 
origin, but environmental factors also play a role. Patients with this rare disease 
may present with ischemic or hemorrhagic symptoms. Ischemic symptoms account 
for the disease in most of the pediatric patients, whereas in adults, hemorrhage is 
more common. Diagnostic imaging like CT angiogram and magnetic resonance 
angiogram helps in demonstrating the narrowing or the collateral vessels like “a 
puff of smoke” (moyamoya) formed at the base of the brain. Moyamoya disease is 
treated medically and/or surgically. Aspirin is the main medication used. Surgical 
options are direct or indirect revascularization techniques to bypass the stenosis. 
The disease is progressive in majority of the patients, but if treated early, they can 
have good prognosis especially children.
Keywords: moyamoya, vascular, CNS, MMD, MMS
1. Introduction
Moyamoya disease (MMD) is a rare disease of the central nervous system 
(CNS). It was first reported in Japan in the year 1957 and later reported from other 
Asian countries. “Moyamoya” in Japanese means “a puff of smoke” alluding to the 
characteristic angiographic appearance of the collateral circulation in the brain of 
the patient with moyamoya disease [1]. It can present either as an isolated condition 
(moyamoya disease) or as a part of a syndrome associated with other conditions. In 
the latter case, it is called moyamoya syndrome (MMS). Moyamoya disease usually 
manifests bilaterally [2], and moyamoya syndrome manifests, unilaterally, to begin 
with, which may progress to become bilateral disease [3].
2. Etiology
Ten to fifteen percent of moyamoya disease (MMD) is familial in origin which indi-
cates a genetic association. East Asian populations with RNF213 gene on chromosome 
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17q25.3 are susceptible to MMD [4]. In another report from Japan, it was observed that 
a variant of RNF213 (c.14576G) was present in 41 patients with familial MMD (95%), 
163 patients with sporadic MMD (79%), and 283 normal control subjects (2%) [5]. In 
a study in Chinese Han population, Wu et al. demonstrated that mutations in RNF213 
gene were associated with increased susceptibility to MMD. In further analysis, they 
observed that ischemic MMD was related to the R4810K mutation, and hemorrhagic 
MMD was associated with the A4399T mutation [6]. Mineharu et al. suggested that 
MMD is an autosomal dominant disease with incomplete penetrance [7]. Inoue et al. 
observed that different alleles of genes of HLA antigen have been found to be associ-
ated with MMD [8]. Several inducers of angiogenesis such as fibroblast growth factor, 
transforming growth factor beta1, and hepatocyte growth factor which promote 
neovascularization were found in high levels in patients with MMD [9–11].
Moyamoya syndrome (MMS) is a different entity when the disease is associated 
with some other conditions such as [12]:
1. Atherosclerosis
2. Infectious diseases: meningitis and other viral or bacterial infections
3. Hematologic conditions: sickle cell disease, beta thalassemia, Fanconi anemia, 
hereditary spherocytosis, homocystinuria and hyper-homocysteinemia, factor 
XII deficiency, essential thrombocythemia
4. Vasculitis and autoimmune diseases: systemic lupus erythematosus, pol-
yarteritis nodosa postinfectious vasculopathy, Graves’ disease thyroiditis, 
Sneddon syndrome, antiphospholipid antibody syndrome, anti-Ro and anti-La 
antibodies
5. Type 1 diabetes mellitus
6. Connective tissue disorders and neurocutaneous syndromes: neurofibroma-
tosis type 1 (NF1), tuberous sclerosis, Sturge-Weber syndrome, phakomatosis 
pigmentovascularis type IIIb, hypomelanosis of Ito, pseudoxanthoma elasti-
cum, Marfan syndrome, chromosomal disorders
7. Chromosomal disorders: down syndrome, turner syndrome, Alagille 
syndrome
8. Other vasculopathies: vasospasm after subarachnoid hemorrhage, radiation 
therapy to the base of the brain, fibromuscular dysplasia
9. Other extracranial cardiovascular diseases: congenital heart disease, Williams 
syndrome, coarctation of the aorta, renal artery stenosis
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15. Hereditary multisystem disorder with short stature, hypergonadotropic 
hypogonadism, and dysmorphism
16. Polycystic kidney disease
There are reports of identical twins with only one among them affected by 
MMD, which question the genetic basis and focus on environmental factors for the 
condition [13].
3. Epidemiology
Although originally reported in the Asian population, moyamoya disease has 
also been reported from Europe and America [1].
In an epidemiological study by Baba et al. [14], MMD was found to have the 
following characteristics in the Japanese population:
• Annual incidence of 0.35–0.94 per 100,000 populations
• A prevalence of 3.2–10.5 per 100,000 populations
• A male-to-female ratio of 1:1.8–1:2.2 reflecting a female predilection
• A family history of MMS in 10.0–15.4% of patients
Although the reported incidence of MMS from Washington and California was 
as low as 0.086 per 100,000 populations generally, in ethnic groups, it was found to 
be as high as 0.28 per 10,000 populations close to the incidence in Japan [15].
MMS shows a bimodal distribution in the Chinese population with a major peak 
in the 5–9-year-old group and another peak in the 35–39-year-old group [16]. In 
the Japanese population, there are two conflicting reports of higher peaks, one in 
childhood and another in adults [14, 17].
4. Clinical presentation
Patients affected by MMD present with ischemia like transient ischemic attack 
(TIA) and stroke and seizures or with intraparenchymal bleeds due to the rupture 
of fragile collateral vessels formed to compensate for the ischemia. They may also 
present with headache due to dilated transdural collateral blood vessels. A 2012 
systematic review of population-based studies by Kleinloog et al. found that the 
predominant mode of presentation was ischemia, especially in children [18]. 
Ninety percent of children present with stroke and 7.5% present with TIA as per 
International Pediatric Stroke Study published in 2017 [19]. In children, exercise, 
crying, coughing, straining, fever, or hyperventilation can trigger symptomatic 
episodes of ischemia.
Adult patients in Japan with MMS mostly present with hemorrhagic stroke in 
some old reports [20] in contrast to patients from the United States in whom the 
ischemic stroke was found to be more common [21]. In a study done on 88 Korean 
patients, 45% of them had only a single ischemic or hemorrhagic stroke, 55% recur-
rent attacks mostly ischemic, and 64% of them presented with hemiplegia [22].
Ischemic symptoms of MMD are typically associated with the anterior circula-
tion regions like frontal, parietal, and temporal lobes supplied by internal carotid 
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(ICA) and middle cerebral artery (MCA). Commonly the symptoms are hemipare-
sis, dysarthria, aphasia, and cognitive impairment [23]. Some patients may present 
with seizures, defective vision, syncopal attacks, or personality changes and can 
mimic psychiatric disorders [24]. Surgical patients undergoing minor procedures 
under anesthesia may present with perioperative stroke due to hyperventilation-
induced cerebral vasoconstriction of the already compromised cerebral vasculature 
of the ischemic penumbra [25]. Patients with MMD can develop cerebral aneurysms 
at the tip of the basilar artery and the posterior communicating artery and present 
with subarachnoid hemorrhage [26].
Choreiform movements are another group of symptoms with which children 
can present due to the moyamoya-associated dilated collateral vessels in the basal 
ganglia [27]. Occasionally a characteristic ophthalmologic finding is seen in associa-
tion with MMD identified as “morning glory disk,” an optic disk enlargement with 
concomitant retinovascular anomalies [28].
5. Pathophysiology
In patients with this condition, large intracerebral arteries show a variable degree 
of stenosis and occlusions. Vascular intima shows fibrocellular thickening; elastic 
internal lamina will be tortuous, duplicate or triplicate; and the media show attenua-
tion. Vessels may be dilated and thin-walled or thick-walled and stenosed in different 
regions. The hallmark of MMD is the meshwork of dilated vessels called moyamoya 
vessels (Figure 1). Aneurysms can form in some parts of cerebral vasculature as well.
6. Diagnostic radiology
Diagnosis can be established by invasive and semi-invasive radiological studies. 
At the bedside, transcranial Doppler (TCD) can detect stenosis of major arter-
ies. Conventional CT or MRI helps to detect ischemic and hemorrhagic signs of 
MMD. CT angiography and conventional angiography are important to establish the 
exact point of narrowing in the circle of Willis.
Figure 1. 
Pathophysiology of moyamoya disease (modified from [29]).
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Suzuki and coworkers studied the angiographic progression of MMD and identi-
fied six stages (Table 1) of progression [1, 2].
This staging neither correlates with disease severity nor allows therapeutic risk 
stratification.
6.1 CT head
Cortical and/or subcortical infarction can be seen in the early stages, but in the 
later stages, dilatation of sulci or ventricles due to loss of volume can be seen. In a 
retrospective case series of 32 patients by Kim et al. [30], early stages (stages 1 and 
2 of MMD) had mainly subcortical ischemic changes, whereas later stages (stage 3 
and above) had cortical ischemic changes.
6.2 Magnetic resonance imaging
Diffusion and perfusion MR techniques are superior to CT scan for detection of 
subtle ischemic brain lesions especially in the acute condition. MRI was sensitive to 
detect watershed infarction in 50% of children as per a study done in Canada [31]. 
Dilated collateral vessels at the base of the brain are considered pathognomonic of 
MMD but seen only in some cases. In T2 sequences asymptomatic microbleeds may 
be seen. FLAIR images and T1 sequences may show a characteristic sign called ivy 
sign as in Figure 2 (a linear pattern of increased signal in the leptomeninges and 
perivascular spaces) [33]. This is due to retrograde flow in leptomeninges resem-
bling ivy creeping a stone. Magnetic resonance angiography (MRA) has surpassed 
conventional angiography in some centers as the primary imaging method although 
the latter is still considered as the gold standard.
6.3 Angiography
Conventional cerebral angiography is the gold standard for the diagnosis of MMD 
as it can clearly demonstrate the stenotic vessels in the anterior circulation as well as 
the collateral tuft of vessels formed (Figure 3). Apart from this, the small aneurysms 
which may be associated with MMD also can be detected in cerebral angiography.
Stage Characteristics
Stage 1 • Narrowing of carotid fork only
• Narrowed ICA bifurcation
Stage 2 • Initiation of basal moyamoya
• Dilated ACA, MCA, and narrowed ICA bifurcation with moyamoya change
Stage 3 • Intensification of the “moyamoya”
• Further increase in moyamoya change of the ICA bifurcation and narrowed ACA and MCA 
together with the reduction of flow
Stage 4 • Minimization of moyamoya vessels
• Moyamoya change reducing with occlusive changes in ICA and tenuous ACA and MCA
Stage 5 • Reduction of moyamoya
• Further decrease in moyamoya change with occlusion of ICA, ACA, and MCA (no flow)
Stage 6 • Disappearance of moyamoya vessels
• The cerebral circulation is supplied only by the external carotid system
Table 1. 
Suzuki staging system for moyamoya.
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Figure 2. 
FLAIR sequence showing ivy sign (modified from [32]).
Figure 3. 
Characteristic “puff of smoke” appearance in cerebral angiography.
6.4 Transcranial Doppler (TCD)
Stenosed vessels will have increased flow velocity proportional to the degree of 
stenosis, which can be detected noninvasively by TCD.
6.5 Electro encephalogram (EEG)
A specific pattern of hyperventilation-induced diffuse monophasic slow waves 
called “build-up” and post-hyperventilation “rebuild-up” waves similar to build-up 
waves in patients without MMD may be observed in patients with MMD [34].
153
Moyamoya Disease: A Rare Vascular Disease of the CNS
DOI: http://dx.doi.org/10.5772/intechopen.88770
Perfusion CT, xenon-enhanced CT, perfusion-weighted MRI, positron emission 
tomography (PET), and single-photon emission CT (SPECT) with acetazolamide 
challenge are other modalities rarely used in diagnosis [12].
7. Diagnostic criteria for MMD
A Japanese research group has put forward the following diagnostic criteria for 
the diagnosis of MMD [35]:
• Stenosis or occlusion at the terminal portion of the internal carotid artery 
and at the proximal portion of the anterior and middle cerebral arteries 
on  magnetic resonance angiography (MRA).
• Abnormal vascular networks in the basal ganglia on MRA; these networks can 
also be diagnosed by the presence of multiple flow voids on brain MRI.
• Bilateral angiographic findings; although unilateral angiographic findings 
are considered probable.
• Conditions to be excluded:
 ○ Arteriosclerosis
 ○ Autoimmune disease
 ○ Brain neoplasm
 ○ A history of cranial irradiation
 ○ Down syndrome
 ○ Head trauma
 ○ Neurofibromatosis
 ○ Meningitis
8. Treatment of MMD
In the acute stage, treatment is symptomatic for those patients with ischemic or 
hemorrhagic stroke as per acceptable guidelines. It should be focused on treating 
elevated intracranial pressure, evacuation of hematoma, draining intraventricular 
hemorrhage by external ventricular drain (EVD), control of seizures, glycemic 
control, and treatment of fever.
In children diagnosed with MMD, crying and hyperventilation should be 
avoided as it can induce cerebral vasoconstriction. Pain management also should be 
taken care of. Supplemental oxygen also helps in avoiding hypoxia. Generally, hypo-
tension, hyperthermia, hypoxia, hypocarbia, and hypovolemia should be avoided.
There are no interventions proved to improve outcome in MMD. The utility 
of thrombolysis has not been studied yet and may be risky due to the possibility 
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of development of hemorrhage from the fragile collateral vessels [36]. Aspirin 
has been recommended by the American College of Chest Physicians (ACCP) for 
children with ischemic stroke [37].
There were no significant differences in outcome between medically and 
surgically treated patients with MMD as per a large survey from Japan, but a later 
review revealed that 38% of 651 patients with MMD who initially underwent 
medical management ultimately had to go for surgery because of progressive 
symptoms [38].
8.1 Secondary stroke prevention
Treatment of underlying diseases like sickle cell disease is helpful in second-
ary prevention. Surgical revascularization is the mainstay of secondary preven-
tion. Antiplatelet medications like aspirin have an important role in preventing 
stroke in mild disease or asymptomatic patients who are at high risk for surgery 
[39]. Oral anticoagulants are not helpful as they can increase the chance of hem-
orrhage. Calcium channel blockers were used in some reports [40]. Endovascular 
embolization has been used for the obliteration of aneurysm associated  
with MMD.
9. Surgical management of moyamoya disease
The aim of surgical management of moyamoya disease is to vascularize and 
restore the blood supply by bypassing the stenosed area. It will stabilize the cere-
brovascular hemodynamics. It prevents bleeding by preventing the progression of 
the thin moyamoya vessels. Improvement and or normalization of cerebral hemo-
dynamics by the surgical intervention will also prevent secondary stroke prevention 
and improve the neurological and neurocognitive outcome.
Revascularization surgery is the most effective treatment for hemorrhagic MMD 
[41] and can be effective in preventing future stroke events in adults [42].
The main indications for the surgical interventions are cerebral hemodynamic 
impairment and repeat ischemic symptoms. The severity of the disease to assign 
a patient for surgical intervention can be made by the Berlin moyamoya grading 
system (Table 2). But the literature has not mentioned the severity at which there is 








Steno-occlusive lesion + extracranial compensation 
routes
3
MRI No signs of ischemia, hemorrhage, or atrophy 0
Signs of ischemia, hemorrhage, or atrophy 1
Cerebrovascular reserve 
capacity
No steal phenomenon (≥5%) 0
Steal phenomenon (<5%) 2
Table 2. 
The Berlin moyamoya grading [43].
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10. The Berlin moyamoya grading
It incorporates digital subtraction angiography (DSA), MRI, and cerebrovascu-
lar reserve capacity (CVRC) which gives the information of the functional cerebro-
vascular assessment of hemodynamic impairment [43].
It was proposed by Czabanka et al. According to the grading system, there are 
three grades:
1. Grades 1–2: mild
2. Grades 3–4: moderate
3. Grades 5–6: severe
11. Indications for surgical revascularization
Patients with ischemic symptoms and progressive disease with impairment in 
cognition benefit from surgical revascularization methods. It can be achieved by 
direct and indirect methods.
11.1 Direct surgical treatment
A branch of the external carotid artery is connected to the branch of the internal 
carotid artery beyond the stenosis to bypass the stenosed segment. Superficial tempo-
ral artery to middle cerebral artery (STA-MCA) (Figure 4) bypass is the commonly 
used technique [45]. Other less common direct techniques are STA-ACA, STA-PCA, 
and occipital artery-PCA anastomosis. These direct techniques are used when an 
immediate recirculation is indicated. The major drawback is that this cannot be easily 
done in children with MMD because of the smaller size of donor and recipient arteries.
11.2 Indirect surgical treatment
In this technique, a vascularized tissue supplied by the external carotid artery 
(e.g., dura, temporalis muscle, or the superficial temporal artery itself) is placed in 
direct contact with the brain surface, which results in ingrowth of new blood vessels 
to the underlying cerebral cortex (Figure 5). In this technique, good cerebral blood 
flow is established after a few weeks and so not suitable for emergency cases [46], 
but good for pediatric patients with MMD because of the lower technical difficulty. 
The following are the options for indirect revascularization [47]:
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• Craniotomy with inversion of the dura
• Multiple burr holes without vessel synangiosis
• Cervical sympathectomy
Figure 5. 
Indirect bypass procedure of indirect bypass procedure: dissected temporal muscle on the brain surface 
(modified from Acker et al. [44]).
Figure 4. 
Direct bypass procedure of superficial temporal artery (STA) and M3 branches of the middle cerebral artery 
(MCA) (modified from Acker et al. [44]).
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11.3 Combined techniques
Houkin et al. first performed a combined revascularization surgery. It com-
bined the superficial temporal artery and M3 branches of the middle cerebral 
artery (STA-MCA) bypass and encephalo-duro-arterio-myosynangiosis (EDAMS) 
(Figure 6). The aim of the combined procedure is to improve the results to serve as 
an alternative in case the direct bypass fails and prevents second surgery. The direct 
bypass immediately improves the hemodynamics [44]. A 2005 systematic review 
from Japan compared direct, indirect, and combined techniques and found that 
there is no statistically significant difference between all these techniques in terms 
of outcome during 58 months of follow-up period [48]. Efficacy of medical and 
surgical management was also compared in a large survey conducted in Japan and 
concluded that there is no significant difference between the two [49]. However, in 
another study, it was found that children initially underwent medical therapy had to 
ultimately go for revascularization surgery more than the children who underwent 
surgery in the first instance [38].
11.4 The complication of the surgical revascularization
Surgical revascularization is not risk-free. This can range from a transient 
increase in intracranial pressure resulting in headache, seizures, and reversible neu-
rological deficits to perioperative stroke. The mechanism is cerebral hyperperfusion 
syndrome because of the revascularization-induced hyperperfusion of the area 
supplied by the chronically vasoconstricted blood vessels, where the autoregulation 
is impaired. Incidence of this phenomenon was found to be up to 47% [50].
Figure 6. 
Combined revascularization procedure. The temporal muscle is positioned on the brain surface, and the STA is 
a bypass graft to the M3 branch of MCA (modified from Acker et al. [44]).
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All adults and children with ischemic MMD or MMS should have aspirin for 
a long term. If there are no contraindication and significant ischemic symptoms, 
surgical revascularization is a reasonable option [47]. AHA guidelines recommend 
it for patients with compromised cerebrovascular perfusion according to blood flow 
studies [39]. As mentioned before there is no evidence for opting for direct or indi-
rect revascularization or vice versa, though the latter is preferred in the pediatric 
age group. Evidence for postoperative use of aspirin is limited. In a recent retrospec-
tive study, patients treated with postoperative aspirin had better outcome [44, 51].
12. Prognosis
Prognosis depends on how fast the blockage occurs and how effective the col-
lateral circulation is established. Fifty to sixty-six percent of patients will have the 
progression of the disease, and they have a poor outcome. Pediatric patients who 
were surgically treated were found to have disease progression in an estimated 2.6% 
of patients only. Among untreated asymptomatic patients, the annual stroke rate 
was found to be 3.2% and disease progression in 80% [52, 53].
© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
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provided the original work is properly cited. 
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Abstract
Spinal epidural haematomas (SEH) occur from extra-dural bleeding, most 
commonly after trauma, epidural anaesthesia or operative intervention. However, 
these also occur in arterio-vascular malformations or spontaneously without an 
obvious inciting event. Spontaneous spinal epidural haematomas (SSEH) are rare, 
with a quoted incidence of 0.1 cases per 100,000 population annually. However, 
these haematomas carry a significant risk of spinal cord or nerve root compression 
potentially resulting in permanent neurological dysfunction or death. This chapter 
reviews the presentation, diagnosis and treatment of SSEH in adults, pregnancy 
and children in order to provide clinicians with an understanding of their typical 
presentation, required investigations and treatment algorithms.
Keywords: epidural, haematoma, spine
1. Introduction
Spinal epidural haematomas (SEH) occur from extra-dural bleeding, most 
commonly after trauma, epidural anaesthesia or operative intervention [1, 2]. These 
haematomas are rare but carry a significant risk of spinal cord or nerve root compres-
sion potentially resulting in permanent neurological dysfunction and death [3, 4].
Spontaneous spinal epidural haematomas (SSEH) occur without an obvious 
inciting event, although they may be associated with vascular malformations of 
the spinal canal. These haematomas are rare with a quoted incidence of approxi-
mately 0.1 cases per 100,000 population annually [5–7]. When they occur they 
often mimic other conditions such as cerebro-vascular accidents [8, 9], which may 
make them a difficult condition to diagnose, resulting in a delayed diagnosis and 
potentially mismanagement with anticoagulation therapy [9, 7, 10]. However, the 
consequences of SSEH can be devastating with progressive neurological decline, 
permanent cord injury and even death [3, 11, 12]. Thus, early and accurate diagno-
sis and management is essential to preserve neurological function and optimise the 
chance of recovery [13].
The aims of treatment in SSEH are to restore normal neurological function with 
minimal risk to the patient, however the method of achieving this remains uncertain 
[13]. Surgical decompression, typically through a partial or complete laminectomy or 
laminoplasty, allows direct decompression of the neural elements and evacuation of 
the haematoma but carries both anaesthetic and surgical risk. Less invasive options 
include radiologically guided aspiration of the haematoma, however this also carries 
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risks of neural injury and further bleeding, often without complete evacuation of the 
haematoma. Medical therapy with steroids and/or pro-coagulation therapy is aimed at 
reducing local swelling and preventing further bleeding but fails to remove the com-
pressive effects of the haematoma. Similarly, embolisation of the bleeding vessel may 
prevent further bleeding, but fails to remove the haematoma. The treatment approach 
is therefore complex and depends on the patient’s presentation. Three defined groups 
of patients where the management varies are adults, pregnant women and children.
2. Adults
2.1 Demographics and risk factors
SSEH can affect all adult age groups, but most reported cases are aged between 50 
and 80 years [14]. There is no obvious gender association, although pregnancy is an 
independent risk factor [14]. In most adult patients no known risk factors are identified, 
but according to the most recent review 19% had hypertension, 14% had cardiovascular 
disease, 3% had bleeding disorders and 6% had diabetes or obesity [14]. Interestingly, 
bleeding disorders did not specifically affect a younger population, but as expected 
by their cumulative medical comorbidities, patients on anticoagulation therapy were 
generally older. The most common anticoagulants identified in adults with SSEH were 
Warfarin (43.9%), Aspirin (36.8%) or Clopidogrel (10.5%).
2.2 Clinical presentation
At presentation, most adults (98%) complain of back and radicular pain [14]. 
Most haematomas reported in the literature cause spinal canal compression with 
severe caudal motor (58% Medical Research Council grade 0) and sensory dys-
function (70% American Spinal Injury Association (ASIA) A-C) [14]. In contrast, 
relatively few patients presented with compression of a nerve root in the neuro-
foramen, and in these cases most patients (63%) maintain normal or near normal 
motor (70% MRC grade 4 or 5) and sensory function (63%) [14].
Of concern, up to 15% of adults with SSEH are suspected of having an alterna-
tive diagnosis, half of which are thought to be affected by an ischaemic incident for 
which anticoagulation therapy is considered or administered. The most common 
diagnoses that SSEH mimic are cerebro-vascular accidents (CVA), myocardial 
infarctions, spinal tumours and disc prolapses. Thus, clinicians should be aware of 
this condition and its ability to mimic alternative diagnoses, prior to considering 
anticoagulation therapy.
2.3 Investigations
The diagnosis is easily confirmed on cross-sectional imaging, most com-
monly an MRI scan or CT myelogram. An MRI is preferential as it offers a clear 
localisation and cause of compression (Figure 1). In contrast to a CT which 
accurately localises compression but is less accurate in determining the underly-
ing cause (Figure 2).
In adults most SSEH affect the cervico-thoracic region between C3 and T3. This 
is attributed to this region being the only area of the spinal canal with a compact 
continuous epidural venous network [15]. These haematomas can be large and 
affect up to 28 spinal levels, with the average number of levels affected being 
5.4 vertebral levels. Furthermore, although rare, multi-site haematomas can occur, 
therefore whole spine imaging is advocated.
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2.4 Treatment
The gold standard of treatment for patients with SSEH and neurological dysfunc-
tion is expeditious surgical decompression. However, in patients with no neurology 
or with improving neurology, non-operative treatment with close neurological 
monitoring is the treatment of choice. There is no evidence to support operative 
intervention based on the presence of back pain or the size of the haematoma, rather, 
neurological dysfunction guides the decision to operatively intervene. In patients 
with a bleeding tendency, systemic pro-coagulant therapy should also be used.
With this approach to treatment, 85% of patients can be expected to make 
a complete or partial recovery [14]. This recovery is usually rapid, but in some 
patients this may take a number of years, which results in a reported average time to 
Figure 1. 
A T1 (a), STIR (b) and GRE (c) sagittal MRI sequence of a C4–6 SSEH compressing the spinal cord.
Figure 2. 
A sagittal non-contrast CT scan of a C2–6 SSEH compressing the spinal cord.
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recovery of 52.4 days [14]. These outcomes are unrelated to patient age, sex, haema-
toma size or location.
According to the current literature, 5% of patients worsen their neurological 
function despite treatment and the mortality rate is 3.5% [14]. The most common 
cause of death is cardiac disease rather than neurological dysfunction from SSEH.
3. Pregnancy
Unlike in the general population, SSEH carry the additional concern for the 
well-being of the foetus. Thus, the goal of treatment is to restore normal neurologi-
cal function to the mother, but with minimal risk to the foetus [13].
Like the general adult population, the treatment options include surgical decom-
pression, but this carries surgical and anaesthetic risks; radiological aspiration with 
or without embolisation, but this too carries anaesthetic risks, rarely evacuates the 
haematoma completely, risks neuro-vascular injury and exposes the mother and 
foetus to radiation; or chemotherapy with steroids and/or coagulation therapy, but 
this fails to remove the compressive effects of the haematoma and requires systemic 
administration of the drug. Thus, the treatment approach is complex and requires 
consideration of both the mother and foetus.
3.1 Demographics and risk factors
In pregnancy, an increased blood volume and pressure predisposes to rupture of 
vascular walls and therefore SSEH [16]. Thus, it is rare for SSEH to occur in the first tri-
mester but the risk increases with the duration of pregnancy with an average gestational 
age of 34.3 weeks being reported in the literature [17]. No cases have been reported dur-
ing labour, although some have been reported in the days and weeks following delivery, 
which suggests that the pregnancy-induced dilation of epidural vessels, rather than the 
mechanical straining of labour, is the predominant cause of SSEH in pregnancy.
There does not appear to be a relationship between the gravid status and the 
risk of SSEH [17]. Furthermore, most patients do not have any known risk factors, 
although pre-eclampsia has been reported in two cases. No pregnant patients with 
SSEH have been reported to be on anticoagulation therapy [17].
3.2 Clinical presentation
Like the general population, patients present with back or neck pain, usually 
with neurological dysfunction [17]. Within the English literature, most patients 
have severe spinal cord dysfunction with gait disturbance, caudal weakness and 
sensory disturbance. Only one reported patient has presented without neurological 
dysfunction [17].
3.3 Investigations
In pregnancy, limited radiation exposure to the foetus is necessary, thus an MRI 
is the investigation of choice. No patients have been reported to have had a CT scan, 
although, if an MRI is not possible and the diagnosis is critical then a CT or CT 
myelogram is necessary with protection of the pelvis [7].
Like the general adult population, the typical location of the SSEH is the 
cervico-thoracic region [17]. The size of the haematoma has been reported to span 
two to six spinal levels [17].
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3.4 Treatment
In mothers with neurological dysfunction and less than 32 weeks of gestation,
surgical decompression with foetal monitoring is advocated. In contrast, in 
mothers with neurological dysfunction and more than 32 weeks of gestation, a cae-
sarean section followed by surgical decompression is advocated. Like in the general 
population, neurological dysfunction guides surgical intervention, not the presence 
of back pain or the size of the haematoma. Thus, in mothers without neurological 
dysfunction, close monitoring without surgical intervention is appropriate [17]. 
With such treatment most mothers are expected to make a complete (56%) or 
partial (38%) recovery.
4. Children
SSEH can occur in children. However, in contrast to adults the difficulty 
conversing with children and attaining investigations, such as cross-sectional 
imaging, makes the diagnosis difficult. In addition, their rarity and occasional 
atypical presentations mimicking alternative diagnoses compounds the chal-
lenges of diagnosis [9, 8]. Yet, the consequences of this condition can be 
devastating.
4.1 Demographics and risk factors
Children of all ages (range 3 months - 18 years) have been identified with SSEH 
[18]. There does not appear to be a gender relationship to the risk of developing 
SSEH, however bleeding tendencies, such as haemophilia, which do construe a 
risk (8% of reported cases), are clearly more common in males [18]. One case was 
reported to be on anti-coagulation therapy and two have been reported to have an 
arterio-venous malformation.
4.2 Clinical presentation
Due to the variance in patient age, young children cannot report the location 
of pain, however, in those that are conversant most complain of back or neck pain, 
with radicular pain being less common [18]. Similarly, the neurological dysfunc-
tion, particularly sensory disturbance, is harder to define than in an adult popula-
tion. However, most children are affected by neurological dysfunction (97%), most 
commonly spinal cord dysfunction, although isolated nerve root dysfunction is also 
reported [18].
Nearly one third of all reported cases are initially suspected of having an alter-
native diagnosis, most commonly Guillain-Barre syndrome, meningitis, cerebral 
palsy, Grisel’s syndrome or an acute abdomen [18].
4.3 Investigations
A whole spine MRI scan is the investigation of choice. A CT myelogram or non-
contrast CT may be required depending on the patient’s compliance and compat-
ibility with an MRI scan, although the ionising radiation risk should be recognised 
and exposure limited.
As with adults the typical location of these haematomas are the cervico-thoracic 
region, and the size of the haematoma may span one to 22 spinal levels [18].
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4.4 Treatment
Similar to adults, neurological dysfunction determines surgical intervention, 
not the presence of back pain or the size of the haematoma. Thus, in patients with 
neurological dysfunction, the gold standard treatment is surgical decompression 
and evacuation of the haematoma. The surgical approach to achieve this depends 
on the haematoma size, location, consistency and surgeon familiarity. While partial 
or complete laminectomies as well as laminoplasties have been reported, the conse-
quences of each approach on the long-term consequences on spinal growth and func-
tion in these patients remain unknown. Thus, the least invasive approach to achieve 
decompression and haematoma evacuation should be utilised, but patients should 
also be counselled of the longer-term risks that surgical intervention may impose.
In patients without neurological dysfunction or with improving neurology, 
non-operative care with close neurological monitoring is appropriate. In patients 
with a bleeding tendency, systemic pro-coagulant therapy should be initiated, and 
if neurological improvement rapidly occurs, then non-operative treatment should 
be continued, but if no improvement occurs, then surgical intervention should be 
undertaken [18].
With this approach most children (83%) are expected to make a complete (69%) 
or partial (14%) neurological recovery [18]. However, this condition can result in 
death, with two children having been reported to have died following a SSEH. One 
child died from respiratory failure after operative intervention and the other with-
out a cause for death being defined, but with evidence of progressive neurological 
dysfunction after surgical decompression [3, 4].
5. Vascular malformations
While most SSEH are believed to occur in the absence of local vascular malforma-
tions, there remains debate as to the number of these haematomas that have a predis-
posing vascular pathology, most notably arterio-venous fistulas, malformations and 
aneurysms. This is predominantly due to a poor specificity of initial imaging modali-
ties to identify small vascular pathologies in the presence of a epidural haematoma, 
the rarity of sending pathological specimens of the local vasculature for histological 
assessment and the lack of follow-up imaging. However, local vascular pathologies 
have been identified in spinal epidural haematomas that develop without an inciting 
event in all age groups, although it is more commonly reported in children [18].
Clearly, an area of vascular fragility, due to an underlying malformation can 
predispose to spontaneous bleeding. The location of the subsequent haematoma 
from the bleed depends on the location of the vascular disruption. In the case of 
an epidural haematoma, the pressure exerted on the neural structures may cause 
neurological dysfunction for which the treatment is the same as that of a SSEH. If 
surgical intervention is necessary then coagulation of the vascular anomaly at the 
time of surgery to prevent further bleeding is necessary. This is often inadvertently 
performed during the coagulation manoeuvres undertaken to stop bleeding at the 
time of surgery. Fortuitously, this typically treats the underlying vascular pathology 
and avoids recurrence.
6. Summary
To date, the major limitations of the literature reporting on SSEH are the low 
numbers, publication bias, the variance in imaging and reporting of vascular 
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malformations and the lack of randomised control trials assessing outcome. 
However, it is clear that all age groups can be affected by SSEH and that three 
subsets of patients exist, namely adults, pregnant women and children.
In all groups, SSEH can present with variable symptoms and signs but most 
have neck or back pain with neurological dysfunction. In adults, SSEHs can mimic 
ischaemic events and lead to inappropriate anticoagulation therapy, which can be 
avoided by clinical awareness of this condition and whole spine cross-sectional 
imaging. Similarly, in children the diagnosis can be challenging due to the problems 
conversing with children and the variable presentations, often mimicking neuro-
muscular disorders. It is further compounded by the challenges of attaining cross-
sectional imaging, which is again diagnostic. In pregnancy, the further difficulties 
lie in the protection of the unborn foetus, with the avoidance of ionising radiation, 
but cross-sectional imaging remains diagnostic.
In all groups, most SSEH affect the cervico-thoracic region and span multiple 
spinal segments. The gold standard of treatment for patients with neurological 
dysfunction is surgical decompression and haematoma evacuation. However, in 
patients without neurological dysfunction, close neurological monitoring without 
surgical intervention is appropriate. In adults with bleeding disorders, pro-
coagulant therapy should be used as an adjunct to treatment, however in children 
with bleeding disorders pro-coagulant therapy may be trialled prior to surgical 
intervention. In pregnancy, surgical intervention involves surgical decompression 
with foetal monitoring in those of gestational age less than 32 weeks and a cae-
sarean section followed by decompression in those of gestational age greater than 
32 weeks. In children, the long-term effect of surgical intervention on spinal growth 
and function should be recognised.
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